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Abstract 
The prenylated indole alkaloids are a large family of natural products that have been isolated from various 
marine and terrestrial strains of Penicillium, Aspergillus and Malbranchea fungi. These compounds 
possess complex polycyclic structures including a characteristic bicyclo[2.2.2]diazaoctane core and have 
displayed wide-ranging biological activities. Chapter 1 gives an introduction to the prenylated indole 
alkaloids and important synthetic strategies to the key bicyclic core. Also included in this Chapter is an 
overview of previous work from our research group towards members of the natural product family as 
well as more recent work focused on asymmetric organocatalytic reactions of related diketopiperazines 
and triketopiperazines. 
Recent work showed that triketopiperazines will undergo highly enantioselective Michael-additions and 
Michael addition–ring-closure reactions, efficiently generating compounds possessing the 
bicyclo[2.2.2]diazaoctane core found in the natural products. Chapter 2 discusses the extension of previous 
methodology towards a bicyclic triketopiperazine derived from proline including its synthesis and 
successful implementation in asymmetric Michael additions. 
Chapter 3 then explores the Michael addition–ring-closure of the proline derived triketopiperazine which 
was found to give highly enantioselective and high yielding access to hydroxy diketopiperazines 
possessing the key bicyclo[2.2.2]diazaoctane. The Chapter also contains further transformations towards 
the natural product scaffold including a radical Barton-McCombie deoxygenation. 
Chapter 4 focusses on a novel Michael–Michael cascade strategy for the synthesis of molecules possessing 
the bicyclo[2.2.2]diazaoctane core of the prenylated indole alkaloids. 
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Chapter One – Introduction to the Prenylated Indole Alkaloids  
Isolation and Background 
The prenylated indole alkaloids are a large and structurally diverse family of natural products that have 
been isolated from various marine and terrestrial strains of Penicillium, Aspergillus and Malbranchea 
fungi.1 These mycotoxins generally possess a characteristic bicyclo[2.2.2]diazaoctane core, in the form of 
a bridged diketopiperazine (DKP) or partially reduced variant. The complex polycyclic structures and 
varied biological activities have been significant in the continued research interest of these compounds.2 
Since the isolation of brevianamide A 1 in 1969 by Birch and co-workers, over 80 members of the 
prenylated indole alkaloid family have been reported with taichunamide A 9 and peniciherquamide A 10 
being recent examples (Figure 1).3–5 
 
Figure 1 – Examples of prenylated indole alkaloids 
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Over eight different families of secondary metabolites possessing the bicyclo[2.2.2]diazaoctane core have 
been reported and members can be more generally grouped as having either spiro or fused skeletons as 
shown by brevianamide A 1 and malbrancheamide 4 respectively.1 The prenylated indole alkaloids 
display complex structural diversity as demonstrated by the examples above, for instance brevianamide A 
and B (1 and 2) are enantiomorphic with respect to the bridged DKP core but the stereochemistry of the 
spiro-oxindole moieties are consistent. Additionally, other members of the family have been isolated from 
different fungal strains in either enantiomeric series, such as notoamide B 7.6 Other areas of 
stereocomplexity include C-6 which can be either syn- or anti- to the pyrrolidine nitrogen, and the presence 
of functionalised pyrrolidine rings as in paraherquamide A 3. Modified indoles, or oxindoles, are also 
found with chlorinated examples such as malbrancheamide and malbrancheamide B (4 and 5) or with a 
pyran or 7-membered ring as in notoamides 6–8 and paraherquamide A 3 respectively.7–9 
Related natural product families include the marcfortines 11–12 and chysogenamide A 13, that bear a 
piperidine ring derived from pipecolic acid, or methylated piperidine, rather than the usual proline derived 
pyrrolidine fused structures. Additional related natural products include the asperparilines, 14 and 15, 
which possess a spiro-succinimide rather than an indole or oxindole moiety (Figure 2).10–12 
 
Figure 2 – Prenylated indole alkloids with strucutral differences 
The discovery of stephacidin A 16, avrainvillamide 17 and its dimer stephacidin B 18 spurred further 
global activity due to the moderate biological activities displayed by these compounds against several 
cancer cell lines including LNCaP (prostate cancer) and the molecular complexity of stephacidin B 18 
(Figure 3).13 
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Figure 3 – Stephacidins and avrainvillamide 
Despite the structural diversity observed of the compounds shown above, as previously mentioned, they 
all possess a common bicyclo[2.2.2]diazaoctane core. It has been proposed by the groups of Sammes and 
Birch that this key bicyclic moiety is formed biosynthetically through a hetero-Diels–Alder reaction 
(Scheme 1).14 
 
Scheme 1 – Proposed biosynthetic Diels–Alder to form the bicyclo[2.2.2]diazaoctane core 
Although the reactivity of the unactivated dienophile was initially questioned, significant research has been 
conducted in support of a biosynthetic Diels–Alder reaction by Williams and co-workers, who have 
spearheaded research on the prenylated indole alkaloids. 
Notable Synthetic Strategies for the Formation of the Bicyclo[2.2.2]di-
azaoctane Core Towards Members of the Prenylated Indole Alkaloids 
Over the past few decades since the first reported synthesis of brevianamide B 2 in 1988, 19 years after its 
discovery, many syntheses of members of the prenylated indole alkaloids and related compounds bearing 
the bicyclo[2.2.2]diazaoctane core have been published.2 Various synthetic strategies have been developed 
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for the synthesis of the key bicyclic core by multiple research groups including the Simpkins group and a 
selection of the notable synthetic methods will be discussed in this Chapter. 
Intramolecular SN2’ Cyclisation 
As mentioned above the Williams research group has spearheaded efforts towards the prenylated indole 
alkaloids and reported the first synthesis of a member of this natural product family using an intramolecular 
SN2’ cyclisation to generate brevianamide B 2 (Scheme 2).15 
 
Scheme 2 – Williams total synthesis of brevianamide B using an intramolecular SN2’ cyclisation 
Seebach acetal 20 was converted to allylated DKP 21 through nucleophilic ring opening followed by 
acylation and ring closure. Oxidative cleavage of the alkene using ozone, followed by Wittig olefination, 
reduction of the aldehyde, TBS protection of the primary alcohol and quenching of the DKP enolate with 
methyl chloroformate gave adduct 22. Coupling of adduct 22 with gramine 23, using tributyl phosphine, 
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afforded indole adduct 24 before ester removal, Boc protection, TBS removal and chloride displacement 
gave key intermediate 25. It was found that the conditions for the SN2’ cyclisation dramatically influenced 
the reaction outcome; NaH in DMF gave adduct 26 in 62% yield and in a 2:1 dr, whereas NaH in benzene 
was found to favour the syn-isomer in 82% and 3:97 dr and the best conditions for the anti-isomer were 
found to be NaH in benzene with 18-crown-6. It was proposed that crown ether stabilisation of the enolate 
creates an unfavourable steric interaction between the sodium enolate and chloride disfavouring 
association of the two groups during the transition state. Treatment of cyclised adduct 26 with concentrated 
HCl resulted in indole deprotection and indole-olefin cyclisation. Oxidation using mCPBA and then 
treatment with NaOMe generated the spiro-oxindole moiety before removal of the PMB group gave 
brevianamide B 2. 
The SN2’ cyclisation strategy was also used to synthesise paraherquamide B 29, this time using the syn-
selective conditions found during the synthesis of brevianamide B 2 (Scheme 3).16 
 
Scheme 3 – Williams synthesis of paraherquamide B 29 
Adduct 27 was prepared in a similar method to adduct 25 above and cyclisation through a proposed 
‘closed’ transition state gave compound 28 as a single epimer in excellent yields. Conversion of cyclisation 
product 28 to paraherquamide B 29 was then completed in 8 steps. 
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Furthermore, the SN2’ cyclisation strategy was also used to synthesise stephacidin A 16, avrainvillamide 
17 and stephacidin B 18 (Scheme 4).17 
 
Scheme 4 – Williams synthesis of Stephacidins and avrainvillamide using SN2’ cyclisation 
Intramolecular SN2’ cyclisation of allylic chloride 30 gave adduct 31 in good yield with excellent syn 
selectivity again thought to be due to a ‘closed’ transition state. Unlike with brevianamide B 2 acidic 
conditions could not be used for the indole deprotection and cyclisation towards stephacidin A 16 due to 
the instability of the pyran ring to those conditions. An alternative palladium mediated cyclisation and 
thermal deprotection of the indole were instead used and afforded stephacidin A 16 in good yield. 
Avrainvillamide 17 was generated following a previously reported reduction-oxidation procedure and 
dimerisation using triethylamine gave stephacidin B 18 in excellent yield. 
Intramolecular Diels–Alder 
A biomimetic intramolecular Diels–Alder (IMDA) was first employed by Williams and co-workers in the 
synthesis of brevianamide B 2 and was used soon after for the synthesis of VM55599 37 (Scheme 5).18,19 
Tautomerisation of adduct 32 to the azadiene is expected under basic conditions allowing the IMDA to 
Chapter 1  Introduction 
7 
 
occur. In this case a mixture of all four possible diastereoisomers were obtained with the major product 
being desired epimer 34 which was converted to VM55599 37 in good yield.  
 
Scheme 5 – Williams IMDA synthesis of VM55599 37 
In contrast to the base mediated IMDA, Liebscher and co-workers reported an alternative neutral IMDA 
cyclisation that displayed excellent diastereocontrol (Scheme 6).20 
 
Scheme 6 – Liebscher neutral conditions for IMDA 
These neutral conditions where then used by Williams to synthesis VM55599 37 enantioselectively since 
the stereochemistry of the -methyl is retained.21 
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Figure 4 – IMDA under neutral conditions 
The IMDA cyclisation of adduct 40 gave a mixture of three of the four possible diastereoisomers and 
epimer 42 was then reduced using DIBAL-H to give (-)-VM55599 37 in 68% yield. 
Since the prenylated indole alkaloids share the characteristic bicyclo[2.2.2]diazaoctane core it was 
envisioned that a common intermediate could be generated to allow divergent access to members of the 
family. With this in mind ketone 46 was generated using similar methodology to that above and was 
converted to adduct 47 using phenyl hydrazine and zinc chloride in a Fischer indole synthesis.22 
 
Scheme 7 – AlCl3 IMDA and Fischer indole synthesis 
Adduct 47 can then be converted to brevianamide B 2 using previously reported oxidative conditions to 
generate the oxindole moiety. This methodology was found to only give the anti-epimer in contrast to the 
mixtures of syn- and anti-epimers above, however it was limited by the anti-selectivity and the harsh 
conditions. 
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Williams and co-workers additionally found that hydroxy prolines such as 48 were suitable reagents for 
the IMDA reaction, using excess tributyl phosphine and diethyl azodicarboxylate (DEAD) to form the 
azadiene through dehydration and tautomerisation.23 
 
Scheme 8 – PBu3/DEAD synthesis of stephacidin A 16 
It was found that both tributyl phosphine and DEAD were required for the IMDA to proceed and a proton 
chaperone mechanism was proposed.24 
Scheerer and co-workers have since reported a diastereoselective domino reaction featuring an IMDA by 
incorporating an endogenous stereocentre in the form of a chiral DKP. This methodology afforded an 
excellent diastereoselectivity of 95:5 when used on a model system only. Use of this methodology allowed 
the enantioselective synthesis of (+)-malbrancheamide B 5 however, only moderate diastereocontrol was 
achieved in the IMDA step (Scheme 9).25,26 
 
Scheme 9 – Scheerer diastereoselective domino reaction sequence including IMDA to synthesise (+)-malbrancheamide B 5 
Adduct 52 is generated from a domino reaction sequence that consists of an aldol addition and 
condensation, olefin isomerisation and IMDA cycloaddition. The diastereofacial control of the IMDA 
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cycloaddition is governed by the chiral aminal directing group which is later reduced to form the 
pyrrolidine ring. 
Oxidative Enolate Coupling 
Baran and co-workers developed an oxidative enolate coupling and employed the methodology to form 
the key bicyclo[2.2.2]diazaoctane core in their synthesis of stephacidin A 16, avrainvillamide 17 and 
stephacidin B 18 (Scheme 10).27–29 
 
Scheme 10 – Baran oxidative enolate coupling 
Key intermediate DKP 55 was generated from the amide coupling of tryptophan derivative 53 with D-
proline derivative 54 followed by deprotective cyclisation and was then reprotected as the MOM ether. 
The key ring forming step was achieved using LDA and iron(III) acetylacetonate to affect an oxidative 
enolate coupling. Removal of the MOM protecting group and conversion of the methyl ester to the 
disubstituted olefin followed by thermal deprotection of the indole and cyclisation gave stephacidin A 16 
from which avrainvillamide 17 and stephacidin B 18 were synthesised. 
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Radical Cyclisations 
Radical cyclisations have been utilised by multiple research groups to form the characteristic bicyclic core 
of the prenylated indole alkaloids. In Myers’ synthesis of avrainvillamide 17 and stephacidin B 18 the key 
bicyclo[2.2.2]diazaoctane core was formed through an aminoacyl radical cyclisation (Scheme 11).30 
 
Scheme 11 – Myers radical cyclisation 
Heating of advanced radical precursor 57 with tert-amyl peroxybenzoate was thought to generate radical 
58 which attacks the double bond at the more substituted carbon and expels a phenylthiyl radical thereby 
generating adduct 59 in good yield. Deprotection, oxidation and iodination afforded adduct 60 which was 
then reacted with aryliodide 61 using an Ullmann-like coupling to generate 62. Reduction of the nitro 
functional group using activated zinc gave avrainvillamide 17 in good yield. Conversion of 
avrainvillamide 17 into stephacidin B 18 was then achieved using triethylamine as used by Williams in 
the synthesis previously discussed. 
A radical cyclisation was also used to generate the bicyclo[2.2.2]diazaoctane moiety by Trost and co-
workers in their synthesis of marcfortine B 12 (Scheme 12).31 
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Scheme 12 – Trost synthesis of marcfortine B 12 
Treatment of advanced xanthate 63 with tributyltinhydride and AIBN generated adduct 64 through attack 
of the enamine by the generated primary radical. The newly formed double bond was proposed to be due 
to trapping of the secondary radical with AIBN followed by H· abstraction and fragmentation. 
Transformation of adduct 64 into marcfortine B 12 was then achieved following several subsequent steps 
to install the 7-membered ring and hydrogenation of the newly formed olefin. 
Dieckmann Condensation of an Isocyanate 
In recent work from Sarpong and co-workers an enolate-isocyanate Dieckmann condensation was used to 
synthesise the bicyclo[2.2.2]diazaoctane core and allowed generation of (+)-stephacidin A 16 (Scheme 
13).32 
 
Scheme 13 – Sarpong synthesis of stephacidin A 16 
Oxidation of secondary alcohol 65 and treatment of the resulting ketone with potassium carbonate forms 
the key bicycle and gave adduct 66 in moderate yield. The simple conditions are proposed to generate 
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enolate-isocyanate intermediate 67 which can then undergo the aforementioned Dieckmann condensation 
to forge the bicyclo[2.2.2]diazaoctane core. 
Oxidative Aza-Prins Cyclisation 
Li and co-workers recently published an elegant oxidative aza-Prins cyclisation route to members of the 
prenylated indole alkaloid family (Scheme 14).33 
 
Scheme 14 – Li aza-Prins cyclisation towards notomaide I 
Prenylation of Seebach acetal 68 followed by acetal cleavage, Boc protection, amide coupling with 
dimethyl aminomalonate and acid mediated deprotection-cyclisation gave 1,3-dicarbonyl adduct 69. 
Cyclisation of adduct 69 using a FeCl3-mediated oxidative aza-Prins reaction gave tricycle 70 in good 
yield and as a single diastereoisomer. Grignard addition of modified indole 71 gave ketone 72 before cobalt 
catalysed cycloisomerisation gave adduct 73 which could be converted in 3 steps to notoamide I 8 which 
in turn was transformed into 3 other family members.  
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Simpkins Research Group Efforts Towards the Prenylated Indole Alkaloids 
The Simpkins research group became interested in the prenylated indole alkaloids following significant 
work into the deprotonation of DKPs and the reactivity of the resulting enolates.34,35 Alkylation of proline 
derived DKPs was found to proceed with initial retention of stereochemistry and further sulfenylation 
generated adduct 75 which was found to undergo a cationic cyclisation to give adduct 76 (Scheme 15). 
 
Scheme 15 – Simpkins’ cationic cyclisation 
Attempts to extend this methodology for the synthesis of brevianamide B 2 and the malbrancheamides on 
mixed proline tryptophan systems were unsuccessful but it was found that a cationic cascade was also 
possible with hydroxy DKP 80 and generated adduct 81 in good yield (Scheme 16).36,37 
 
Scheme 16 – Simpkins’ cationic cascade synthesis of malbrancheamide B 5 
Key hydroxy-DKP 80 was synthesised from Seebach acetal product 77 through an amide coupling with 
indole adduct 78 and then acid cyclisation. Treatment of DKP 80 with TMSOTf simultaneously promoted 
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the cationic cyclisation and deprotected the indole to afford adduct 81 which was then deprotected and 
reduced to give (-)-malbrancheamide B 5. 
It was later envisioned that this cascade of ring closures could be achieved using radicals and was 
employed for the synthesis of stephacidin A 16 since the cationic cascade was not suitable due to the 
instability of the pyran ring to the acidic conditions of the reaction (Scheme 17).38 
 
Scheme 17 – Simpkins’ radical cascade to stephacidin A 16 
Key thioether 85 was synthesised from prenyl proline derivative 82 and modified tryptophan adduct 83 
using an amide coupling, followed by Boc removal and cyclisation, reprotection and then sulfenylation 
using LDA and phenyl disulfide. The key radical cyclisation was then affected using tributyltinhydride 
and AIBN and gave a mixture of 3 of the possible 4 diastereoisomers of indoline 86–88. Oxidation of the 
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mixture of indoline adducts 86 and 87 using DDQ gave indole adducts 89 and 90 and deprotection of 
adduct 89 gave (-)-stephacidin A 16 in good yield. 
Self-Replication of Stereocentres 
The previous cascade routes for the synthesis of the prenylated indole alkaloids developed within the 
Simpkins research group, as have many of the synthesis discussed earlier in the Chapter, relied on 
Seebach’s self-replication of stereocentres (SRS) methodology to access highly stereoenriched alkylated 
proline derivatives. Seebach and co-workers found that alkylation of pivaldehyde-based oxazolidinone 
91a occurred with retention of stereochemistry using a range of electrophiles (Figure 5).39 
 
Figure 5 – Advances in Seebach’s SRS methodology 
Problems with the stability of 91a led to the more robust choral-based oxazolidinone 91b being reported 
by Germanas and Wang.40 It has since been found by Trauner that the selectivity can be reversed, giving 
inversion of stereochemistry, by pregeneration of silyl enol ether 95.41 Further to this Ferriera has recently 
reported that stereocomplementary products can be generated by isobutyraldehyde or 1-naphthaldehyde-
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derived imidazolidinones 97a and 97b.42 The single diastereoisomer oxazolidinones and imidazolidinones 
can then be converted into amino acids or amino amides such as 93 allowing these adducts to be used in 
further reactions. 
Asymmetric Organocatalytic Methodology of Diketopiperazine Derivatives  
With the limitation of the SRS methodology requiring strong base and early assignment of the 
enantiomeric series meant that an organocatalytic methodology to access either enantiomeric series would 
be highly powerful. To this aim recent work from the Simpkins research group has investigated the 
Michael addition of DKP derivatives possessing additional activating groups, such as N-acyls.43 
Unfortunately it found that the pKa of the -proton could not be lowered sufficiently to enable 
deprotonation by the commonly used cinchona derived asymmetric bifunctional catalysts.  
However, it was found that incorporation of the additional activating group within the ring in the form of 
a triketopiperazine (TKP) successfully allowed highly enantioselective Michael additions to a range of 
Michael acceptors to give adducts 103a-c, mediated by cinchona alkaloid derived catalyst 101 (Scheme 
18).43,44  
 
Scheme 18 – Assymetric Michael additions of triketopiperazines 
Excellent yields and levels of asymmetric induction were achieved with glycine-derived TKP 100a and 
its carboxymethyl analogue 100b with results up to 99% and 99:1 er. However, when the reaction was 
performed on alkylated TKPs 100c (Allyl, Bn or nPr) the reactions with Michael acceptors were found to 
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be much slower than those with TKPs 100a and 100b and reduced yields and enantioselectivities were 
obtained with the best result being 82% and 77:23 er.  
In addition to the excellent results obtained for the Michael addition reactions of TKPs 100a and 100b a 
Michael addition–ring-closure process was also reported with certain acceptor classes with the 
intermediate enolate 102a-c undergoing an ‘aldol’-like ring-closure to afford Michael addition–ring-
closure adducts 104a-c (Scheme 19). 
 
Scheme 19 – Michael addition–ring-closure process of TKPs 
The products generated from this tandem process possess the key bicyclo[2.2.2]diazaoctane core found 
within the prenylated indole alkaloids, suggesting that this methodology could be a useful strategy for the 
enantioselective synthesis of members of the natural product family. Since the start of this project further 
work has been conducted on -arylated TKPs and also an -CF3 TKP and investigations are currently 
ongoing within the research group. 
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Chapter Two – Enantioselective Synthesis of Functionalised 
Proline Derived Triketopiperazines 
Aims and Objectives 
The development of novel enantioselective approaches to members of the prenylated indole alkaloid 
family has been a significant area of research within the Simpkins research group as outlined in the 
introduction. With new members of the family and novel synthetic strategies being reported, the area 
remains the subject of widespread interest to the scientific community.32,33,36–38,45 
As discussed earlier, recent work from the Simpkins research group has found that triketopiperazines 
undergo highly enantioselective Michael additions, mediated by a cinchona alkaloid derived catalyst, to a 
range of Michael acceptors to give adducts 103a-c (Scheme 20).43,44 
 
Scheme 20 – Overview of previous asymmetric Michael additions of TKPs 
A Michael addition–ring-closure process was also reported with certain acceptor classes, generating 
products 104a-c which contain the key bicyclo[2.2.2]diazaoctane core found within the prenylated indole 
alkaloids. Excellent yields and levels of asymmetric induction were achieved with glycine-derived TKP 
100a and its carboxymethyl analogue 100b (Scheme 20). However, when exploring different -
substituents on the TKP ring it was found that the asymmetric Michael additions of alkylated TKPs 100c 
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were noticeably slower and less selective, than 100a and 100b, with the best result involving addition to 
phenyl vinyl ketone, which required 7 days at 0 °C and gave an er of only 77:23.  
The aim of this project was to extend the asymmetric Michael addition and Michael addition– ring-closure 
methodology to a bicyclic triketopiperazine derived from proline, and enable enantioselective Michael 
additions with or without in situ ring closure, to form 106 and 107 respectively (Figure 6). 
 
Figure 6 – Overview of proline derived TKP and comparision to stephacidin A 
The similarity between tricyclic compound 107 and the tricyclic core of the prenylated indole alkaloids, 
as highlighted in stephacidin A 16, is highly evident (Figure 6). This methodology had the potential to give 
novel access to the pyrrolidine fused bicyclo[2.2.2]diazaoctane core, compared to the stereocontrolled 
syntheses discussed earlier, since either enantiomeric series should be accessible just by switching 
catalysts. 
A key issue was the potential for proline-derived TKP 105 to react in a similar fashion to the alkylated 
derivatives 100c, mentioned above, meaning that the asymmetric Michael additions could have been slow 
and had lower than desired selectivity. However, considering the fact that proline-derived DKPs have been 
shown to be more acidic than DKPs derived from other amino acids we had hope that TKP 105 would 
react more similarly to glycine-derived TKP 100a than the alkylated analogues.46,47 Another potential issue 
regarding proline-derived TKP 105 was the configurational stability of the -centre (Figure 7). 
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Figure 7 – Consideration on configurational stability 
If the proline TKP is configurationally stable under the reaction conditions, it could be envisioned that only 
one enantiomer of TKP 105 would be deprotonated to generate prochiral enolate 108, before addition to 
the Michael acceptor to give adduct 106 along with enantiomerically enriched TKP 105, in a kinetic 
resolution. Alternatively a stereoablative enantioconvergent synthesis may be in effect if the TKP is 
configurationally labile, with prochiral enolate 108 formed from both enantiomers of 105, allowing adduct 
106 to be generated in up to 100% yield.48,49 
Despite the questions regarding the potential reactivity of the proline TKP the appreciable overlap of the 
potential Michael addition and Michael addition–ring-closure products with the prenylated indole 
alkaloids made for an interesting project. 
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Synthesis of Proline Derived Triketopiperazine 
In order to investigate the asymmetric Michael reaction of proline-derived TKP 105 the first priority was 
the development of a route to the desired TKP. Therefore proline-N-benzyl amide 111 was synthesised 
from commercially available Boc-L-proline 109 following a literature procedure (Scheme 21).50 The 
benzyl amide was chosen because it had been previously used within our research group on other TKP 
systems with excellent results.44 
 
Scheme 21 – Synthesis of proline-N-benzyl amide 111 
In the first step Boc-L-proline 109 was reacted with i-butyl chloroformate, to generate a mixed anhydride 
and subsequent addition of benzylamine gave amide 110 in good yield, following purification by 
recrystallisation. Removal of the Boc protecting group using trifluoroacetic acid (TFA), in 
dichloromethane followed by a basic work-up, gave desired amino amide 111 in excellent yield. 
The next step was then the cyclisation of the amino amide using an oxalyl derivative in order to access 
proline-N-benzyl TKP 113. Previous work within the research group had shown that oxalyl benzotriazole 
112 was an effective and easily accessible oxalyl coupling partner for this process and was prepared in 
excellent yield of 90% (Scheme 22).44,51  
 
Scheme 22 – Synthesis of oxalyl benzotriazole 112 
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The reaction of amino amide 111 with oxalyl benzotriazole 112 was then attempted using a microwave 
reactor as previously developed within the research group (Scheme 23).44 
 
Scheme 23 – Oxalyl benzotriazole cyclisation 
The reaction gave desired proline-TKP 113, but the yield was poor and considerably lower than that for 
the previous synthesis of glycine-derived TKP 100a (67%). Attempts to increase the yield by varying the 
solvent, temperature, reaction time, concentration and equivalents of 112 had no significant effect. 
Alternative procedures for the preparation of proline-TKP 113 were then investigated. Diethyl oxalate was 
successfully used by the groups of Safir, Person and Boa to generate TKPs 115a-e (Figure 8).52–55  
 
Figure 8 – Previous TKP syntheses using diethyl oxalate 
However, the reaction of amino amide 111 under these conditions yielded no desired product, returning 
only unreacted starting material. 
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Previous work within the research group had also shown that commercial oxalyl imidazole gave 
comparable yields to oxalyl benzotriazole.43 Oxalyl imidazole was also successfully used by the groups of 
Makino and Overman for the synthesis of proline derived TKP 118 and TKP 120 (Figure 9).56,57 
 
Figure 9 – Makino solid supported TKP synthesis (A) and Overman TKP synthesis (B) 
Earlier attempts within the research group to synthesise and isolate oxalyl imidazole, due to its relatively 
high cost and instability, had proved troublesome and had given poor yields of TKP formation. As an 
alternative a solution of oxalyl imidazole was prepared in situ, following a modified literature procedure, 
from oxalyl chloride, imidazole and Hünig’s base (Scheme 24).58  
 
Scheme 24 – Synthesis of proline-TKP using oxalyl imidazole 
The addition of amino amide 111 to the solution of oxalyl imidazole followed by overnight stirring yielded 
proline-TKP 113 in excellent yield. Using oxalyl imidazole showed a considerable improvement in yield 
over oxalyl benzotriazole (84% ca. 23%), required milder conditions and allowed easier scale-up to multi-
gram reactions. Additionally, TKP 113 could be isolated following a simple extraction, washing with 1M 
HCl and purification by recrystalisation from isopropyl alcohol, further aiding the gram scale synthesis of 
113. 
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Since TKP 113 was synthesised from S-N-benzyl prolinamide 111 we expected the isolated product to be 
the S-enantiomer. However, when the optical rotation of proline TKP 113 was measured it was found to 
be zero, implying that racemisation had occurred (D = 0). The racemisation of a TKP had been previously 
reported in the synthesis of phenylalanine derived TKP 115a by Person and Boa, shown above (Figure 8), 
although the conditions of sodium alkoxides in refluxing alcohol were harsher than those in the oxalyl 
imidazole synthesis of 113. Racemisation has also been reported for related Cbz protected proline DKP 
123 (Scheme 25). Katritzky found that when synthesising DKP 123, using benzotriazole-mediated 
conditions, only racemic 123 was isolated regardless of starting with either enantiomer of 121.59 
 
Scheme 25 – Racemisation of a proline DKP observed by Katritzky 
In hindsight, since Cbz proline DKP 123 underwent racemisation and previous work had shown that TKPs 
were more acidic than acylated DKPs, it was unsurprising that proline TKP 113 had racemised in the 
presence of amines.43  
Attempts to isolate enantiomerically enriched samples of proline TKP 113 under modified reaction 
conditions or using chiral HPLC were unsuccessful. The compound appeared to racemise on the HPLC 
column as shown by unresolved and unusually shaped peaks (Figure 10).  
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Figure 10 – HPLC traces (A) – racemic sample of Proline TKP 113, (B) – reinjection of sample from the peak at 8.67 mins,       
(C) – reinjection of sample from the peak at 9.61 mins 
Samples were collected from the middle of both peaks and were reinjected onto the chiral column. The 
two samples showed peaks for both enantiomers, suggesting that TKP 113 was partially racemised on the 
column. 
The racemisation of 113 demonstrated the activating power of the TKP ring towards enolisation and was 
encouraging for the desired enantioselective Michael reactions, since the -proton of the TKP should be 
readily removed by the basic nitrogen of the chiral catalysts. With the implied configurational lability of 
TKP 113, a kinetic resolution during the planned asymmetric Michael reaction was deemed unlikely 
compared to the stereoablative outcome shown earlier and will be discussed later in the Chapter. 
With benzyl protected proline-TKP 113 in hand, 4-methoxybenzyl (PMB) protected TKP 125 was also 
synthesised. The PMB group has been shown to be a more labile amide protecting group, than the benzyl 
group, potentially allowing facile removal at a later date (Scheme 26).60 
 
A 
B
  A 
C 
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Scheme 26 - Synthesis of PMB amide 124 and PMB TKP 125 
Amino amide 124 was synthesised in excellent yield (90% over 2 steps), following the same procedure as 
for benzyl amide 111, and was then reacted with oxalyl imidazole to generate PMB protected proline TKP 
125 (Scheme 26). Oxalyl imidazole was generated in situ, as described above, and gave TKP 125 in 
excellent yield as a racemate (D = 0) matching the prior result with benzyl protected proline TKP 113.  
Synthesis of a Homo-Proline Triketopiperazine 
Although the vast majority of the prenylated indole alkaloids possess a fused pyrrolidine ring there is a 
small proportion of the family that possess a fused piperidine ring, including marcfortines A–C (11, 12 
and 126) and chrysogenamide A 13 as mention briefly in Chapter 1(Figure 11).11,31 
 
Figure 11 – Examples of prenylated indole alkaloids containing a fused piperidine ring 
In this context, it was interesting to synthesis a homo-proline TKP derived from pipecolic acid, in parallel 
to proline-derived TKP 113, to investigate the access of adducts related to the natural products shown 
above. It was hypothesised that a homo-proline-derived TKP would be easier to synthesise than proline 
TKP 113 since Makino and co-workers had reported that TKPs based on six-membered cyclic amino 
acids formed in higher yields compared to five-membered cyclic amino acids and required no 
modification of the method (Scheme 27).56 
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Scheme 27 – Makino solid supported TKP synthesis of piperidine fused system 
Benzyl amino amide 132 was synthesised in good yield from commercially available (±)-pipecolic acid 
129 in three steps (Scheme 28). 
 
Scheme 28 – Synthesis of homo-proline TKP 133 
Pipecolic acid was protected with Boc anhydride, then coupled with benzylamine, via the mixed anhydride 
to give adduct 131. Removal of the Boc group, using TFA, and then cyclisation with a prepared solution 
of oxalyl imidazole, provided homo-proline TKP 133 in excellent yield. 
Enantioselective Michael Additions of Proline Triketopiperazines 
With sufficient quantities of proline TKPs 113 and 125 and homo-proline TKP 133 in hand, the next 
objective was to establish the organocatalytic conjugate addition to Michael acceptors. Previous work had 
shown that glycine-derived TKP 100a and carboxymethyl TKP 100b underwent Michael addition to a 
number of enones in good yield using triethylamine as the base. Methyl vinyl ketone (MVK) was used to 
test the reactivity of TKPs 113, 125 and 133 as Michael donors using triethylamine as base at an initial 
reaction temperature of –20 °C (Figure 12). Katritzky’s Cbz protected proline DKP 123 was also 
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synthesised and submitted to the reaction conditions, since enolisation had previously been seen using 
triethylamine, but no Michael adduct was observed. 
 
Figure 12 – Michael addition of TKPs 113, 125 and 133 to methyl vinyl ketone 
The reaction of proline TKPs 113 and 125 with MVK proceeded quickly and gave Michael adducts 134 
and 135 in moderate to good yields even at –20 °C. This was an excellent result considering alkylated 
TKPs had previously shown poor reactivity, compared to glycine-derived TKP 100a, or activated TKP 
100b, and required significantly longer reaction times to reach completion.43 However, homo-proline TKP 
133 showed more similarity to previous alkylated TKPs with less than 5% conversion after reacting 
overnight at –20 °C. Performing the reaction at room temperature gave compound 136 but the reaction 
required 18 hours for consumption of the starting material by TLC. 
With the alkyl TKPs, the low apparent reactivity and selectivity was attributed to the low basicity of the 
catalyst and the increased steric hindrance at the reactive centre. Carboxymethyl TKP 100b overcomes 
the increased steric hindrance with additional activation from the 1,3-dicarbonyl moiety. Although proline 
TKP 113 does not have the additional activation through resonance it appeared to be similar in reactivity 
to glycine and carboxymethyl TKPs 100a and 100b. 
In DKP systems it has been reported that the -protons of proline residues are more acidic compared to 
other amino acid sub-units.47,59,61,62 In recent work by the O’Donoghue research group, proline residues in 
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DKPs have been measured to be kinetically more acidic than glycine, alanine and tyrosine residues (Figure 
13). 
 
Figure 13 – DKP acidity measurements by O’Donoghue and co-workers 
In comparison to non-cyclic DKPs, that assume a planar form, proline-derived DKPs must adopt a boat 
conformation, due to the constraints of the pyrrolidine ring.46,63 This difference in conformation places the 
-proton into a position with enhanced orbital overlap between 
CH
 and *
CO
 in proline-derived DKPs 
compared to monocyclic DKPs, lowering the barrier to enolate formation, thereby explaining the 
difference in acidity (Figure 14).47 
 
Figure 14 – Orbital overlap  
The observed increased reactivity of proline TKP 113 compared to homo-proline TKP 133 was also 
attributed to this enhanced orbital overlap caused by the strained 5,6-system. Whereas, piperidine fused 
homo-proline TKP 133 was hypothesised to have reduced stereoelectronic enhancement and there would 
be increased steric interactions during deprotonation with hydrogens on the pyrimidine ring. 
In collaboration the AstraZeneca, pKa values for several TKPs have been predicted using DFT calculations 
(B3LYP) with correlation-consistent basic set [cc-pVTZ(+)] in a water SCRF solvent mode.64 The 
calculations have a predicted pka range of 10.6–11.4, with the pkas of proline TKP 113 and glycine TKP 
100a predicted to be 10.6. This information supported the observed similar reactivity shown by TKPs 113 
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and 100a. Previous NMR studies in MeCN-d3 estimated the pka of glycine TKP 100a and carboxymethyl 
TKP 100b between 12 and 16.43 Calculation of the acidity of proline and glycine TKPs 113 and 100a is 
currently ongoing in collaboration with the O’Donoghue group. Preliminary results have indicated that 
proline TKP 113 is more acidic than glycine TKP 100a which was encouraging for the future asymmetric 
reactions. 
Inspired by the results obtained using triethylamine the asymmetric Michael reaction was then 
investigated. TKPs 113, 125 and 133 were reacted with MVK using cinchona derived catalyst 141 and 
showed promising results (Figure 15). 
 
Figure 15 – Initial asymmetric Michael reaction with TKPs 
The initial enantioselectivity for the reactions of proline TKPs 113 and 125 were found to be higher than 
previous results of alkylated TKPs (best result with MVK was 70:30 er). On the proline system, the N-
benzyl and N-PMB adducts had the same measured er as expected due to the similarity of TKPs 113 and 
125. Elevated temperatures were again needed with homo-proline TKP 133, with less than 10% 
conversion after 1 day at –20 °C, at room temperature a reduced enantiomeric ratio was measured in 
comparison the proline adducts 134 and 135 but was similar to the alkylated TKPs results. 
The results also showed that the cinchona derived catalyst could interact with both enantiomers of the TKP 
since yields of greater than 50% were obtained. This is an example of stereoablative enantioconvergent 
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catalysis since catalyst 141 converts either enantiomer to an achiral intermediate enolate that then 
undergoes enantioselective conversion to the product.48 
Katritzky’s Cbz protected proline DKP 123 was also submitted to the asymmetric reaction conditions 
above, in case the bifunctional nature of the catalyst would enable the reaction. However, no Michael 
adduct was observed, which demonstrates the increased activation of the TKP systems in comparison to 
acylated DKPs and is in agreement with previous work within the research group.43,59 
With the promising preliminary results shown with MVK, work then concentrated on screening a number 
of catalysts in an attempt to increase the enantioselectivity of the reaction. The screen was performed using 
the addition of benzyl proline TKP 113 to MVK, due to the fast reaction time, moderate yields and 
established HPLC conditions (Table 1). 
 
Table 1 – Catalyst screening for the Michael reaction of TKP 113 with MVK a – isolated yield, b – determined by HPLC 
Natural cinchona alkaloid, quinidine 143, showed moderate enantioselectivity for the same enantiomer as 
quinine derived catalyst 141. This switch in selectivity can be attributed to the differing hydrogen bond 
donors, with 143 having a C9 hydroxyl while 141 has a C6’ ‘phenol’ resulting in a change in the transition 
state organisation. Catalyst 101 showed equal selectivity to the initial result (80:20 er, Figure 15 vs          
Entry Catalyst 
Time 
(h) 
Temp  
(°C) 
Yield  
(%)a 
erb 
1 143 3 –20 60 77:23 
2 101 4 –20 74 19:81 
3 145 18 –20 60 44:56 
4 146 2 –20 65 19:81 
5 147 16 –20 79 28:72 
6 148 19 –20 63 30:70 
7 149 23 –20 51 35:65 
8 144 2.5 –20 42 12:88 
9 144 22 –30 72 10:90 
 
10 142 21 –30 81 78:22 
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entry 2) but in favour of the opposite enantiomer as expected due to the psuedo-enantiomeric relationship 
of catalysts 101 and 141. Benzoyl catalyst 146 was also tested and showed similar selectivity to benzyl 
catalysts 101 and 141 (entry 4). Benzoyl protected quinidine 145, intermediate in the synthesis of benzoyl 
catalyst 146, was also tested and as expected showed virtually no enantioselectivity (entry 3). This is due 
to the lack of a hydrogen bond donor required to effectively organise the transition state.65 Two thiourea 
catalysts 148 and 149 were also tested but showed inferior enantioselectivities (entries 6–7). Catalyst 144, 
with the larger phenanthryl C9 substituent, showed an improved enantioselectivity compared to 
benzylated catalyst 101, however, the rate of reaction was decreased, with only partial conversion after 
two and a half hours (entry 8). An improved yield and enantioselectivity were obtained for catalyst 144 
when the reaction was conducted overnight at a lower temperature (entry 9 vs. entry 8). Catalyst 142 gave 
the enantiocomplementary product although with reduced selectivity (entry 10). 
As a result of the catalyst screen the conditions in entry 9 were deemed to be the best for future Michael 
additions, since they afforded 134 in good yield and with the highest er. 
To explore the asymmetric Michael addition further, a number of enones and an unsaturated N-acyl 
oxazolidinone were tested with benzyl proline TKP 113. Methyl and ethyl vinyl ketones were also tested 
under the optimised conditions with PMB proline TKP 125 and homo-proline TKP 133 (Figure 16). 
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Figure 16 – Scope of Michael addition 
Good levels of enantioselectivity were measured for Michael adducts 135, 136 and 150–155, with phenyl 
vinyl ketone adduct giving the best enantiomeric ratio of 6:94. This was also the first time a TKP had been 
reacted with an oxazolidinone Michael acceptor. 
The enantioselectivity for PMB MVK adduct 135 increased slightly over the previous result (17:83 vs 
80:20) and inverted due to the use of the pseudoenatiomeric catalyst family. Unfortunately, despite trying 
all available columns, no HPLC conditions were found to split PMB EVK adduct 154. 
For the reactions of homo-proline TKP 133, the enantioselectivity of MVK adduct 136 was increased 
(23:77 vs 72:28) and the enantiomeric ratio of EVK adduct 155 was found to be good. However, the 
reactions took 11 days, reducing the practicality of the asymmetric Michael addition with TKP 133 and 
therefore no further Michael acceptors were tested. 
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Nonetheless, with proline TKP giving selectivities up to 6:94 er, and homo-proline up to 16:84 er, these 
were the best results for Michael additions of -substituted TKPs, other than the doubly-activated 
carboxymethyl TKP 100b. 
During analysis of the Michael adducts it was found that acrolein adduct 152 required conversion to acetal 
157 in order for HPLC analysis to be performed and allow easier purification of the product. Acetal 157 
was synthesised in moderate yield from the crude Michael adduct, after evaporation of excess acrolein, 
using 2-ethyl-2-methyl-1,3-dioxolane 156 as the solvent with a catalytic amount of pTSA (Scheme 29). 
 
Scheme 29 – Conversion of acrolein adduct 152 to acetal 157 
In an attempt to improve the enantiomeric ratio of the Michael adducts an enantioenrichment by 
crystallisation was attempted.66,67 Recrystallisation of a sample of MVK adduct 134 (10:90 er) provided 
crystals of enriched enantiopurity (5:95 er) and subsequent recrystallisation gave an enantiopure sample 
of 134 (<1:99) (Figure 17). 
 
Figure 17 – HPLC traces showing enantioenrichment, A – 10:90 er, B – 5:95 er, C – <1:99 er 
A
  A 
B C 
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In order to confirm the stereochemistry of the Michael adducts, a crystal was grown from a sample of 
phenyl vinyl ketone adduct 151, synthesised using catalyst 144, and the X-ray crystal structure was 
determined (Figure 18). 
 
Figure 18 – X-ray structure of 151 with ellipsoids drawn at the 50% probability level 
The crystal structure of 151 established the stereogenic centre to be S which is in agreement with previous 
work within the research group.43,44 The crystal structure also showed the strained conformation of the 
bicyclic proline TKP and implied that the -centre of proline TKPs should be readily accessible for the 
catalyst to deprotonate. The conformation of proline TKP 133 is thought to be main contributing factor for 
the observed improved rate of reaction for proline TKP 113 over homo-proline TKP 133 and previously 
mentioned alkyl TKPs. 
The assignment of the stereogenic centre was also in agreement with models proposed by Deng and Houk, 
in which the Michael donor and acceptor are arranged with the catalyst through a network of hydrogen 
bonds.68–70 The Deng and Houk models were modified to fit the synthesis of 151, with the three 
components arranged as shown in Figure 19. 
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Figure 19 – Models for asymmetric Michael addition 
In both models the catalyst can be drawn along the C-8–C-9 bond, resulting in two planes, with the 
quinuclidine portion above (bold) and hydroxy quinoline portion below. In the Deng inspired model the 
TKP enolate associates to the protonated quinuclidine and the Michael acceptor associates to the hydroxy 
quinoline. Whereas, Houk found on related C-9 thiourea catalysts, using DFT calculations, that activation 
of the acceptor by the protonated quinuclidine and orientation of the nucleophile, after deprotonation by 
the quinuclidine, by the hydroxy quinoline was the lowest energy transition state.  
With good results obtained from simple enones, proline TKP was then reacted with chalcone to further 
explore the enone class (Scheme 30). Chalcone had previously shown good results, with glycine-derived 
TKP 100a undergoing the Michael addition in excellent yield. However, no reaction was seen with 
activated TKP 100b or the alkylated TKPs 100c, presumably due to the increased steric demand of those 
systems, therefore chalcone was deemed to be a good indicator of reactivity. 
 
Scheme 30 – Michael addition of proline TKP 113 to chalcone 
Surprisingly, two products were isolated, the minor product was found to be the anticipated Michael 
adduct 158 while the major product was found to be tricyclic Michael addition– ring-closure product 159. 
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Hydroxy DKP 159 was isolated as a single diastereoisomer having four contiguous stereocentres and 
bearing the pyrrolidine fused bicyclo[2.2.2]diazaoctane core found within the prenylated indole alkaloids. 
This unexpected Michael addition– ring-closure process will be further discussed in Chapter 3. 
Unveiling of the Aminoamide 
With the proline TKP showing successful activation of the amino acid system toward organocatalysed 
Michael additions, a method of removing the oxalyl functionality of the TKP and unveiling the amino acid 
derivative would give access to novel fully substituted prolines. Functionalised prolines have been key 
building blocks in natural product syntheses, including the synthesis of the prenylated indole alkaloids as 
discussed in the introduction. Quaternary prolines are also valuable in peptidomimetics where they can be 
incorporated into peptides to induce -turns or to improve their biological stability.71,72 Additionally, 
proline derivatives, including quaternary examples, have played an important role as catalysts in 
asymmetric enamine organocatalysis reactions as shown in several examples from the List group   
(Scheme 31).73,74 
 
Scheme 31 – List’s asymmetric -alkylation of aldehydes 
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Previous work within our research group showed that the oxalyl moiety could be removed from Michael 
adducts in moderate yield using ethanolamine (Scheme 32). In the example shown in situ cyclisation of 
the generated amino amide 167 with the pendant ketone gave hemi-aminal 168.43 
 
Scheme 32 – Previous example of oxalyl removal 
However, when these reaction conditions were applied to MVK adduct 134, compound 169 was isolated 
in moderate yield and none of the desired aminoamide or hemi-aminal were observed (Scheme 33). 
 
Scheme 33 – Attempted oxalyl removal 
Enamine ring-closure followed by ring-opening of the N-acyl hemiaminal and enolisation of the newly 
formed 1,3-diketone moiety afforded compound 169. The proline TKP system had shown its 
susceptibility to undergo ring-closure of the side chain onto the C-3 carbonyl in the result with chalcone 
(Scheme 30). This type of ring opening had not previously been seen with ethanolamine and will be 
discussed in more depth in the next Chapter. 
In order to prevent the observed ring-closure, protection of the ketone functionality of MVK adduct 134 
was proposed. Since conversion of aldehyde 152 to dioxolane 157 had been successful, it was chosen for 
the protection of Michael adduct 134. Compound 134 was converted to ketal 170 in good yield, using the 
same conditions as for the protection of acrolein adduct 152 (Scheme 29 and Scheme 34).  
Chapter 2  Proline Derived Triketopiperazines 
 
40 
 
 
Scheme 34 – Attempted oxalyl removal on protected adduct 
Ketal 170 was submitted to the same ethanolamine conditions and cleavage of the imide functionality was 
found to occur, generating 171 in good yield after heating under reflux for 1 hour, although no desired 
amino amide was observed (Scheme 34). Ethanolamine addition product 171 was further heated in THF 
under reflux overnight but no change was observed. Compound 171 was also heated in a microwave 
reactor, at 125 °C, in THF and then in THF:ethanolamine (5:1), in case another equivalent of 
bisnucleophile was required, but 171 was returned unchanged in both cases.  
With compound 171 seemingly unable to undergo intermolecular cyclisation, to remove the oxalyl 
functionality, it was hypothesised that using a diamine may enable the intramolecular cyclisation giving 
access the desired amino amide. Therefore, ketal 170 was reacted with ethylenediamine and N,N’-
dimethyl ethylenediamine however disappointingly both reagents gave the same result as when 
ethanolamine was used, with cleavage of the imide but no further reaction. 
Unfortunately no method was found to successfully remove the oxalyl moiety, but further research into 
this area is currently ongoing within the research group.75 
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Summary and Future Work 
Bicyclic TKPs derived from proline and pipecolic acid have been successfully synthesised in high yields 
from the respective amino acids. Despite the use of Boc-S-proline, synthesised proline TKPs 113 and 125 
were found to be racemic which attests to the activating effect of the TKP ring towards enolisation. 
Proline TKPs 113 and 125 were found to undergo Michael additions with simple enones using either 
triethylamine or cinchona derived catalysts with good rates of reactivity even at low temperatures. 
Excellent levels of enantioselectivity have been achieved using phenanthryl quinidine derivative 144 (up 
to 4:96 er) and similar selectivities can be achieved for both the benzyl and PMB protected TKPs. 
Homo-proline TKP 133 was found to be less reactive, requiring longer reaction times and when catalyst 
144 was used gave moderately lower enantioselectivities (up to 16:84 er). This is in agreement with 
previous results with alkylated TKPs that found longer reaction times were required, compared to glycine 
TKP 100a and its carboxymethyl derivative 100b, and obtained enantiomeric ratios were lower. 
A crystal structure was obtained of Michael adduct 151 and allowed the absolute stereochemistry to be 
established with quinidine derived catalyst 144 found to generate the S enantiomer. This was in agreement 
with previous work within the research group and with models proposed by Deng and Houk. 
Attempts to remove the oxalyl moiety from the Michael adducts using ethanolamine, and other 
bisnucleophiles, were unsuccessful either undergoing a ring-closure–ring-opening process or stopping 
after imide cleavage when the ketone was protected. 
Further studies into the removal of the oxalyl moiety are ongoing within the Simpkins group which will 
hopefully find a mild and general method applicable to the bicyclic systems. Catalyst development is also 
required for the homo-proline TKP in order to obtain Michael adducts with excellent enantiomeric ratios 
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in practical reaction times. The apparent decreased reactivity may require the need for more basic catalysts 
such as chiral bifunctional guanidines, cyclopropenimines or Dixons iminophosphoranes.76–78 Ongoing 
collaborations with the O’Donoghue research group and AstraZeneca interested in the acidity of the TKP 
systems may aid future catalyst choices. Lastly, a deprotection strategy needs to be further investigated. 
Previous work in our research group has shown that PMB groups can be removed from proline TKP 
adducts in moderate yield using cerium ammonium nitrate but optimisation of the result is needed.79 
Additionally DMB and OBn protecting groups have also been used by the research group on DKP and 
TKP systems but not on the proline TKP system.5,44 
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Chapter Three – Synthesis of Tricyclic Diketopiperazines 
Possessing the Bicyclo[2.2.2]diazaoctane Core 
Aims and Objectives 
Over the past decade, the Simpkins research group has developed several cascade methods to synthesise 
the bicyclo[2.2.2]diazaoctane core of the prenylated indole alkaloids. In recent work, it was shown that a 
tandem Michael addition–ring-closure process between TKPs and vinyl esters, nitriles and sulfones gave 
access to cyclic compounds 103, that possess the core of the natural product family.43,44 In addition to 
providing a novel route into the bicyclo[2.2.2]diazaoctane motif, this methodology also gave highly 
enantioselective access to either enantiomer in excellent yields (Scheme 35). 
 
Scheme 35 – Overview of previous TKP Michael-ring closure and extension to proline TKP 
This section of the project focussed on the extension of the Michael addition–ring-closure methodology 
to proline-derived bicyclic TKP 104. It was envisioned that this process would give novel asymmetric 
access to tricyclic product 106, which possesses the pyrrolidine fused bicyclo[2.2.2]diazaoctane core seen 
in a large majority of the prenylated indole alkaloids, such as stephacidin A 16. Further transformation 
could then allow access to derivatives or fragments of this natural product family. 
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Organocatalysed Tandem Michael Addition–Ring-Closure 
Methodology: Synthetic Access to Tricyclic Diketopiperazines 
Preliminary exploration of the Michael addition of proline TKP 113 to enones gave promising results in 
terms of both reactivity and enantioselectivity when using cinchona derived catalysts (Figure 16). 
Unexpectedly, when proline TKP 113 was reacted with chalcone, to further explore the enone acceptor 
class, the major product was hydroxy DKP 159 formed by the aforementioned Michael addition–ring-
closure process (Scheme 36).  
 
Scheme 36 – Michael addition of TKP 113 with chalcone 
Previously, this tandem process had only been seen with vinyl esters, nitriles and sulfones (Scheme 36) 
with enones only giving ‘open’ Michael adducts, such as 172, with alkyl TKPs. Subsequent ring closure 
of the ‘open’ adducts could be partially affected in an additional step, using trimethyltinhydroxide, but was 
only observed with a small number of Michael adducts.43  
 
Scheme 37 – Ring closure of chalcone adduct 172 
In contrast, the tandem ring closure was seen with enones in more recent research on the Michael addition 
of -CF3 TKP 173. The reaction afforded a mixture of desired product 175 and cyclic product 176 when 
the reaction was quenched at low-temperature. NMR studies showed that closed adduct 176 is initially 
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formed and is slowly converted to open adduct 175 over the course of the reaction. Conversion of closed 
adduct 176 to open Michael adduct 175 was found to occur by heating to 50 °C for 1 hour (Scheme 38).81 
 
Scheme 38 – Ring closure with enones on -CF3 TKP 173 
In this research Takemoto’s catalyst 174 was found to give the best results, with excellent yields and 
enantiomeric ratios achieved (up to 91% and 97:3 er). Cyclic product 176 was also observed using 
triethylamine and cinchona alkaloid catalyst 101, but in reduced yield and enantioselectivity compared to 
catalyst 174. 
Since -CF3 TKP 173 had shown some degree of ring closure in the presence of bifunctional catalysts 
101 and 174, the reaction of proline TKP and chalcone was completed under the previously optimised 
conditions with catalyst 144 (Scheme 39).  
 
Scheme 39 – Asymmetric reaction of TKP 113 with chalcone 
The reaction gave tricycle 159 in excellent yield (96%) and ‘open’ product 158 was not observed. Not 
only was the product isolated as a single diastereoisomer in excellent yield but exceptional levels of 
enantioselectivity were also achieved (99:1 er). This was the first example of an -substituted TKP 
undergoing an asymmetric Michael addition with a -substituted enone. Moreover, use of pseudo-
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enantiomeric catalyst 142 gave the enantiocomplementary result, with 159 isolated again as a single 
diastereoisomer in excellent yield and with exceptional enantioselectivity. This result showed the power 
of this methodology to allow access to either enantiomer of the tricyclic product from a racemic starting 
material just by switching pseudo-enantiomers of the catalyst. Furthermore, four contiguous stereocentres 
were created with excellent diastereoselectivity and enantioselectivity in a single step from a racemic 
starting material. 
The absolute stereochemistry was established from the X-ray crystal structure of 159 synthesised using 
catalyst 144 (Figure 20). 
 
 
 
 
 
Figure 20 – X-ray structure of tricycle 159 with ellipsoids drawn at the 50% probability level 
The structure was found to contain two crystallographically independent molecules of 159, of which only 
one is shown for clarity. Both molecules had the same absolute stereochemistry that was determined to be 
SSRR, as shown above, labelled starting from the TKP -centre (Figure 20). The assignment of the initial 
stereocentre was in agreement with the previous X-ray data for phenyl vinyl ketone adduct 151 (Figure 
18, page 36). The established stereochemistry was also in accordance with models, previously used in 
Chapter 2, that were adapted from models proposed by Deng and Houk (Figure 21). 
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Figure 21 – Models for the synthesis of chalcone adduct 159 
Both models predicted that the addition of the TKP enolate to chalcone should give the first and second 
stereocentres as S in agreement with the X-ray structure. The models required the -phenyl substituent of 
chalcone to be positioned endo to the TKP, which although it appeared sterically disfavoured should be 
plausible due to the planar nature of the two groups. Enolate 177 was then expected to minimise steric 
interactions with the phenyl group, before adding into the reactive C-3 carbonyl, thereby setting the final 
two stereocentres both as R, with the final stereocentre predetermined by the initial facial selectivity of the 
Michael addition (Figure 21 and Figure 22).  
 
Figure 22 – Reorientation of enolate 177 
It is interesting that the presence of a -substituent changed the outcome of the Michael addition, with 
phenyl vinyl ketone affording open adduct 151 whilst the reaction with chalcone gave ‘closed’ adduct 159. 
In addition to the -substituent, the bicyclic structure of 113 must also have an effect since the reaction of 
chalcone with glycine TKP 100a gave ‘open’ adduct 172 (Figure 23).   
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Figure 23 – Different reaction outcomes for TKPs 113 and 100a with chalcone and phenyl vinyl ketone 
This difference in reaction outcome has been previously attributed to a ‘buttressing effect’ in which the 
five membered ring has a steric interaction with the -substituent, which in turn forces the intermediate 
enolate closer to the reactive C-3 carbonyl promoting ring closer over protonation.82  
An alternative rational can be sought by considering the different energies for rotation around the newly 
formed C-C bond of the respective enolates generated from the Michael addition (Figure 24). 
The ‘open’ enolate from addition of proline TKP 113 to phenyl vinyl ketone, 178a, is expected to be of 
lower energy than ‘closed’ enolate 178b. This is thought to be the case due to the reduced steric interactions 
from positioning the hydrogens over the TKP and pyrrolidine rings compared to placing the enolate over 
the TKP ring. The open enolate is also expected to be the lowest energy rotamer for enolate 179 since both 
the enolate and phenyl ring can be positioned away from the TKP ring. In contrast, the ‘open’ and ‘closed’ 
rotamers of enolate 177 are expected to be of similar energy since they both position one group over either 
the TKP or pyrrolidine rings. The suspected energy similarity would then allow the enolate to adopt the 
‘closed’ rotamer thereby facilitating attack of the C-3 carbonyl. 
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Figure 24 – Energy difference of enolate rotamers following Michael additions, note - the third enolate has been omitted for 
clarity 
Inspired by previous work with -CF3 TKP 173, in which a retro-‘aldol’ ring opening of closed adducts 
could be affected through heating the reaction mixture, the ring opening of chalcone adduct 159 was 
attempted (Scheme 40). 
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Scheme 40 – Attempted opening of chalcone adduct 159 
Heating the reaction mixture at 50 °C for 1 hour and for 16 hours was found to return 159 unchanged and 
no opening was observed even after 16 hours under reflux. Since catalyst 174 was present in the -CF3 
reaction mixtures, is was suspected that the reaction may be base catalysed therefore the reaction was 
repeated with triethylamine, which resulted in decomposition, or in the presence of catalyst 144, which 
returned the starting material unchanged. 
The Michael addition of PMB protected proline TKP 125 was also found to be catalysed by catalyst 144, 
giving tricycle 180 as a single diastereoisomer in good yield and in excellent enantiomeric excess   
(Scheme 41). 
 
Scheme 41 – Michael addition of PMB proline TKP 125 to chalcone 
Unfortunately, the reaction of homo-proline TKP 133 was not found to occur with chalcone even when 
the reaction mixture was allowed to warm to room temperature (Scheme 42).  
 
Scheme 42 – Attempted Michael addition of homo-proline TKP 133 to chalcone 
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The lack of reaction was attributed to a combination of the lower reactivity of TKP 133, in comparison to 
proline-derived TKP 113, and the increased steric demands of chalcone compared to simple enones, with 
which TKP 133 had previously reacted. This result was consistent with previous results that had found -
substituted TKPs were unreactive towards chalcone.43 
Inspired by the excellent result with chalcone, other -substituted enones and a -substituted 
oxazolidinone were then engaged in productive enantioselective Michael addition–ring-closures with 
proline TKP 113 (Figure 25). 
 
Figure 25 – Scope of Michael addition with -substituted enones 
Pleasingly, the reaction of proline TKP 113 with chalcone variants gave adducts 182-188 with excellent 
enantioselectivity and were once again isolated as single diastereoisomers in good to excellent yields. 
Alkyl adducts 186-188 were also generated as single diastereoisomers, in excellent yield and with 
outstanding enantiomeric ratios, which showed that neither of the aromatic groups were required for ring-
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closure to occur, nor for the high diastereoselectivity of the step. Cinnamoyl oxazolidinone adduct 185 
was also synthesised in high yield and enantiomeric excess. 
Since -substituted enones had shown excellent results, the Michael addition with mesityl oxide 189, a 
,-disubstituted enone, was also attempted (Scheme 43). 
 
Scheme 43 – Attempted reaction of proline TKP 113 with mesityl oxide 189 
Unfortunately, the formation of Michael adduct 190 or Michael-ring closure adduct 191 was not observed. 
Presumably, the additional steric demands imposed by the second -methyl prevented the Michael 
addition of TKP 113 occurring. 
Following the success of the Michael addition–ring-closure process with -substituted enones, alternative 
Michael acceptors were then sought. Previous work had shown that methyl acrylate, acrylonitrile, vinyl 
sulfones and maleimides were suitable acceptors, reacting with glycine and carboxymethyl TKPs 100a 
and 100b in excellent yields and enantioselectivities.43,44 The reactions of proline TKP 113 with 
acrylonitrile and phenyl vinyl sulfone, under the optimised conditions, gave a multitude of products and 
were not further pursued. On the other hand, methyl acrylate gave clean conversion to tricycle 192               
(R = Me), although low and variable yields were obtained following silica-gel chromatography suggesting 
the instability of tricycle 192 to silica (Figure 26).  
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Figure 26 – Michael addition–ring-closure with acrylates 
The instability of tricycle 192 was also observed during chiral HPLC analysis with multiple peaks with 
poor resolution, therefore, tricycle 192 was converted to carbonate 193. Potassium carbonate was used to 
effect ring opening of tricycle 192 (R = Me), as seen with ethanolamine in Chapter 2, before acylation with 
methyl chloroformate to yield carbonate 193 in good yield over 2 steps from TKP 113. HPLC analysis of 
carbonate 121 showed a good level of enantioselectivity had been achieved, and a similar result was 
obtained when the process was repeated with t-butyl acrylate to give carbonate 194. 
Thiourea catalysts 148 and 195 had previously shown improved enantiomeric ratios in some Michael 
addition–ring-closure examples and were therefore tested in the reaction of TKP 113 with methyl acrylate 
(Figure 26).43 Quinine derived catalyst 148 was found to give methyl acrylate adduct 193 in an equivalent 
enantiomeric ratio to catalyst 144, although an improved enantioselectivity of the opposite enantiomer was 
obtained when quinidine thiourea 195 was employed in the reaction. The switch in the observed selectivity 
is due to the different location of the H-bond donor and the inversion of the C-9 centre and was expected 
from previous work. 
The absolute stereochemistry of 192 was assumed from previous work within our research group, which 
found the electron withdrawing group of the Michael acceptor preferred to be located over the carbonyl 
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rather than the bulky N-benzyl substituent. The stereochemistry was also supported by a crystal structure 
of a related adduct, which is included and discussed later in this Chapter. The asymmetric reaction 
generated a single diastereoisomer of tricycle 192, however, when triethylamine was used as the catalyst 
an approximate 4:1 mixture of epimers was obtained. Ultimately this was not a concern for the synthesis 
of carbonates 193–194, due to the removal of the epimeric centre in the products. Since only a single 
diastereoisomer was observed with the bifunctional catalysts we inferred that the catalyst remains 
associated with the enolate during the ring closure resulting in the observed diastereocontrol.  
The scope of the Michael addition–ring-closure was then expanded to include -substituted acrylates, 
which were found to successfully react with TKP 113, giving adducts 196 and 197 in good to excellent 
yields (Figure 27).  
 
Figure 27 – Michael addition–ring-closure with -substituted acrylates 
In contrast to acrylate adducts 193 and 194, -substituted adducts 196 and 197 were found to be stable to 
silica, which removed the need for conversion into carbonate derivatives. In the reaction with methyl 
crotonate, compound 196 was generated in an improved enantiomeric ratio of 4:96 when thiourea catalyst 
195 was used compared to 85:15 er with phenanthryl catalyst 144. For this reason, the reaction with ethyl 
cinnamate was only performed using thiourea catalysts 195 and 148 and gave compound 197 in moderate 
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yields and excellent enantiomeric ratios. Once again the enantiocomplementary result could be achieved 
through the use of pseudo-enantiomeric catalysts. 
Thiourea catalysts 148 and 195 had previously given poor enantiomeric ratios with methyl vinyl ketone 
(up to 30:70 er, Table 1, page 32) however, the catalysts had given excellent results with acrylates (up to 
97:3 er). The justification for this dramatic improvement in enantioselectivity is currently unknown but is 
consistent with some previous results.43 
Previous results had shown that maleimides were also suitable Michael acceptors, however in the reaction 
of N-phenyl maleimide 198 with proline TKP 113, N-phenyl maleimide adduct 199 was isolated only in 
moderate yield and the measured enantiomeric ratio was low (Scheme 44). 
 
Scheme 44 – Michael addition to N-phenyl maleimide 
The reduced yield was thought to be due to the poor solubility of adduct 199, which made purification 
difficult. Alternative maleimides were not tested due to the poor enantioselectivity, which was not 
expected to significantly increase and for the same reason thiourea catalysts were not tested. 
With the excellent results provided by unsaturated esters and oxazolidinones, research then turned to the 
question of whether ,-unsaturated amides would be suitable Michael acceptors. Acrylamides are known 
to be significantly less reactive Michael acceptors in comparison to unsaturated esters or enones.83 Despite 
the lower reactivity, asymmetric Michael additions have been reported with a couple of examples shown 
below (Figure 28).84,85 
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Figure 28 – Examples of asymmetric Michael additions with acrylamides 
Kobayashi and co-workers have shown that chiral metal complexes can be used to catalyse the asymmetric 
Michael addition of adduct 200 to Weinreb acrylamide 201 in moderate yield and good enantiomeric 
excess. In work more relevant to this project, Dixon and co-workers reported the addition of -keto ester 
204 to N-acyl pyrrole 205 using the familiar cinchona derived catalyst 144. An excellent yield and 
enantiomeric excess were obtained but the reaction required the use of an activated pyrrole-acrylamide, 
which is expected to react more like an enone than an acrylamide due to the aromatic nature of pyrrole.  
Previous work within our research group had found that TKPs were unreactive towards acrylamides, 
however since proline TKP had already shown novel reactivity, the reaction with N-phenyl acrylamide 
was attempted (Figure 29). Adduct 207 was isolated in good yield, although an extended reaction time 
was required in comparison to enones, presumably due to the reduced reactivity of acrylamides. This was 
thought to be the first example of a cinchona alkaloid catalysed Michael addition to a non-activated 
acrylamide. In addition to the novel reactivity, the enantioselectivity of adduct 207 was found to be 
excellent. Spurred on by this result, a range of other acrylamides were tested with TKP 113 (Figure 29). 
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Figure 29 – Scope of Michael addition with acrylamides [(a) – 5–10% of amide epimer observed in crude reaction mixtures] 
The Michael addition of TKP 113 was found to be successful with a range of secondary and tertiary 
acrylamides, including cyclic examples, giving adducts 207–215 in good to excellent yields. Exceptional 
enantiomeric ratios were measured for all adducts with the lowest selectivity (96:4 er) measured for bulky 
diphenyl adduct 211. Adducts 207–215 were isolated as single diastereoisomers, although approximately 
5–10% of the C-6 epimers were observed for diphenyl and indoline adducts 211 and 215 in the crude 
reaction mixtures. This reduction in diastereoselectivity with adducts 211 and 215 was thought to be due 
to the bulkiness of the nitrogen substituents which resulted in a reduced catalyst enolate interaction. The 
generally high diastereocontrol observed with adducts 207–215 gave further weight to the hypothesis 
suggested following the results with acrylates, that the catalyst was involved in the ring-closure step. 
Further to this, a mixture of epimers at C-6 were observed (approx. 3:1) when triethylamine was used as 
base for the reaction of TKP 113 with with N-phenyl and N-benzyl acrylamides, matching the result seen 
earlier with methyl acrylate. To overcome this issue, the reactions were conducted using a 1:1 mixture of 
catalysts 142 and 144, which allowed access to racemic adducts 207–215 as single diastereoisomers in 
good yield and enabled chiral HPLC conditions to be established.  
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The absolute stereochemistry was determined from an X-ray crystal structure of NMePh adduct 209 
(Figure 30).  
 
 
 
 
Figure 30 – X-ray structure of NMePh adduct 209 with ellipsoids drawn at the 50% probability level 
The solved structure clearly showed the amide group was positioned over the ‘front’ carbonyl, away from 
the bulky N-benzyl group. This result was in agreement with previous work and was also used to assign 
the absolute structure of acrylate adducts 192. 
During the screen of acrylamide acceptors, it was found that Michael addition of proline TKP 113 with 
indole vinyl ketone 216 gave ‘open’ adduct 217 rather than the expected ‘closed’ adduct 218 (Scheme 45). 
 
Scheme 45 – Michael addition with indole vinyl ketone 216. 
A plausible explanation for the generation of ‘open’ adduct 217 is that the acceptor, 216, is more ‘ketone-
like’ than the other acrylamides above, because of the aromatic indole. The poor solubility of acrylamide 
216 and of the product, 217, was thought to be responsible for the long reaction time and low yield. In light 
of this result, pyrrole acrylamide 204 was not tested as it was expected to react in the same way. 
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Determination of the enantiomeric ratio of Weinreb adduct 212 by chiral HPLC could not be achieved 
with the available columns, due in part to the high polarity of adduct 212. Consequently, conversion of 
adduct 212 into a compound suitable for HPLC analysis was required. Weinreb amides are well known 
for their ability to be converted into ketones through the reaction with Grignard reagents or alkyl 
lithiums.86,87 Therefore, Weinreb adduct 212 was treated with methylmagnesiumbromide (Scheme 46). 
 
Scheme 46 – Conversion of Weinreb adduct 212 
Grignard addition was found to occur and generated adduct 219, as a 2.5:1 mixture of epimers at C-6, as 
seen in the NMR spectrum of the crude reaction mixture, with epimerisation of the C-6 stereocentre 
adjacent to the amide thought to be caused by the excess Grignard reagent. Surprisingly, when the mixture 
was purified ‘closed’ adduct 219 was found to fully convert, presumably via a retro-‘aldol’ ring opening, 
to adduct 134. Since HPLC conditions had already been found for methyl vinyl ketone adduct 134, the 
enantiomeric ratio of 134 was quickly determined to be 98:2. The enantioselectivity of 214 was confidently 
inferred from 134 since the initial bond, at the TKP’s -centre, is unaffected by the Grignard addition and 
subsequent ring opening. The moderate and variable yield of the reaction was attributed to cleavage of the 
N-acyl hemiaminal, which had been previously seen under basic conditions. Attempts to reduce the 
equivalents of methylmagnesiumbromide used resulted in incomplete reactions and reduced yields. It was 
found that methyl lithium could also be successfully employed to convert 212 into MVK adduct 134 in 
similar 50–60% yields. It was envisioned that this methodology could be used to generate a large number 
of ‘open’ adducts, through the addition of different Grignard reagents, alkyl lithiums or lithium aluminium 
hydride to Weinreb adduct 212. Generation of ‘open’ compounds in this way would provide them in 
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improved enantioselectivity compared to direct synthesis from the respective vinyl ketone/aldehyde, as 
seen in Chapter 2 (134 98:2 er from Weinreb adduct 212 or 90:10 er from the reaction of proline TKP 113 
and MVK). 
Once again, the observed enantioselectivity was found to be consistent between the N-benzyl and N-PMB 
protected TKPs, with adduct 221 synthesised in good yield and with an excellent er. 
 
Scheme 47 – Michael addition of PMB proline TKP 125 with NMePh acrylamide 220 
Since -substituted enones and acrylates had previously proved successful,-substituted acrylamides 222 
and 223 were also tested with proline TKP 113 (Scheme 48).  
 
Scheme 48 – Attempted Michael addition with cinnamoyl amides 222 and 223 
However, no reaction was observed with either Michael acceptor even when the reaction mixtures were 
warmed to room temperature. Seemingly, the combination of the increased steric demands and the reduced 
reactivity of acrylamides meant that -substituted acrylamides were unsuitable Michael acceptors for this 
chemistry.  
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Further Transformations of Michael Addition–Ring Closure Adducts 
As shown, the Michael addition–ring-closure process provided a variety of adducts that possess the 
pyrrolidine fused bicyclo[2.2.2]diazaoctane core that is found within the prenylated indole alkaloids. The 
tandem process afforded a range of adducts in good to excellent yields and with excellent levels of 
enantioselectivity and diastereoselectivity (Figure 31). The next stage of the project concentrated on the 
synthetic transformation of these adducts with the aim to access the aforementioned natural product family. 
 
Figure 31 – Overview of Michael addition–ring-closure and the overlap of product 226 with the natural products 
It was noted that to increase the potential utility of this methodology for access towards natural product 
derivatives or fragments, there were two main requirements (Figure 31). Firstly, the Michael addition–
ring-closure generated compounds possessing an N-acyl hemiaminal. This functionality is not present in 
the natural product skeleton and had also caused some stability issues, therefore, a strategy was needed for 
the removal of the bridgehead hydroxyl functionality. Secondly, the natural products have an unprotected, 
or in some circumstances a methylated, nitrogen so a method for deprotecting the DKP adducts was also 
sought.  
Deoxygenation of Michael-Ring Closure Adducts 
Examining the literature showed that N-acyl iminium chemistry was a plausible method for the 
deoxygenation of N-acyl hemiaminals, with examples including tertiary hydroxyamides such as the one 
below (Scheme 49). 
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Scheme 49 – Example reduction of N-acyl hemiaminal88 
In fact, N-acyl iminium chemistry had even been used within our research group on a TKP system.43 Diol 
230, generated from the reduction of the acrolein Michael adduct 229, using sodium borohydride, was 
converted to bicycle 231 using TMS triflate in excellent yield (Scheme 50). 
 
Scheme 50 – N-acyl iminium ring closure 
However, with the tricyclic proline adducts the N-acyl hemiaminal is not only tertiary, but also at the 
bridgehead position, meaning that generation of the intermediate iminium was unlikely to occur. Despite 
this, two sets of conditions were tested with adducts 159 and 209, but unsurprisingly no reaction was 
observed (Scheme 51). 
 
Scheme 51 – Attempted N-acyl iminium reduction 
Due to the bridgehead position of the hemiaminal a different method was needed for the deoxygenation 
of the Michael addition–ring-closure products. The Barton–McCombie radical deoxygenation was 
identified as a potential method, with examples reported for the reduction and alkylation of tertiary 
bridgehead hydroxyls (Figure 32). 
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Figure 32 – Examples of radical deoxygenation of tertiary bridgehead hydroxyls89,90 
Wood and co-workers reported the reduction of alcohol 233, via methyl xanthate 234, using water and 
trimethylborane as initiator (Scheme A, Figure 32), whereas Inoue and co-workers generated 238 from 
alcohol 236, using a Keck allylation on intermediate thiocarbonate 237 (Scheme B, Figure 32).89,90 
The literature precedent strongly suggested that reduction of the bridgehead position should be possible 
using the Barton–McCombie reaction and it gave the possibility for alkylation of the bridgehead position, 
potentially allowing access towards natural product scaffolds. However, the method required an additional 
step for the functionalisation of the alcohol to either a xanthate, thiocarbonate or thiocarbamate 240, in 
order to achieve deoxygenation. (Figure 33). 
 
Figure 33 – General Barton–McCombie deoxygenation scheme 
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In order to gauge whether functionalisation of the bridgehead hydroxyl was viable, due to the known 
cleavage of the N-acyl hemiaminal under basic conditions, acylation with methyl chloroformate was 
attempted. Initial studies into the functionalisation of the bridgehead hydroxyl were completed on adduct 
209 (Scheme 52). 
 
Scheme 52 – Acylation of bridgehead hydroxyl 
Acylation using sodium hydride gave ‘opened’ product 243 in good yield and attempts to prevent ring 
opening with colder reaction temperatures were unsuccessful. Substitution of the base to n-butyl lithium 
was then performed but only partial conversion to product 242 was achieved (approx. 10%), even with 3 
equivalents of base. However, when LiHMDS was used the conversion to product was increased to 90%, 
although 242 could not be isolated cleanly from starting material 209. 
With LiHMDS showing promising results with methyl chloroformate, reaction with O-phenyl 
chlorothionoformate was then attempted (Scheme 53). 
 
Scheme 53 – Synthesis of thiocarbonate 244 
Reaction of 209 under the previous conditions, using LiHMDS, gave approximately 20% conversion of 
the starting material and the product was found to be a 4:1 mixture of desired product 244 and ‘opened’ 
compound 245. Swapping the base to NaHMDS was found to give significant improvements, with 
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thiocarbonate 244 generated in 72% yield. Small quantities of opened thiocarbonate 245 were isolated (up 
to 10%) but could be separated from the desired product.  
Synthesis of methyl xanthate 247 using a range of bases and quenching with carbon disulphide and methyl 
iodide or imidazolyl dithioester 246 was also attempted (Scheme 54). Unfortunately all attempts were 
unsuccessful, either returning unreacted 209 or decomposition products in some cases, and consequently 
xanthate intermediates were not further investigated. 
 
Scheme 54 – Attempted synthesis of xanthate 247 
Concurrently, the acylation and thioacylation reactions were also attempted with chalcone adduct 159 
(Figure 34). 
 
Figure 34 – Functionalisation of chalcone adduct 159 
Acylation of 159 with methyl chloroformate afforded 248 in good yield using n-butyl lithium, but despite 
trying various conditions the synthesis of thio-derivative 249 was not achieved. Unfortunately compound 
159 was not stable under the reaction conditions, with warmer reaction temperatures needed due to the 
lower reactivity of thionoformate or carbon disulphide compared to methyl chloroformate. Chalcone 
Chapter 3  Tricyclic Diketopiperazines 
 
66 
 
adduct 159 was seen to either undergo cleavage of the N-acyl hemiaminal or retro-‘aldol’ ring opening 
and therefore synthesis of 249 was not pursued any further.  
With thiocarbonate 244 in hand, research then focussed on the radical cleavage of the C-O bond. Tributyl 
tin hydride and AIBN were found to be the predominant conditions for the Barton–McCombie 
deoxygenation and were therefore employed on thiocarbonate 244 in toluene (Scheme 55).91,92 
 
Scheme 55 – Barton McCombie deoxygenation 
Desired product 251 was not observed in the reaction mixture, but instead the reaction generated 
pentacycle 250 in moderate and variable yields along with significant regeneration of alcohol 209. 
Pentacycle 250 is a very interesting compound that was presumably formed by a homolytic aromatic 
substitution, with addition of the intermediate bridgehead radical into the phenyl ring followed by 
oxidation (Scheme 56).93,94 
 
Scheme 56 – Proposed mecahnism for generation of pentacycle 250 through a homolytic aromatic substitution 
Regeneration of the alcohol is a common problem of the Barton–McCombie deoxygenation although it is 
normally only a minor side reaction.95 Unfortunately, in the case of 244, alcohol regeneration was found 
to be the predominant reaction, and was thought to be caused by a formal 1,2-addition of tributyltinhydride 
to the thiocarbonyl and then degradation to give alcohol 209. Slow addition of the Bu
3
SnH has been shown 
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to reduced alcohol regeneration but application of this to the reaction of 244 showed no significant change 
to the result. 
Significant work has been completed by the group of Chatgilialoglu into alternative reagents to Bu
3
SnH 
and have reported that tris(trimethylsilyl)silane (TTMSS) is a suitable alternative radical reducing 
agent.96,97 Reduction of 244 using TTMSS and AIBN resulted in decomposition of the starting material 
but swapping the initiator to 1,1′-azobis(cyclohexanecarbonitrile) (ACCN) gave pentacycle 250 in 
moderate but variable yields but with no alcohol regeneration (Scheme 57). 
 
Scheme 57 – Radical cyclisation of thiocarbonate 244 
It was later found that performing the reaction under air, rather than under nitrogen, resulted in an increased 
yield of pentacycle 250, of up to 70%, although the reaction time was extended to 8 hours and additional 
TTMSS and ACCN had to be added for the reaction to reach completion. The increase in yield was 
attributed to the improved oxidation of aromatic radical intermediate 253 and the increased reaction times 
may have been caused by auto-oxidation of the silane to a siloxane and also quenching of radical species 
by molecular oxygen.98 
Chapter 3  Tricyclic Diketopiperazines 
 
68 
 
 
Figure 35 – X-ray structure of pentacycle 250 
The X-ray structure of pentacycle 250 was solved and clearly showed the new bridgehead bond to the 
phenyl ring (Figure 35). The structure also showed that the C-6 amidic centre had not been epimerised 
during either the thiocarbonate formation or deoxygenation steps. This was a remarkable result, with 
pentacycle 250 isolated as a single diastereoisomer in only three steps from TKP 113. Since amide 209 
was synthesised with excellent enantioselectivity, as shown earlier, it was confidently expected that either 
enantiomer of adduct 209 could be accessed. Furthermore, with the clear similarity of 250 to the natural 
product family, it demonstrated the utility of the methodology for the access of natural product derivatives. 
Since aromatic homolytic substitution had occurred with thiocarbonate 244, related thiocarbonates 254 
and 255, devoid of an aromatic substituent, were synthesised and reduced (Scheme 58). 
 
Scheme 58 – Deoxygenation of non-aromatic amide adducts 
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Synthesis of dimethyl and Weinreb thiocarbonates 254 and 255 proceeded smoothly and in good yield, 
with approximately 10% of the open thiocarbonate observed, matching the result with adduct 209. Initial 
attempts at the radical reduction of NMe2 thiocarbonate 254 using the previous conditions, found for 244, 
only gave reduced adduct 256 in poor yield (approx. 5%) and completing the reaction with Bu3SnH 
resulted in decomposition. However, an excellent yield was obtained when increased quantities of TTMSS 
(5 equiv.) and ACCN (1.5 equiv.) were used with adduct 256 generated in quantitative yield. Subjecting 
Weinreb thiocarbonate 255 to the same conditions also resulted in reduction in excellent yield but with 
concomitant cleavage of the hydroxylamide N–O bond to give secondary amide 257. Although no reports 
were found of using Bu3SnH or TTMSS to effect N–O cleavage, the reductive cleavage of 
hydroxylamines has been reported for a number of other reducing agents, including Na, Li, SmI2 and also 
organic electron donors.99–101 
With the excellent results obtained for the deoxygenation of adduct 210, the procedure was repeated on 
the PMB variant 258, with the aim of synthesising adduct 260 which could then later be deprotected 
(Scheme 59). 
 
Scheme 59 – Deoxygenation of PMB amide adduct 258 
Synthesis of thiocarbonate 259 proved more challenging than for the previous examples above, with 
significant epimerisation of the amidic stereocentre observed, affording thiocarbonate 259 as a mixture of 
diastereoisomers. The combination of the diastereomeric mixture and the formation of the usual opened 
thiocarbonate sideproduct, resulted in the purification of product 259 using preparative HPLC. With 
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thiocarbonate 259 in hand reduction using TTMSS and ACCN under the previously optimised conditions 
afforded compound 260 in good yield, ready for deprotection which will be discussed later in this Chapter. 
In an effort to extend the radical deoxygenation chemistry, the Keck allylation of thiocarbonate 254 was 
also attempted (Scheme 60). 
 
Scheme 60 – Keck allylation of NMe2 thiocarbonate 254 
The reaction was found to proceed but gave a mixture of allylated products which were tentatively 
assigned as 261 and 262. Unfortunately, the products could not be separated by silica gel flash 
chromatography or preparative HPLC so determination of the structure was not achieved. The proposed 
mechanism for formation of the two isomers is shown below (Figure 36). 
 
Figure 36 – Proposed mechanism for generation of allylated compounds 261 and 262 
In the presence of Bu3Sn· thiocarbonate 254 was expected to be converted to bridgehead radical 263 which 
could then react directly with a molecule of allyl tributyl tin to generate the expected Keck allylation 
product 261. Alternatively radical 264 could formed from a 1,5–H abstraction before reaction with allyl 
tributyl tin that would then generate compound 262 (Figure 36).  
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Inspired by the homolytic aromatic substitution that generated pentacycle 250, it was envisioned that a 
similar cyclisation could occur with indole thiocarbonate 265 (Scheme 61). Incorporation of an indole 
moiety into the radical adduct was desired to further increase overlap with the natural products, with 
cyclised product 266 showing significant similarities to several family members. 
 
Scheme 61 – Proposed radical cyclisation via indole thiocarbonate 
Oxidation of indoline adduct 215 with DDQ was achieved in good yield but the conversion of indole 267 
to thiocarbonate 265 was unsuccessful, instead affording ‘open’ indole adduct 217 (Scheme 62). 
 
Scheme 62 – Attempted synthesis of indole thiocarbonate 265 
Treatment of indole 267 with base resulted in a retro-‘aldol’ ring opening giving  indole adduct 217, which 
was in contrast to the N-acyl hemiaminal cleavage seen in the previous thiocarbonate syntheses. This was 
presumably due to the more ketone-like nature of the acyl indole, compared to the other amides, which 
made it a better leaving group than the amide. Considering this, the order of the steps was altered and 
thiocarbonate formation followed by indoline oxidation gave access to indole thiocarbonate 265 in good 
yield (Scheme 63). 
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Scheme 63 – Synthesis of indole thiocarbonate 265 
Radical cyclisation of indole thiocarbonate 265 was then attempted but unfortunately compound 266 was 
not isolated. Various conditions, with both Bu3SnH and TTMSS, were employed but in all cases no 
significant products could be identified from the crude reaction mixtures (Scheme 64). 
 
Scheme 64 – Attempted radical cyclisation of indole thiocarbonate 265 
With this result and other attempts to access compounds with an alkylated bridgehead position being 
unsuccessful, other than generation of pentacycle 250, research in this area was stopped, however, an 
alternative approach was undertaken and will be discussed in the next Chapter. 
Nitrogen Deprotection 
The second desired transformation to increase the structural overlap with the natural product family, was 
the deprotection of the tricyclic Michael addition–ring-closure adducts. Due to the known difficulty in 
removing N-benzyl groups from amides, the deprotection was only attempted on PMB adducts.102 
Consultation of the literature and based on some preliminary results from our research group, indicated 
that cerium ammonium nitrate (CAN) should be a suitable oxidant for the removal of the PMB protecting 
group from Michael addition–ring-closure products. 
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Deprotection of chalcone adduct 179 with an aqueous CAN solution, proceeded in moderate yield 
although product 269 was found to have poor solubility which made isolation and purification difficult. 
 
Scheme 65 – Deprotection of chalcone adduct 179  
Despite the purification and isolation problems this was an impressive result, especially since removal of 
the PMB group from similar structures had previously proved troublesome.45,102 With this promising result 
the deprotection of other compounds was attempted.  
Amide 258, thiocarbonate 259 and reduced compound 260 were all submitted to the same reaction 
conditions as used with chalcone adduct 179 (Scheme 66). In all three reactions, anisaldehyde was 
observed, indicating the progression of the reaction, but no desired compound was isolated. 
 
Scheme 66 – Attempted deprotection of compounds 258, 259 and 260 
Various modifications were made to the reaction conditions in an attempt to access compound 270, 
including shorter reaction times, lower equivalents of CAN and changing the solvent to t-BuOH:CH2Cl2 
in order to reduce the reaction temperature. However, none of the modifications were found to improve 
the outcome of the reaction. Unfortunately the deprotection method appeared to only be suitable for 
chalcone adduct 179 but ongoing research on the removal of a dimethoxy benzyl (DMB) group has given 
promising results on other TKP systems.  
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Summary and Future Work 
The Michael addition–ring-closure has been observed with a number of acceptors, including -substituted 
enones, acrylates and N-phenyl maleimide. The tandem process was also found to occur with a wide range 
of acrylamides, and is believed to be the first example of cinchona alkaloid catalysed Michael addition to 
unactivated ,-unsaturated amides. Exceptional levels of enantioselectivity have been recorded across a 
range of acceptor classes with results up to 99:1 er using cinchona derived catalysts. 
As with previous results, the enantioselectivity of the Michael addition appears to be consistent regardless 
of the use of N-benzyl or N-PMB protecting groups. The latter of which was oxidatively removed from 
chalcone adduct 179 in good yield using cerium ammonium nitrate, although attempts at the deprotection 
of amide adducts were unsuccessful. 
To increase structural overlap with the natural product family, deoxygenation of the bridgehead hydroxyl 
was attempted. No reaction was observed using N-acyl iminium chemistry but reduction and cyclisation 
were found to occur using the Barton–McCombie reaction. Conversion of Michael addition–ring-closure 
adducts to thiocarbonates was found to proceed in good yield using NaHMDS and O-phenyl chloro- 
thionoformate, although ring opening was observed in low yield (up to 10%). Use of TTMSS and ACCN 
with NMePh thiocarbonate 244 gave cyclised product 250 in good yield from an aromatic homolytic 
substitution, whereas the reductions of non-aromatic amides 210 and 212 were achieved using slightly 
modified conditions in excellent yields. It was also found that reduction of Weinreb adduct 212 occurred 
with concomitant hydroxylamine cleavage to generate a secondary amide. The deoxygenation of a PMB 
protected amide adduct was also successful, although lower yields for the formation of thiocarbonate were 
obtained, due to epimerisation of the centre adjacent to the amide. The Keck allylation of NMe2 adduct 
254 was also attempted but the reaction gave a mixture of allylated products with a side product thought 
to be caused by 1,5-H abstraction of the bridgehead radical. 
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Work is currently ongoing within the group on an alternative DMB protecting group which should allow 
for a milder deprotection of Michael addition–ring-closure and deoxygenation adducts. Previous work on 
the synthesis of brevianamide B 2 and malbrancheamide B 5 found that an OBn protecting group could 
be used and later removed using SmI2.
36 With the observed cleavage of the hydroxylamine in the 
deoxygenation of Weinreb adduct 212, there is potential for completing the deoxygenation and 
deprotection reactions in one step if an OBn or OMe protected proline TKP could be synthesised and taken 
through the additional steps. 
As mentioned earlier, the reaction of Weinreb TKP adduct 212 with Grignard reagents, alkyl lithiums or 
lithium aluminium hydride should allow access to a number of ‘open’ adducts all in excellent 
enantioselectivity which would be set from the initial Michael reaction with Weinreb acrylamide. 
Additional work is also needed with acrylonitrile and vinyl sulfones, which gave multiple products under 
the standard conditions used for the other acceptors. Alternative catalysts and solvents could be screened 
to see if the expected Michael addition–ring-closure adduct could be established for these acceptor classes, 
thereby broadening the scope of the reaction. An alternative catalyst such as those mentioned at the end of 
Chapter 2 may also allow the Michael addition with -substituted acrylamide and/or with ,-disubstituted 
enones and give improved enantioselectivity with the addition to maleimides. 
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Chapter Four – Accessing the Bicyclo[2.2.2]diazaoctane Core 
Through a Michael–Michael Cascade 
Aims and Objectives 
The removal of the problematic bridgehead hydroxyl generated from the Michael-addition–ring-closure 
process was successfully achieved using a Barton–McCombie radical deoxygenation on a small selection 
of amide adducts. Attempts to extend this methodology towards the natural products, such as stephacidin 
A 16, through inter- or intra-molecular additions were unfortunately not successful. This resulted in a 
desire to find an alternative cascade process for generating compounds possessing the 
bicyclo[2.2.2]diazaoctane core without the bridgehead hydroxyl. Our proposed alternative strategy was to 
replace the reactive carbonyl of the TKPs with an electron deficient alkene to give methylene DKP 272. 
It was anticipated that adduct 272 would undergo a Michael addition to give intermediate enolate 273 
which would then hopefully close onto the intramolecular Michael acceptor. This Michael–Michael 
cascade strategy should generate adduct 274, which possesses the bridgehead C-C bond, as seen in 
stephacidin A 16, rather than the problematic N-acyl hemiaminal previously generated (Figure 37). 
 
Figure 37 – Proposed Michael–Michael cascade with proline DKP derivative 
It was envisioned that methylene DKP 272, like the previously used TKPs, would also be activated for 
deprotonation at the -position, since the electron withdrawing group would withdraw electron density in 
a similar fashion to the C-3 carbonyl in the TKP system. Although the activation of the extended system 
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was expected to be less than that seen in the TKP systems, it was hoped that it would be sufficient to allow 
deprotonation of the -centre by amine bases, specifically the chiral cinchona alkaloids used for the 
asymmetric Michael additions with the proline TKPs, enabling the organocatalytic Michael–Michael 
cascade. 
On consultation of the literature it was found that asymmetric Michael–Michael cascades with oxindole 
derivatives have been previously reported, catalysed by cinchona derived catalysts (Figure 38).103,104 
 
Figure 38 – Examples of Michael–Michael cascades 
Xu and co-workers showed that catalyst 277 can deprotonate enol 275 and catalyse the asymmetric 
Michael addition into nitroolefin 276 before cyclisation of the generated nitronate into the intramolecular 
acrylate. Wang and co-workers showed that squaramide catalyst 282 can deprotonate oxindole 279 which 
adds into methylene oxindole 280 followed by cyclisation on to the acrylate moiety of 279 to form spiro-
bisoxindole 281. Both Michael–Michael cascades above were found to be highly enantio- and diastereo-
selective, giving products 277 and 281 in good to excellent yields. These results gave confidence for the 
Michael–Michael strategy towards DKP 274 and the natural product family. 
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Synthesis of Electron Deficient Methylene Diketopiperazines 
The first aim was the synthesis of electron deficient methylene DKPs and examination of the literature 
showed several potential synthetic routes (Figure 39).53,105,106 
 
Figure 39 – Examples of the synthesis of electron deficient methylene DKPs 
Williams and co-workers synthesised DKP 285 from prolinamide 283 with pyruvic acid derivative 284 
through an amide coupling reaction in good yield (A, Figure 39) whilst Person and Le Corre reported the 
non-classical Wittig reaction of TKPs 115a+e with several ylides which gave methylene DKP 286 in good 
yield (B, Figure 39). Finally, Shin and co-workers synthesised DKP 288 from diethyl oxalpropionate 287, 
firstly forming the N-acyl enamine condensation product before chlorine displacement and then 
cyclisation using benzylamine (C, Figure 39). 
Of the methods shown above, the Wittig reaction was chosen to be investigated first, since this divergent 
synthesis potentially allowed access to a number of DKPs to be synthesised through varying the choice of 
ylide. 
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With a significant quantity of benzyl TKP 113 to hand and inspired by the chemistry of Person and Le 
Corre the reaction with cyano ylide 289, which was readily prepared following a literature procedure, was 
investigated (Scheme 67).107  
 
Scheme 67 – Conversion of proline TKP to cyano proline DKP 
Under the conditions reported by Person and Le Corre no reaction was found to take place, which was 
thought to be due to the added steric bulk of the N-benzyl protecting group compared to the secondary 
imide in the literature example. As an alternative to conventional reflux conditions and to allow the reaction 
to be performed at higher temperature, the reaction mixture was heated in a sealed vessel using a 
microwave reactor at 140 °C for 3 hours. Using these conditions DKP 290 was synthesised in excellent 
combined yield of 99% as a 1:1.6 mixture of E and Z isomers which could be separated using silica-gel 
column chromatography. The minor E-isomer was assigned with the newly installed cyano group trans to 
the N-benzyl due to an observed correlation of the alkene CH to the methylene protons of the benzyl group 
in the NOESY NMR experiment. Considering the limitations of microwave reactors for the synthesis of 
gram-quantities of cyano-DKP the batch reaction was repeated using xylene to achieve a reaction 
temperature of 140 °C under reflux, but was found to only give partial conversion to the desired product 
after 18 hours. Extended reaction times and increased quantities of ylide 289 were investigated, however 
the reaction yield was found to plateau around 25% and so the microwave conditions were used in multiple 
batches. 
Following the successful synthesis of cyano DKP 290, a number of other stabilised ylides were tested with 
proline TKP 113 under the same conditions (Scheme 68). 
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Scheme 68 – Attempted Wittig reactions 
Disappointingly, no reaction or decomposition of 113 was observed for the majority of the ylides, except 
for methyl (triphenylphosphoranylidene)acetate which afforded carboxymethyl DKP 291 in moderate but 
highly variable yields. Attempts were made to improve the yield and reproducibility for the synthesis of 
291, including using additives (Et3N, LiCl and K2CO3), changing solvents (xylene and THF) and varying 
the temperature of the reaction (140–200 °C), however, no significant improvement could be made.  
Along with the moderate and variable yield for the synthesis of 291, isolation of clean product without 
triphenylphosphine oxide, the by-product from the Wittig reaction, was found to be difficult. In an attempt 
to remove this purification issue and potentially increase the yield of 291, a Horner–Wadsworth–Emmons 
(HWE) reaction was attempted (Scheme 69). 
 
Scheme 69 – Attempted HWE reaction on proline TKP 
The benefit of the HWE reaction is that the phosphate by-product is water soluble so can be easily removed 
from the desired product through an aqueous wash and also the phosphonate carbanion is more reactive 
than phosphonium ylides. Unfortunately the reaction was unsuccessful, returning TKP 113 along with 
some minor degradation products. The reaction mixture was observed to turn bright yellow in colour, 
which was previously found to be indicative of the formation of the TKP enolate, suggesting that the HWE 
reaction was unsuccessful due to the deprotonation of the acidic -proton on TKP 113. Generation of the 
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TKP enolate was then expected to prevent addition of the phosphonate carbanion into the C-3 carbonyl. 
This result indicated that phosphonate reagents would not be suitable for the olefination of TKP 113, due 
to the high acidity of the -proton and the increased basicity of phosphonates compared to phosphonium 
ylides, and therefore were not investigated further. 
At the same time cyano ylide 289, which had shown excellent reactivity with proline TKP 113, was 
reacted with a variety of TKPs to investigate the scope of the Wittig reaction (Figure 40). 
 
Figure 40 – Scope of the Wittig reaction of cyano ylide with various TKPs 
Gratifyingly the reaction was found to be successful with a range of TKPs, with PMB protected DKP 295 
and homo-proline adduct 296 generated in good to excellent yields, with E:Z ratios consistent with the 
previous result with TKP 113. The reactions involving glycine and carboxymethyl TKPs 100a and 100b 
were found not to reach completion, irrespective of the equivalents of ylide added. The Z-isomers of 293 
and 294 could be isolated in moderate yield with the E-isomers co-eluting with the unreacted starting 
materials. In the case of carboxymethyl TKP 100b, some glycine TKP 100a also co-eluted with the E-
isomer, presumably the result of a decarboxylation reaction under the harsh reaction conditions. 
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Investigation of the Michael–Michael Cascade with Methylene DKPs 
With a number of methylene DKPs in hand the next step was to investigate whether they would undergo 
a Michael–Michael cascade reaction. Initial research was conducted with cyano DKP Z-290 and MVK, 
as shown below (Table 2).  
  
Entry Catalyst Temp (°C) Time (d) 297 (%)a 298 (%)a erb 
1 Et3N -30 3 10% conv.c 0 ND 
2 Et3N 20 3 70 0 ND 
3 144 20 4 83 0 61:39 
4 101 2 10 87 0 68:32 
5 194 2 10 90 0 50:50 
6 174 2 3 47 (35% rsm) 0 49:51 
Table 2 – Asymmetric Michael addition of cyano DKP, a – isolated yield, b – determined by HPLC, c – determined by NMR 
The reaction of DKP 290 with MVK was found to be slow when conducted at –30 °C, and the new product 
was identified as Michael adduct 297 with Michael–Michael adduct 298 unfortunately not observed   
(entry 1). Michael adduct 297 was isolated in good yield when the reaction was performed at room 
temperature but again Michael–Michael adduct 298 was not observed (entry 2). The previous optimal 
catalyst was then employed at room temperature and, as with triethylamine, gave adduct 297 in good yield 
but the enantiomeric ratio was found to be only moderate (entry 3). Nevertheless this was important 
progress as it is the first example of this class of Michael donor undergoing an asymmetric Michael 
addition. It was found that the enantioselectivity could be slightly increased to 68:32 er by using catalyst 
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101 at 2 °C but the reaction time had to be extended by 6 days to achieve full conversion (entry 4). Thiourea 
catalyst 194 and Takemoto’s catalyst 174 were also tested but afforded product 297 as racemic mixtures 
(entries 5 and 6). The Michael reaction was also found to proceed with the E-isomer of cyano DKP 290 
using triethylamine, with a comparable yield of 72%, however, a method for splitting the enantiomers of 
product E-297 using chiral HPLC could not be established. Therefore, the reaction was not completed 
using the chiral catalysts since the enantioselectivity could not be determined. 
Unfortunately, no Michael–Michael product 298 was observed in any of the reactions above, but inspired 
by the successful reaction of cyano DKP 290 in the initial Michael addition with MVK, the same reaction 
was attempted with carboxymethyl DKP Z-291 (Table 3). 
 
Entry Base Temp (°C) Time (d) 299 (%)a 300 (%)a 
1 Et3N 20 3 No reaction ND 
2 101 20 3 No reaction ND 
3 DBU 20 1 (h) Decomposition ND 
4 DBU -30 4 30 23 
5 DBU 2 4 0 69 (7:1 dr) 
Table 3 – Michael–Michael cascade of carboxymethyl DKP, a – isolated yield 
Disappointingly, no reaction was observed using either triethylamine or catalyst 101 even when conducted 
at room temperature. This lack of reactivity in comparison to cyano DKP 290 was thought be due to the 
decreased electron withdrawing nature of the ester group compared to the nitrile, which results in reduced 
activation of the -proton. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) was then employed as a stronger 
base in order to deprotonate DKP 291 but was unfortunately found to decompose DKP 291 after 1 hour 
at room temperature (entry 3). When the reaction was repeated using DBU at –30 °C it was pleasingly 
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found to give both Michael adduct 299 and also Michael–Michael adduct 300 in 30% and 23% yields 
respectively (entry 4). Increasing the reaction temperature to 2 °C afforded Michael–Michael adduct 300 
as the sole product in a good yield of 69%. Gratifyingly, 300 was also formed in a good diastereomeric 
ratio, with the major epimer drawn above assigned from correlations in the NOESY NMR and was 
thought to match the predominate stereochemistry of the desired natural product family. This exceptional 
result is the first example of a Michael–Michael cascade on a DKP substrate. It also demonstrates that this 
methodology can be successfully used to access compounds possessing the pyrrolidine fused 
bicyclo[2.2.2]diazaoctane ring system, with good diastereo-control. 
Following the success with the carboxymethyl DKP, the reaction between cyano DKP Z-290 with MVK 
was repeated using DBU at 2 °C (Scheme 70). 
 
Scheme 70 – Attempted Michael–Michael cascade of cyano DKP 
Despite the observation of Michael–Michael product 298 in the NMR spectrum of the crude reaction 
mixture, neither compound 297 nor 298 could be isolated following purification by silica-gel flash column 
chromatography. Due to the observed instability of 298 and success of the carboxymethyl system this 
particular reaction was not investigated further. 
Investigating the Scope of the Michael–Michael Cascade 
Although the Michael–Michael cascade had been successfully established, the reaction required the use 
of DBU with the chiral cinchona catalysts showing reduced reactivity. In the asymmetric Michael 
additions of proline TKP 113, -substituted enones were found to undergo a Michael–‘aldol’ ring closure 
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in comparison to the Michael reaction observed with simple enones. It was hypothesised that the same 
reactivity might be seen for the methylene DKP system enabling the Michael–Michael cascade to proceed 
with-substituted enones while using the cinchona derived catalysts. Therefore, the reaction of cyano 
DKP 290 with chalcone using catalyst 101 was investigated (Scheme 71). 
 
Scheme 71 – Reaction of cyano DKP with chalcone 
The reaction of DKP 290 with chalcone, using catalyst 101, was found to afford Michael adduct 301 in 
good yield and as a single diastereoisomer, with Michael–Michael adduct 302 not observed. 
Unfortunately, despite the presence of the -substituent, catalyst 101 could not affect the second Michael 
addition with protonation of the intermediate enolate instead favoured. Despite this, the reaction is a 
surprising but notable result as in all previous work only glycine TKP 100a and proline TKP 113 had 
reacted with chalcone.43 Moreover, it was also found that the ring closure of adduct 301 could be 
successfully affected in a second step using DBU at 2 °C, affording 302 in good yield and impressively as 
a single diastereoisomer. Racemic Michael–Michael adduct 302 could also be directly generated in one 
step using DBU in moderate yield (Scheme 72). 
 
Scheme 72 – Michael–Michael cascade of cyano DKP with chalcone 
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Further to this, it was found that adduct 302 could be synthesised asymmetrically in one-pot using catalyst 
101 followed by addition of DBU once full conversion of DKP 290 was observed by TLC. The 
enantiomeric ratio of the Michael–Michael adduct 302 synthesised using this strategy was measured to be 
67:33 er, which is similar to the previous er measured for MVK adduct 297.  
Following the asymmetric Michael addition shown with proline DKP 290 the reaction of DKPs 294 and 
293 with MVK were attempted to investigate the scope of the Michael addition and to see if improved 
enantiomeric ratios could be achieved (Figure 41). 
 
Figure 41 – Exploring the scope of the Michael addition with other cyano DKPs 
Carboxymethyl DKP 294 was found to react with MVK, using catalyst 101, to afford Michael adduct 303 
in excellent yield and with a good enantiomeric ratio. The improved enantioselectivity of 85:15 er, in 
comparison to the 68:32 er result for proline adduct 290, was thought to be due to the increased acidity of 
the -proton in DKP 294 because of the added activation offered by the 1,3-dicarbonyl functionality. On 
the other hand glycine DKP 293 appeared to be less reactive and required increased catalyst loading, time 
and temperature with the reaction seeming to not reach completion after 30 days as observed by TLC. 
However when the reaction mixture was purified, the major product was found to be double Michael 
adduct 305, with the minor product being identified as Michael adduct 304. A small amount of racemic 
Michael adduct 304 was synthesised using DBU for the development of chiral HPLC conditions to 
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determine the er of adduct 304. Unfortunately, a method to separate the enantiomers could not be 
established with the chiral columns available and therefore the enantiomeric ratio could not be measured. 
Nonetheless this result is optimistic that DKP 293 underwent not only one but two Michael additions, 
meaning that this strategy should also work for alkyl methylene DKPs and also allow sequential reactions 
with two different Michael acceptors to be carried out, as previously established with TKPs.43 The high er 
achieved with carboxymethyl DKP 294 also suggests that further Michael adducts should be accessible 
with good levels of enantio-enrichment however this would require further investigation. 
As with the proline derivative, catalyst 101 only achieved the first Michael addition, therefore in an attempt 
to affect the ring closure, Michael adduct 303 was reacted with DBU (Scheme 73). 
 
Scheme 73 – Attempted Michael ring closure of monocyclic adduct 
Various attempts with modifications of the reaction temperature, time and concentration were made to try 
to generate cyclised compound 306, however, in all cases only decomposition was observed. 
Extension of the Michael–Michael Cascade towards the Prenylated Indole 
Alkaloid Family 
Following the success of the Michael–Michael cascade with the proline DKP, research then focussed on 
how the cascade process could be extended towards the prenylated indole alkaloid family. The previously 
generated Michael–Michael adducts demonstrated the utility of the method for generating products 
possessing the pyrrolidine fused bicyclo[2.2.2]diazaoctane core of the prenylated indole alkaloids. 
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However, it was hypothesised that the similarity to the skeleton of the natural products could be improved. 
Comparing the skeleton of members of the natural product family with the products of the Michael–
Michael cascade it was noted that adduct 307, which incorporates the common 2-alkyl indole moiety, 
shows excellent overlap with the skeleton of stephacidin A 16 for example (Figure 42). 
 
Figure 42 – Proposed extension of Michael–Michael chemistry 
It was hypothesised that adduct 307 should be readily accessible from proline DKP 272 and an indole 
vinyl ketone 308 through the previously established Michael–Michael cascade. 
In order to assess whether indole adduct 307 could be accessed, a number of indole vinyl ketones with 
various protecting groups were synthesised from indole-2-carboxylic acid 309 via Weinreb amide 310 
inspired by literature precedent of similar substrates (Scheme 74).108 
 
Scheme 74 – Generation of indole vinyl ketones 
Weinreb amide 310 was synthesised in good yield from an amide coupling reaction before either nitrogen 
protection followed by Grignard addition (indoles 311, 312 and 313) or Grignard addition followed by 
protection (indole 314) gave indole vinyl ketones 311–314 in variable yields without optimisation. With 
Michael acceptors 311–314 in hand the reaction with cyano proline DKP 290 and its carboxymethyl 
variant 291 were conducted (Figure 43). 
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Figure 43 – Exploring scope of Michael–Michael chemistry with indole vinyl ketones 
Gratifyingly the reaction was successful with both cyano and carboxymethyl DKPs affording adducts 
315–320 in good yields. The diastereomeric ratio of the products ranged from very good with methyl 
indole adduct 317 (>10:1) to 1.1:1 with Boc protected adduct 315. Interestingly the dr differed depending 
on the electron withdrawing group, with carboxymethyl derivatives displaying significantly better 
diastereocontrol. Although the reason behind this is not known, it was found that epimerisation of tosyl 
adduct 320 occurred when resubmitted to the reaction conditions, with the dr measured dropping from 
5.0:1 to 1.5:1 after 1 day, suggesting that DBU was causing epimerisation and a less basic catalyst may be 
required to obtain products in higher dr. Nevertheless, since the natural product family contains examples 
of either stereochemistry, the ability to synthesise both epimers of the products increases the utility of this 
reaction towards the desired natural product derivatives. 
Inspired by the interesting results obtained with the proline DKPs the Michael–Michael cascade was also 
attempted on homo-proline DKP 296 to see if other bicyclic systems would undergo this tandem process. 
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Three Michael acceptors were utilised; MVK, chalcone and Boc indole vinyl ketone 314, since these had 
proved the most successful with the proline DKPs (Figure 44). 
 
Figure 44 – Michael–Michael reaction with homo-proline cyano DKP 
Unfortunately in the reaction with MVK the product could not be isolated, as with cyano proline DKP 
290, despite being observed in the NMR spectrum of the crude reaction mixture. However, the reaction of 
DKP 296 with chalcone and Boc indole vinyl ketone 314 were pleasingly found to give 322 and 323 in 
good yields. Chalcone adduct 322 was once again synthesised as a single diastereoisomer whereas indole 
adduct 323 was generated as a mixture of epimers, matching the result with proline DKP shown earlier. 
All three reactions were also attempted using cinchona catalyst 101, however, no reaction was observed 
in all cases which was presumed to be due to the reduced acidity of DKP 296, compared to cyano proline 
DKP 290, which prevented generation of the DKP enolate. 
These excellent results show that the Michael–Michael cascade methodology could also be used to access 
derivatives of the natural products possessing a piperidine fused bicyclo[2.2.2]diazaoctane core. 
Additionally it suggested that the methodology could be further extended to other multi-cyclic DKP 
systems further increasing its potential utility. 
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Further Transformations of the Michael–Michael Adducts 
With the Michael–Michael cascade successfully established giving access to a number of compounds 
possessing the pyrrolidine and piperidine fused bicyclo[2.2.2]diazaoctane cores, found within the 
prenylated indole alkaloids. Work then concentrated on further transformations towards the natural 
product polycyclic scaffold focused on the indole adducts (315–320) that had previously been targeted 
because of their appreciable overlap with the natural products (Figure 45). 
 
Figure 45 – Comparision of indole adduct  
Comparison of indole adduct 307 to stephacidin A 16 identified two key transformations to increase the 
similarity of derivative 307 with the prenylated indole alkaloids (Figure 45). The two desirable 
transformations were the conversion of the ketone to a gem-dimethyl group and also the cyclisation 
between C-8 and C-3’ to form a six-membered ring. 
Methodology concerning the geminal disubstitution of carbonyls is dominated by the addition of 
organometallics into amides and thioamides, as demonstrated in a comprehensive review by Seebach in 
2011, occurring through iminium ion intermediates. The transformation of ketones to gem-dimethyls has 
also been reported but only a handful of times, with the reported examples limited to the three sets of 
conditions shown below (Scheme 75).109 
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Scheme 75 – Examples of dimethylation chemistry  
Meisters and co-workers found that trimethyl aluminium can be used to effect the gem-dimethylation of 
ketones but high reaction temperatures are required, although further work later found that in the presence 
of catalytic nickel acetylacetonate the transformation could be completed at low temperature.110,111 
Alternatively, Reetz and co-workers reported that dichloro-dimethyl titanium, which can be synthesised 
in situ from titanium tetrachloride and dimethyl zinc, can also be used for the dimethylation of ketones as 
well as the trimethylation of acid chlorides at low temperatures.112–114 
Inspired by the literature examples, Boc indole adduct 315 was initially reacted with Reetz’s reagent, 
generated in situ, in an attempt to generate dimethyl adduct 327 (Scheme 76). 
 
Scheme 76 – Reaction of indole adduct with Reetz reagent 
Unfortunately, gem-dimethylation product 327 was not observed, with the reaction conditions instead 
found to afford deprotected indole adduct 326 in excellent yield. With the known lability of the tert-butoxy 
carbonyl (Boc) protecting group under Lewis acidic conditions, in hindsight this outcome was not 
surprising.31 Repetition of the reaction with PMB protected indole adduct 316, which was expected to be 
more stable to the reaction conditions, resulted again in indole deprotection with adduct 326 isolated in 
good yield. Resubmission of adduct 326 to the reaction conditions returned compound 326 unchanged 
which suggested that disappointingly the indole adducts are not suitable for the dimethylation chemistry. 
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Exploration of the use of trimethyl aluminium to afford dimethylated adduct 327 is proposed for further 
investigations. 
With the attempted gem-dimethylation proving troublesome, work then focussed on the aforementioned 
cyclisation between the 3-position of indole (C-3’) and the carbon adjacent to the electron withdrawing 
group (C-8) to form the six-membered ring key to accessing the natural product skeleton. Inspired by the 
successful Barton-McCombie deoxygenation discussed in Chapter 3 it was envisioned that a Barton-
McCombie decarboxylation could be used to affect the desired cyclisation, generating cyclised product 
330 from carboxymethyl adduct 328 (Scheme 77). 
 
Scheme 77 – Proposed cyclisation via Barton-McCombie radical decarboxylation 
In order to attempt the radical decarboxylation, the synthesis of Barton ester 329 was first required, which 
in turn required the conversion of methyl ester 328 to the corresponding carboxylic acid. The 
saponification of adduct 328 was attempted under standard aqueous lithium hydroxide conditions but the 
reaction resulted in decomposition of the indole adducts. As an alternative to using basic aqueous solutions 
a Krapcho demethylation, the first step of the well-known Krapcho decarboxylation reaction sequence, 
was attempted for the synthesis of carboxylic acid 332 using conditions reported by Magnus and co-
workers applied to indole adduct 318 (Scheme 78).115 
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Scheme 78 – Attempted Krapcho demethylation using LiI based on work by Magnus and co-workers115 
Unfortunately under these conditions adduct 318 underwent a Krapcho decarboxylation along with ring 
opening of the bridgehead C–N bond and removal of the Boc protecting group to generate adduct 331 in 
good yield. Using an alternative solvent resulted in conversion of adduct 318 to deprotected adduct 333 
after 1 hour with a trace quantity of acid 334, extending the reaction time to 16 hours allowed the 
conversion of adduct 318 to acid 334 in a moderate yield of 53% with a trace quantity of adduct 333 
remaining (Scheme 79). 
 
Scheme 79 – Krapcho demethylation 
With acid 334 in hand, the coupling reactions with 2-mercaptopyridine N-oxide 335 and its sodium salt 
Na-335 were then attempted following standard procedures but unfortunately Barton ester 336 could not 
be isolated (Scheme 80).116,117 
 
Scheme 80 – Attempted synthesis of Barton ester 
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With the moderate yields for the generation of acid 334 and the unsuccessful synthesis of Barton ester 336, 
combined with the limited supplies of ester 318, an alternative approach for forming the desired indole    
C-3’ to C-8 bond was therefore needed. 
Baran and co-workers reported the coupling of the 3-position of indole with a range of ketones and esters 
using LiHMDS and a copper oxidant, successfully using the methodology for the gram-scale synthesis of 
adduct 339 (Scheme 81).118 
 
Scheme 81 – Baran’s direct coupling of indole with carbonyl compounds118 
The reaction is proposed to progress through the deprotonation of both carvone 337 and indole 338 to 
afford enolate 340 and indole anion 341 that are then oxidised to radicals 342 and 343 to allow diradical 
coupling to give product 339.118 
Inspired by this research an alternative approach towards the polycyclic natural product framework was 
therefore hypothesised (Figure 46). 
 
Figure 46 – Proposed radical cyclisation. 
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It was envisioned that radical 345 could be generated from the deprotonation of indole adduct 344 at C-8 
followed by oxidation, which could then undergo radical cyclisation onto the indole moiety or radical 
coupling (if R = H) to give access to adduct 346. The reaction of adduct 344 (where R = PMB) under the 
conditions reported by Baran was attempted but unfortunately resulted in multiple decomposition products 
thought to arise from a competing deprotonation at C-6 and the resulting ring opening of bridgehead C–N 
bond. 
To prevent this competing deprotonation, an alternative route to radical 345 was envisioned from Michael 
adduct 347, through oxidation of the anion that is formed during the Michael–Michael cascade reaction 
(Figure 47). 
 
Figure 47 – Proposed oxidative enolate cyclisation 
Deprotonation of adduct 347 at C-6’ followed by either Michael addition to give anion 350 then oxidation, 
or by oxidation to give radical 349 that could undergo radical cyclisation, could afford radical 345 which 
could then generate cyclised adduct 346 as previously discussed. Investigation of this route began with the 
synthesis of racemic Michael adduct 351 using a 1:1 mixture of quinine (Qn) and quinidine (Qd), and was 
generated in excellent yield (Scheme 82). 
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Scheme 82 – Attempted oxidative enolate coupling 
Unfortunately the attempted cyclisation of adduct 351 was not successful under the conditions reported by 
Baran and co-workers. Variations to the reaction temperature and equivalents of base and oxidant were 
made without success, and alternative oxidants including FeCp2PF6 and Fe(acac)3 were also attempted. 
The reactions were mainly found to return starting adduct 351 but as a mixture of E- and Z-isomers, with 
no Michael–Michael adduct or cyclised product 352 observed. 
The reaction was also attempted with the unprotected indole adduct 353 to investigate a possible bis-radical 
coupling (Scheme 83). 
 
Scheme 83 – Attempted oxadative enolate coupling with free indole 
Adduct 353 was synthesised in good yield, however attempts to affect the radical cyclisation were once 
again unsuccessful, with adduct 353 again returned as a mixture of E- and Z-isomers. Variation of the 
reaction conditions and reagents as with the previous attempted cyclisation also proved unsuccessful. 
Despite multiple attempted strategies to cyclise both 351 and 353, the radical cyclisations proved 
troublesome and were unsuccessful. Further investigation into this ring closure are still required. 
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Summary and Future Work 
A range of electron deficient methylene DKPs were successfully synthesised from several cyclic and non-
cyclic TKPs using a Wittig reaction. Multiple DKP products could be synthesised using the cyano Wittig 
ylide in good to excellent yields of up to 99% whereas proline carboxymethyl DKP 291 could only be 
generated in variable yields of 30–60%. The Wittig reaction was also attempted with a number of other 
stabilised ylides however were found to be unsuccessful as was a HWE reaction.  
The reaction of cyano proline DKP 291 with MVK using triethylamine and cinchona alkaloid 101 was 
found not to undergo the expected Michael–Michael cascade, instead affording the product of a single 
Michael addition. This is the first example of this class of Michael donor undergoing a Michael addition 
although the enantioselectivity of MVK adduct 297 was found to be only moderate, with the best er 
measured at 68:32. 
Conversely, no reaction was observed between carboxyl methyl proline DKP 291 and MVK using 
triethylamine or cinchona catalyst 101, however in the presence of DBU, the Michael–Michael cascade 
was successfully established in a yield of 69% and in a 7:1 dr. This result is thought to be the first example 
of a Michael–Michael cascade on a DKP substrate and demonstrated that this strategy could be used to 
synthesise the pyrrolidine fused bicyclo[2.2.2]diazaoctane ring system found in the prenylated indole 
alkaloid natural products. 
Pleasingly, cyano proline DKP 290 was also found to react with chalcone using cinchona catalyst 101 but 
the reaction was again found to stop at the Michael product, although cyclisation could be achieved using 
DBU in a second step. Conducting the reaction with DBU directly gave Michael–Michael adduct 302 and 
gratifyingly a one-pot asymmetric route to adduct 302 was also established, affording adduct 302 in 70%, 
67:33 er and as a single diastereoisomer using catalyst 101 followed by addition of DBU. 
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An improved enantioselectivity of 85:15 er was achieved for the reaction of doubly activated DKP 294 
with MVK suggesting that improved levels of enantio-enrichment of this class of DKP products should 
be accessible with further investigation. Subsequent ring-closure could be achieved using DBU, but the 
product could not be isolated due to suspected instability to silica gel column chromatography. 
Extension of the Michael–Michael strategy towards the prenylated indole alkaloid family was successfully 
achieved from the reaction of both cyano DKP 290 and its carboxymethyl derivative 291, with a variety 
of protected indole vinyl ketones. Products were obtained in good yields of up to 89% and with 
diastereomeric ratios ranging from excellent (>10:1) to 1.1:1. However, DBU appeared to cause 
epimerisation of the products upon resubmission to the reaction conditions, suggesting that further 
investigation into alternative bases is required and may increase the dr’s of the products. 
Homo-proline cyano DKP 296 was also successfully shown to undergo the Michael–Michael cascade, 
with chalcone and Boc indole vinyl ketone in up to 83% yield. This demonstrates that the tandem Michael 
addition strategy could also be used to generate adducts possessing the piperidine fused 
bicyclo[2.2.2]diazaoctane core present in some members of the prenylated indole alkaloid family. 
Attempts to further functionalise the Michael–Michael adducts towards members of the natural product 
family through gem-dimethylation and cyclisation were unfortunately unsuccessful with a variety of 
different radical based cyclisation strategies attempted. Further investigations into both of these steps are 
needed with the alternative trimethyl aluminium dimethylation conditions one possible area of study. 
Additional work is also required to improve the moderate enantioselectivity achieved using cinchona 
catalyst 101 in the Michael addition step, and alternative chiral bases should be investigated such as chiral 
bifunctional guanidines, cyclopropenimines or Dixons and co-workers iminophosphoranes.76–78 These 
more basic catalysts may also affect the secondary intramolecular Michael addition, which has so far only 
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been affected using DBU, potentially allowing Michael–Michael adducts to be obtained with improved 
diastereoselectivity over the current results. 
Finally, inspired by the improved enantioselectivity that was achieved with doubly activated DKP 294, it 
would be interesting to investigate the reaction of bicyclic DKPs that incorporate additional activating 
groups, such as oxo-proline DKP 355 and lactone 356 (Figure 48). 
 
Figure 48 – Potentially interesting doubly activated bicyclic DKPs 
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Chapter Five - Experimental 
General Methods 
Reactions were carried out under nitrogen using dry solvents. All reagents were used as received from 
commercial suppliers unless otherwise indicated.  
NMR data were recorded on a Bruker AVIII300, or AVIII400 spectrometer in deuterated chloroform 
(unless otherwise indicated) and spectra were calibrated using residual solvent peaks (1H = 7.26 ppm; 13C 
= 77.16 ppm). The multiplicities of 1H NMR signals are abbreviated as follows: s (singlet), d (doublet), t 
(triplet), q (quartet), m (multiplet) and coupling constants (J) are quoted in Hz to one decimal place. Carbon 
and proton assignments, where reported, were made on the basis of correlations in COSY, HSQC and 
HMBC spectra as well as PENDANT spectra. Insufficient carbon peaks are quoted for most compounds 
due to equivalent resonances. Infrared spectra were recorded on a Perkin Elmer Spectrum 100 FT-IR 
spectrometer or a Varian 660-IR, FT-IR spectrometer using Agilent Resolutions Pro software. Absorption 
maxima (νmax) are reported in wavenumbers (cm-1). 
Reaction progress was monitored by thin layer chromatography using Merck silica gel 60 F254 plates, 
which were visualized with UV light and potassium permanganate. Flash column chromatography was 
carried out using Davisil 60Å or Geduran Si 60 Å (40-63 µm, VWR) silica gel and the indicated solvent 
systems. Melting points were measured using a Gallenkamp melting point apparatus and are uncorrected. 
Optical rotations were measured using an Optical Activity PolAAr 2001 automatic polarimeter. ESI mass 
spectra were recorded on either a Micromass LCT time of flight, Waters Xevo G2-XS Tof or Synapt G2-
S mass spectrometer. 
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Microwave reactions were conducted in either a CEM discovery system or a CEM discoveryS system 
with synergy computer control and monitoring. High performance liquid chromatography (HPLC) 
analysis was performed using either a P580 Pump from Dionex, Chromeleon Client, version 6.80 SP1 
Build 2238, Diacel Chiralcel OD Column (250 × 4.6 mm) or Chiralpak AD Column (250 × 4.6 mm) and 
Waters 996 Photodiode Array Detector for the UV detection, monitored at 210 or 230 nm, or using a 
Shimadzu LC–20 Prominence system, Chromeleon client, version 6.80 SR9 Build 2673, Phenomenex 
Cellulose – 1 (250 × 4.6 mm), Cellulose – 3 (250 × 4.6 mm) or Amylose – 2 (250 × 4.6 mm) columns and 
Shimadzu SPD–M20A or SPD–20A detectors for the UV detection, monitored at 220, 230 or 254 nm. 
Experimental for Chapter 2 
Preparation of Catalysts 
Catalysts 101, 142–149, and 194 were prepared according to literature procedures.65,68,119–126 
 
Catalyst 174 was purchased from Sigma Aldrich. 
  
Chapter 5  Experimental 
 
103 
 
Preparation of Triketopiperazines 
Benzyl proline TKP 113 
 
Oxalyl chloride (3.60 mL, 42.6 mmol) in CH2Cl2 (40 mL) was added over 10 mins to a stirred solution of 
imidazole (5.80 g, 85.2 mmol) and diisopropylethylamine (14.8 mL, 85.2 mmol) in CH2Cl2 (80 mL). The 
reaction mixture was stirred for 1 hour at room temperature (rt). The solution was then cooled to 0 °C 
before L-proline-N-benzylamine50 111 (5.80 g, 28.2 mmol) in CH2Cl2 (20 mL) was added over 5 mins. 
The reaction mixture was stirred and allowed to warm to rt over 16 hours. The reaction was quenched with 
HCl (1.0 M, aq., 100 mL) and then quickly extracted with CH2Cl2 (3 × 100 mL). The organic layers were 
combined, dried over MgSO4, filtered and the solvent removed under reduced pressure. The residue was 
then recrystallized from hot isopropanol, to give TKP 113 (6.12 g, 23.7 mmol, 84%) as a colourless solid; 
m.p. 125 – 127 °C; IR (thin film) νmax /cm-1: 2963, 2885, 1744, 1678, 1460, 1434, 1383, 1354, 1318, 1196, 
747, 702, 608, 525; δ H (300 MHz, CDCl3) 7.50 – 7.40 (2 H, m, H-Ar), 7.35 – 7.28 (3 H, m, H-Ar), 5.06 
(1 H, d, J 13.6, H-10a), 4.99 (1 H, d, J 13.6, H-10b), 4.44 (1 H, dd, J 10.2, 6.1, H-6), 3.90 – 3.76 (1 H, m, 
H-9a), 3.75 – 3.61 (1 H, m, H-9b), 2.64 – 2.54 (1 H, m, H-7a), 2.23 – 1.91 (3 H, m, H-7b, H-8); δ C (101 
MHz, CDCl3) 168.0 (C-1), 158.1 (C-3), 151.8 (C-4), 135.4 (C-11), 129.5 (C-13), 128.6 (C-14), 128.16 
(C-12), 60.4 (C-6), 45.8 (C-9), 44.2 (C-10), 29.3 (C-7), 21.5 (C-8); m/z (ESI) 259.1 ([MH]+, 100), 281.1 
([MNa]+, 38); HRMS (ESI/[MH]+) Calcd. For C14H15N2O3: 259.1083, Found 259.1078. 
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4-Methoxyl benzyl Proline TKP 125 
 
Oxalyl chloride (2.46 mL, 29.1 mmol) in CH2Cl2 (10 mL) was added over 10 mins to a stirred solution of 
imidazole (3.97 g, 58.3 mmol) and diisopropylethylamine (10.2 mL, 58.3 mmol) in CH2Cl2 (50 mL). The 
reaction mixture was stirred for 1 hour at rt. The solution was then cooled to 0 °C before L-proline-N-(4-
methoxy)benzylamine 124 (synthesised by the same method as L-proline-N-benzylamine2) (4.55 g, 19.4 
mmol) in CH2Cl2 (10 mL) was added over 5 mins. The reaction mixture was stirred and allowed to warm 
to rt over 15 hours. The reaction was quenched with HCl (1.0M, aq., 100 mL) and then quickly extracted 
with CH2Cl2 (3 × 100 mL). The organic layers were combined, dried over MgSO4, filtered and the solvent 
removed under reduced pressure. The residue was then recrystallized from hot isopropanol, giving TKP 
125 (4.98 g, 17.3 mmol, 89%) as a colourless solid; m.p. 134 – 136 °C; IR (thin film) νmax /cm-1: 2968, 
2889, 1739, 1682, 1450, 1431, 1364, 1311, 1190, 747, 608, 525; δ H (300 MHz, CDCl3) 7.48 – 7.32 (2 H, 
m, H-Ar), 6.92 – 6.72 (2 H, m, H-Ar), 5.00 (1 H, d, J 13.6, H-10a), 4.92 (1 H, d, J 13.6, H-10b), 4.50 – 
4.32 (1 H, m, H-6), 3.92 – 3.75 (4 H, m, H-9a, H-15), 3.73 – 3.57 (1 H, m, H-9b), 2.65 – 2.45 (1 H, m, H-
7a), 2.24 – 1.84 (3 H, m, H-7b, H-8); δ C (101 MHz, CDCl3) 167.9 (C-1), 159.5 (C-14), 158.1 (C-3), 151.9 
(C-4), 131.1 (C-11), 127.7 (C-13), 113.9 (C-12), 60.4 (C-6), 55.3 (C-15), 45.8 (C-9), 43.7 (C-10), 29.3 (C-
7), 21.5 (C-8); m/z (ESI) 577.2 ([2MH]+, 100), 289.1 ([MH]+, 62), 121.0 (58); HRMS (ESI/[MH]+) Calcd. 
For C15H17N2O4: 289.1188, Found 289.1192. 
 
Chapter 5  Experimental 
 
105 
 
Homo-proline TKP 133 
 
Oxalyl chloride (0.15 mL, 1.72 mmol) in CH2Cl2 (2.0 mL) was added over 5 mins to a solution of 
imidazole (235 mg, 3.45 mmol) and DIPEA (0.62 mL, 3.57 mmol) in CH2Cl2 (10 mL). The reaction 
mixture was stirred for 1 hour. The solution was cooled to 0 °C before N-benzylpiperidine-2-
carboxamide127 132 (250 mg, 1.15 mmol) in CH2Cl2 (5 mL) was added over 10 mins, and the reaction 
mixture was stirred for 16 hours. The solvent was removed under reduced pressure and the crude residue 
was purified by flash chromatography (silica gel,  80% EtOAC in hexane) followed by trituration in Et2O 
to give homo-proline TKP 133 as a colourless solid (250 mg, 0.92 mmol, 80%); m.p. 129–131 °C; IR 
(thin film) νmax /cm-1: 1742, 1677, 1445, 1384, 1358, 1319, 1253, 1204, 732, 698; δ H (400 MHz, CDCl3) 
7.52 – 7.37 (2 H, m, H-Ar), 7.37 – 7.18 (3 H, m, H-Ar), 5.07 (1 H, d, J 13.6, H-11a), 5.00 (1 H, d, J 13.6, 
H-11b), 4.81 – 4.66 (1 H, m, H-6), 4.18 (1 H, dt, J 14.9, 7.6, H-10a), 2.67 (1 H, td, J 13.1, 3.0, H-7a), 2.46 
(1 H, ddd, J 7.7, 6.1, 4.5, H-10b), 2.13 – 1.97 (1 H, m, H-9a), 1.91 – 1.77 (1 H, m, H-8a), 1.74 – 1.46 (3 
H, m, H-7b, H-8b, H-9b); δ C (101 MHz, CDCl3) 168.1 (C-1), 156.1 (C-3), 151.1 (C-4), 135.3 (C-12), 
129.3 (C-14), 128.6 (C-15), 128.1 (C-13), 60.2 (C-6), 44.0 (C-11), 43.5 (C-10), 32.6 (C-7), 24.8 (C-9), 
24.0 (C-8); m/z (ESI) 273.1 ([MH]+, 100), 436.1 (42); HRMS (ESI/[MH]+) Calcd. For C15H17N2O3: 
273.1239, Found 273.1233. 
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Preparation of Racemic Michael Adducts 
Michael acceptor (2.5 eq) was added to a solution of TKP 113, 125, or 133 (1 eq) in CH2Cl2 at –78 °C, 
followed by addition of triethylamine (10 mol%) or a 50:50 mixture of 142 and 144 (10 mol%) in CH2Cl2. 
The reaction was then transferred to the freezer and allowed to warm to –30 °C. Reaction progress was 
monitored by TLC and when the starting material had been consumed the reaction mixture was directly 
purified by flash chromatography using the indicated solvent system. 
Enantioselective Michael Additions of TKPs 
General procedure A – Michael acceptor (2.5 eq) was added to a solution of TKP 113, 125, or 133 (1.0 
eq) in CH2Cl2 (0.8 mL) at –78 °C, followed by addition of catalyst 144 (10 mol%) in CH2Cl2 (0.2 mL). 
The reaction was then transferred to the freezer and allowed to warm to –30 °C. Reaction progress was 
monitored by TLC and when the starting material had been consumed the reaction mixture was directly 
purified by flash chromatography using the indicated solvent system. 
Michael adduct 134 
 
General procedure A was followed with TKP 113 (100 mg, 0.39 mmol), MVK (68 mg, 79 μL, 0.97 mmol) 
and 144 (19 mg, 0.040 mmol) as base. Flash chromatography (90% EtOAc in hexane) gave Michael 
adduct 134 (118 mg, 0.36 mmol, 93%) as a colourless solid in 10:90 er [Amylose-2, MeCN:H2O 50:50 
+0.05%TFA, 0.7 mLmin-1, t1= 10.52 mins, t2= 12.84 mins or Cellulose-3, MeCN:H2O 50:50, 1.0     
mLmin-1, t1= 6.38 mins, t2= 8.28 mins]; m.p. 136 – 138 °C; IR (thin film) νmax /cm-1: 2965, 1744, 1714, 
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1687, 1429, 1356, 1330, 1181, 752; δ H (300 MHz, CDCl3) 7.52 – 7.43 (2 H, m, H-Ar), 7.38 – 7.28 (3 H, 
m, H-Ar), 5.04 (1 H, d, J 13.5, H-10a), 4.98 (1 H, d, J 13.5, H-10b), 3.99 – 3.84 (1 H, m, H-9a), 3.69 – 
3.56 (1 H, m, H-9b), 2.32 – 1.96 (8 H, m, H-7, H-8, H-15, H-16), 1.94 (3 H, s, H-18); δ C (101 MHz, 
CDCl3) 205.4 (C-17), 170.9 (C-1), 157.9 (C-3), 152.0 (C-4), 135.4 (C-11), 129.7 (C-Ar), 128.7 (C-Ar), 
128.3 (C-14), 68.6 (C-6), 45.2 (C-9), 44.3 (C-10), 37.1 (C-15), 34.2 (C-16), 33.1 (C-7), 29.9 (C-18), 19.6 
(C-8); m/z (ESI) 351.1 ([MNa]+, 100), 329.2 ([MH]+, 52); HRMS (ESI/[MH]+) Calcd. For C18H21N2O4: 
329.1501, Found 329.1509; [𝛼]𝐷
21= –32.1 (c 1.01, CH2Cl2). Compound 134 can be recrystallized from 
isopropanol, two successive recrystallisations led to an enhancement of the er up to 99:1 
(90:1095:599:1). 
Michael adduct 135 
 
General procedure A was followed with PMB-proline-TKP 125 (30 mg, 0.10 mmol), MVK (21 L, 0.26 
mmol) and 144 (5 mg, 0.010 mmol) as base. Flash chromatography (80% EtOAc in hexane) gave Michael 
adduct 135 (32 mg, 0.089 mmol, 86%) as a colourless solid in 17:83 er [Cellulose-3, MeCN:H2O 25:75, 
1.0 mLmin-1, t1= 10.55 mins, t2= 12.08 mins]; m.p. 138 – 139 °C; IR (thin film) νmax /cm-1: 1741, 1714, 
1686, 1612, 1512, 1354, 1248, 1177, 1030; δ H (300 MHz, CDCl3) 7.46 – 7.35 (2 H, m, H-12), 6.92 – 6.77 
(2 H, m, H-13), 4.97 (1 H, d, J 13.5, H-10a), 4.91 (1 H, d, J 13.5, H-10b), 3.90 (1 H, m, H-9a), 3.74 (3 H, 
s, H-15), 3.58 (1 H, m, H-9b), 2.32 – 2.14 (2 H, m, H-7a, H-16a), 2.12 – 1.86 (9 H, m, H-7b, H-8, H-16b, 
H-17, H-19); δ C (101 MHz, CDCl3) 205.4 (C-18), 170.9 (C-1), 159.6 (C-14), 157.9 (C-3), 152.1 (C-4), 
131.2 (C-12), 127.6 (C-11), 113.9 (C-13), 68.5 (C-6), 55.3 (C-15), 45.2 (C-9), 43.7 (C-10), 37.1 (C-16), 
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34.2 (C-17), 33.2 (C-7), 29.8 (C-19), 19.6 (C-8); m/z (ESI) 381.1 ([MNa]+, 100), 359.2 ([MH]+, 7); HRMS 
(ESI/[MNa]+) Calcd. For C19H22N2O5Na: 381.1426, Found 381.1435; [𝛼]𝐷
21= –70.5 (c 0.93, CH2Cl2). 
Michael adduct 136 
 
General procedure A was followed with TKP 133 (30 mg, 0.11 mmol), MVK (23 L, 0.27 mmol) and 
144 (6 mg, 0.012 mmol) as base. Flash chromatography (75% EtOAc in hexane) gave Michael adduct 
136 (32.7 mg, 0.10 mmol, 87%) as a colourless solid in 23:77 er [Cellulose-3, MeCN:H2O 40:60, 1.0 
mLmin-1, t1= 5.30 mins, t2= 7.50 mins]; m.p. 142 – 143 °C; IR (thin film) νmax /cm-1: 1740, 1715, 1675, 
1428, 1361, 1269, 1218, 1167, 731, 699; δ H (300 MHz, CDCl3) 7.53 – 7.40 (2 H, m, H-Ar), 7.38 – 7.24 
(3 H, m, H-Ar), 5.10 (1 H, d, J 13.4, H-11a), 5.01 (1 H, d, J 13.4, H-11b), 4.66 (1 H, dd, J 13.9, 4.1, H-
10a), 2.78 (1 H, app. td, J 13.5, 3.0, H-10b), 2.65 – 2.48 (1 H, m, H-7a), 2.39 – 2.21 (1 H, m, H-9a), 2.11 
– 1.65 (10 H, m, H-7b, H-8a, H-16, H-17, H-19), 1.59 – 1.37 (1 H, m, H-8b); δ C (101 MHz, CDCl3) 205.6 
(C-18), 171.3 (C-1), 155.8 (C-3), 152.3 (C-4), 135.4 (C-12), 129.5 (C-13), 128.7 (C-14), 128.3 (C-15), 
64.4 (C-6), 44.1 (C-11), 38.6 (C-10), 36.7 (C-17), 35.5 (C-16), 29.9 (C-19), 28.7 (C-7), 24.5 (C-9), 19.4 
(C-8); m/z (ESI) 365.1 ([MNa]+, 100), 343.2 ([MH]+, 22); HRMS (ESI/[MNa]+) Calcd. For 
C19H22N2O4Na: 365.1477, Found 365.1475; [𝛼]𝐷
21= –31.1 (c 0.81, CH2Cl2). 
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Michael adduct 150 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), EVK (25 mg, 30 μL, 0.30 mmol) 
and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (75% EtOAc in hexane) gave Michael adduct 
150 (31 mg, 0.09 mmol, 75%) as a colourless solid in 13:87 er [Cellulose-3, MeCN:H2O 30:70, 1.0 
mLmin-1, t1= 9.11 mins, t2= 10.87 mins]; m.p. 148 – 150 °C; IR (thin film) νmax /cm-1: 2970, 2936, 1740, 
1718, 1680, 1431, 1381, 700; δ H (300 MHz, CDCl3) 7.55 – 7.41 (2 H, m, H-Ar), 7.37 – 7.29 (3 H, m, H-
Ar), 5.03 (1 H, d, J 13.6, H-10a), 4.97 (1 H, d, J 13.5, H-10b), 4.00 – 3.83 (1 H, m, H-9a), 3.70 – 3.54 (1 
H, m, H-9b), 2.30 – 1.93 (10 H, m, H-7, H-8, H-15, H-16, H-18), 0.95 (3 H, t, J 7.3, H-19); δ C (101 MHz, 
CDCl3) 208.3 (C-17), 170.9 (C-1), 157.9 (C-3), 152.0 (C-4), 135.4 (C-11), 129.7 (C-Ar), 128.7 (C-Ar), 
128.3 (C-Ar), 68.6 (C-6), 45.2 (C-9), 44.3 (C-10), 35.9 (C-18), 35.9 (C-16), 34.2 (C-7), 33.2 (C-15), 19.6 
(C-8), 7.6 (C-19); m/z (ESI) 365.1 ([MNa]+, 100), 343.2 ([MH]+, 27); HRMS (ESI/[MNa]+) Calcd. For 
C19H22N2O4Na: 365.1477, Found 365.1491; [𝛼]𝐷
21= –39.4 (c 0.94, CH2Cl2). 
Michael adduct 151 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), PhVK3 (41 mg, 0.30 mmol) and 
144 (6 mg, 0.012 mmol) as base. Flash chromatography (70% EtOAc in hexane) gave Michael adduct 
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151 (41 mg, 0.105 mmol, 88%) as a colourless solid in 6:94 er [Chiralcel OD, IPA:Hexane 20:80, 1.5 
mLmin-1, t1= 24.92 mins, t2= 40.65 mins]; m.p. 162 – 164 °C; IR (thin film) νmax /cm-1: 3021, 1744, 1695, 
1681, 1368, 1187, 748, 726; δ H (300 MHz, CDCl3) 7.61 – 7.28 (7 H, m, H-Ar), 7.26 – 7.13 (3 H, m, H-
Ar), 5.04 (2 H, s, H-10), 4.02 – 3.88 (1 H, m, H-9a), 3.65 (1 H, ddd, J 13.0, 8.2, 4.8, H-9b), 2.63 – 2.39 (2 
H, m, H-15), 2.38 – 1.97 (6 H, m, H-7, H-8, H-16); δ C (101 MHz, CDCl3) 197.0 (C-17), 171.0 (C-1), 
157.9 (C-3), 152.0 (C-4), 135.9 (C-18), 135.4 (C-11), 133.5 (C-21), 129.8 (C-Ar), 128.7 (C-Ar), 128.6 (C-
Ar), 128.4 (C-Ar), 127.9 (C-Ar), 68.8 (C-6), 45.2 (C-9), 44.3 (C-10), 34.4 (C-16), 33.6 (C-7), 32.3 (C-15), 
19.7 (C-8); m/z (ESI) 391.2 ([MH]+, 100), 338.4 (50); HRMS (ESI/[MH]+) Calcd. For C23H23N2O4: 
391.1658, Found 391.1670; [𝛼]𝐷
21= –58.3 (c 1.05, CH2Cl2). 
Michael adduct 153 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), acryloyl-2-oxazolidinone4             
(28 mg, 0.20 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (90% EtOAc in hexane) 
gave Michael adduct 153 (47 mg, 0.12 mmol, 98%) as a colourless gum in 15:85 er [Cellulose-3, 
MeCN:H2O 30:70, 0.4 mLmin
-1, t1= 18.03 mins, t2= 18.97 mins]; IR νmax /cm-1: 2968, 1777, 1741, 1687, 
1386, 1359, 1224, 1039, 752, 702; δ H (300 MHz, CDCl3) 7.49 – 7.36 (2 H, m, H-Ar), 7.34 – 7.25 (3 H, 
m, H-Ar), 5.08 – 4.90 (2 H, m, H-10), 4.52 – 4.32 (2 H, m, H-20), 4.01 – 3.78 (3 H, m, H-9a,  H-21), 3.70 
– 3.55 (1 H, m, H-9b), 3.02 – 2.85 (1 H, m, H-16a), 2.76 – 2.60 (1 H, m, H-7a), 2.42 – 1.97 (6 H, m, H-
7b, H-8, H-15, H-16b); δ C (101 MHz, CDCl3) 171.0 (C-17), 170.9 (C-1), 157.7 (C-3), 153.3 (C-4), 152.0 
(C-19), 135.4 (C-11), 129.5 (C-Ar), 128.6 (C-Ar), 128.0 (C-Ar), 68.9 (C-6), 62.3 (C-21), 45.3 (C-9), 44.5 
(C-10), 42.5 (C-20), 34.2 (C-16), 33.8 (C-7), 29.8 (C-15), 19.7 (C-8); m/z 422.13 ([MNa]+, 100), 400.15 
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([MH]+, 8); HRMS (ESI/[MNa]+) Calcd. For C20H21N3O6Na: 422.1328, Found 422.1320; [𝛼]𝐷
21= –54.1 
(c 0.99, CH2Cl2). 
Michael adduct 154 
 
General procedure A was followed with TKP 125 (29 mg, 0.10 mmol), EVK (21 mg, 25 μL, 0.25 mmol) 
and 144 (5 mg, 0.010 mmol) as base. Flash chromatography (70% EtOAc in hexane) gave Michael adduct 
154 (28 mg, 0.074 mmol, 74%) as a colourless solid; m.p. 134 – 135 °C; IR (thin film) νmax /cm-1: 1741, 
1686, 1612, 1512, 1376, 1248, 1178, 1109, 1030; δ H (400 MHz, CDCl3) 7.33 (2 H, d, J 8.8, H-12), 6.75 
(2 H, d, J 8.8, H-13), 4.88 (1 H, d, J 13.5, H-10a), 4.84 (1 H, d, J 13.5, H-10b), 3.89 – 3.78 (1 H, m, H-9a), 
3.70 (3 H, s, H-15), 3.58 – 3.49 (1 H, m, H-9b), 2.22 – 1.80 (10 H, m, H-7, H-8, H-16, H-17, H-19), 0.87 
(3 H, t, J 7.3, H-20); δ C (101 MHz, CDCl3) 208.2 (C-20), 170.9 (C-1), 159.5 (C-14), 157.9 (C-3), 152.1 
(C-4), 131.2 (C-12), 127.6 (C-11), 113.9 (C-13), 68.6 (C-6), 55.2 (C-15), 45.2 (C-9), 43.7 (C-10), 35.9 (C-
19), 35.8 (C-17), 34.3 (C-7), 33.2 (C-16), 19.6 (C-8), 7.6 (C-20); m/z (ESI) 395.0 ([MNa]+, 100); HRMS 
(ESI/[MNa]+) Calcd. For C20H24N2O5Na: 395.1583, Found 395.1577; [𝛼]𝐷
21=        –64.7 (c 0.92, CH2Cl2). 
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Michael adduct 155 
 
General procedure A was followed with TKP 133 (30 mg, 0.11 mmol), EVK (27 L, 0.28 mmol) and 
144 (5 mg, 0.011 mmol) as base. Flash chromatography (60% EtOAc in hexane) gave Michael adduct 
155 (28 mg, 0.079 mmol, 72%) as a colourless solid in 16:84 er [Cellulose-3, MeCN:H2O 40:60, 1.0        
mLmin-1, t1= 6.17 mins, t2= 8.25 mins]; m.p. 114 – 116 °C; IR (thin film) νmax /cm-1: 2940, 1741, 1713, 
1676, 1429, 1363, 1269, 1217, 700; δ H (400 MHz, CDCl3) 7.46 – 7.40 (2 H, m, H-Ar), 7.33 – 7.26 (3 H, 
m, H-Ar), 5.10 (1 H, d, J 13.4, H-11a), 4.99 (1 H, d, J 13.4, H-11b), 4.69 – 4.57 (1 H, m, H-10a), 2.78 (1 
H, td, J 13.6, 3.0, H-10b), 2.59 (1 H, ddd, J 14.1, 10.9, 4.5, H-7a), 2.29 – 2.21 (1 H, m, H-16a), 2.20 – 1.88 
(4 H, m, H-16b, H17a, H-19), 1.88 – 1.65 (5 H, m, H-7b, H-8, H-9a, H-17b), 1.55 – 1.39 (1 H, m, H-9b), 
0.91 (3 H, t, J 7.3, H-20); δ C (101 MHz, CDCl3) 208.4 (C-18), 171.3 (C-1), 155.8 (C-3), 152.4 (C-4), 
135.4 (C-12), 129.5 (C-Ar), 128.6 (C-Ar), 128.3 (C-15), 64.5 (C-6), 44.1 (C-11), 38.6 (C-10), 36.0 (C-
19), 35.5 (C-16), 35.4 (C-17), 28.8 (C-7), 24.6 (C-9), 19.4 (C-8), 7.6 (C-20); m/z (ESI) 379.2 ([MNa]+, 
25), 357.2 ([MH]+, 100); HRMS (ESI/[MH]+) Calcd. For C20H25N2O4: 357.1814, Found 357.1822; 
[𝛼]𝐷
21= –30.5 (c 0.87, CH2Cl2).  
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Michael adduct 157 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), acrolein (17 mg, 20 L, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Once the reaction was complete by TLC, the volatiles were 
removed under reduced pressure. The residue was then dissolved in 2-ethyl-2-methyl-1,3-dioxolane (0.5 
mL) and p-toluenesulfonic acid monohydrate (pTSA) (cat., approx. 5 mg) was added and the reaction 
mixture was stirred for 16 hours. Volatiles were removed under reduced pressure and the residue was 
purified by flash chromatography (60–70% EtOAc in hexane) and gave Michael adduct 157 (28 mg, 0.077 
mmol, 64% w.r.t TKP 113) as an off-white solid in 21:79 er [Cellulose-3, MeCN:H2O 40:60, 1.0 mLmin
-
1, t1= 4.54 mins, t2= 7.69 mins]; m.p. 110 – 112 °C; IR (thin film) νmax /cm-1: 2889, 1744, 1683, 1356, 
1187, 1134, 1029, 702; δ H (300 MHz, CDCl3) 7.49 – 7.36 (2 H, m, H-Ar), 7.34 – 7.23 (3 H, m, H-Ar), 
4.98 (2 H, s, H-10), 4.68 (1 H, t, J 4.2, H-17), 3.92 (1 H, dt, J 13.1, 8.4, H-9a), 3.87 – 3.71 (4 H, m, H-18), 
3.61 (1 H, ddd, J 13.1, 7.2, 5.9, H-9b), 2.33 – 2.12 (2 H, m, H-7a, H-16a), 2.10 – 1.91 (3 H, m, H-8, H16b), 
1.77 (1 H, ddd, J 14.0, 10.4, 6.1, H-7b), 1.42 – 1.27 (2 H, m, H-15); δ C (101 MHz, CDCl3) 171.0 (C-1), 
158.0 (C-3), 152.1 (C-4), 135.4 (C-11), 129.5 (C-Ar), 128.6 (C-Ar), 128.1 (C-14), 102.6 (C-17), 69.0 (C-
6), 65.0 (C-18), 45.0 (C-9), 44.3 (C-10), 34.4 (C-16), 33.5 (C-7), 28.1 (C-15), 19.7 (C-8); m/z 381.1 
([MNa]+, 100), 359.2 ([MH]+, 44), 739.3 ([2MNa]+, 44); HRMS (ESI/[MNa]+) Calcd. For 
C19H22N2O5Na: 381.1426, Found 381.1434; [𝛼]𝐷
21= –26.7 (c 0.69, CH2Cl2). 
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Ethanolamine enol adduct 169 
 
Ethanolamine (19 L, 0.32 mmol) was added to a solution of Michael adduct 134 (52 mg, 0.16 mmol) in 
THF (0.5 mL) and the reaction mixture was heated under reflux for 1 hour. Volatiles were removed under 
reduced pressure and the residue was triturated with THF to give ethanolamine enol adduct 169 (30 mg, 
0.082 mmol, 52%) as an off-white solid; m.p. decomp. 210 °C; IR (thin film) νmax /cm-1: 3323 (br), 1765, 
1732, 1518, 1421, 1254, 1197, 729, 699; δ H (400 MHz, DMSO) 12.33 (1 H, t, J 5.6, H-22), 8.57 (1 H, t, 
J 6.0, H-2), 7.27 – 7.21 (2 H, m, H-Ar), 7.20 – 7.14 (1 H, m, H-Ar), 7.06 – 7.01 (2 H, m, H-Ar), 5.01 (1 
H, s, H-23), 4.29 (1 H, dd, J 15.3, 6.0, H-10a), 4.15 (1 H, dd, J 15.3, 6.0, H-10b), 3.64 – 3.52 (3 H, m, H-
9a, H-21), 3.52 – 3.39 (3 H, m, H-9b, H-20), 3.29 (1 H, d, J 14.4, H-15a), 2.53 (1 H, d, J 14.4, H-15b), 
2.28 – 2.20 (1 H, m, H-7a), 2.01 – 1.85 (5 H, m, H-7b, H-8a, H-18), 1.68 – 1.53 (1 H, m, H-8b); δ C (101 
MHz, DMSO) 175.8 (C-17), 173.1 (C-3), 166.7 (C-1), 161.7 (C-4), 140.0 (C-11), 128.6 (C-Ar), 127.0 (C-
Ar), 126.9 (C-14), 97.5 (C-16), 68.9 (C-6), 60.3 (C-21), 46.2 (C-20), 45.8 (C-9), 42.9 (C-10), 38.1 (C-7), 
34.4 (C-15), 22.2 (C-8), 15.3 (C-18); m/z (ESI) 394.2 ([MNa]+,100), 765.4 ([2MNa]+, 90). 
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Ketal adduct 170 
 
To a solution of Michael adduct 134 (381 mg, 1.16 mmol) in 2-ethyl-2-methyl-1,3-dioxolane (1.0 mL) 
and CH2Cl2 (2.0 mL) was added p-toluenesulfonic acid monohydrate (pTSA) (cat., 10 mg) the reaction 
mixture was stirred for 16 hours at room temperature. Volatiles were removed under reduced pressure and 
the residue was purified by flash chromatography (60–70% EtOAc in hexane) and gave ketal adduct 170 
(390 mg, 1.05 mmol, 90%) as a colourless solid; m.p. 130 – 131 °C; IR (thin film) νmax /cm-1: 1743, 1687, 
1431, 1379, 1358, 1219, 772, 701; 2:1 mix of rotamers δ H (400 MHz, CDCl3) 7.49 – 7.41 (2 H, m), 7.36 
– 7.23 (3 H, m), 5.07 – 4.93 (2 H, m), 4.02 – 3.69 (4 H, m), 3.67 – 3.57 (1 H, m), 2.34 – 2.14 (2 H, m), 
2.12 – 1.95 (3 H, m), 1.95 – 1.92 (1 H, m), 1.36 – 1.18 (2 H, m), 1.10 (2 H, s); δ C (101 MHz, CDCl3) 
205.3, 171.1, 170.9, 158.0, 157.9, 152.1, 152.0, 135.4, 135.4, 129.7, 129.6, 128.7, 128.6, 128.3, 128.1, 
108.5, 77.4, 77.0, 76.7, 69.0, 68.5, 64.6, 45.2, 45.0, 44.3, 44.2, 37.1, 34.4, 34.2, 34.1, 33.1, 33.0, 29.8, 23.8, 
19.7, 19.6; m/z 395.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C20H24N2O5Na: 395.1583, Found 
395.1584. 
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Ketal ethanolamine adduct 171 
 
Ethanolamine (0.5 mL) was added to a solution of Michael adduct 170 (51 mg, 0.13 mmol) in THF (0.5 
mL) and the reaction mixture was heated under reflux for 1 hour. Volatiles were removed under reduced 
pressure and the residue was directly purified by flash chromatography (EtOAc) and gave adduct 171 (43 
mg, 0.094 mmol, 72%) as a pale yellow oil; IR (thin film) νmax /cm-1: 3332 (br), 2940, 1636, 1527, 1418, 
1190, 1061, 749; δ H (400 MHz, CDCl3) 7.79 (1 H, t, J 5.8, H-20), 7.50 (1 H, t, J 5.7, H-2), 7.35 – 7.26 (3 
H, m, H-Ar), 7.26 – 7.21 (2 H, m, H-Ar), 4.47 (1 H, dd, J 15.0, 6.0, H-10a), 4.36 (1 H, dd, J 15.0, 5.4,      
H-10b), 4.19 – 4.06 (1 H, m, H-9a), 3.94 – 3.75 (5 H, m, H-9b, H-19), 3.73 – 3.61 (2 H, m, H-22), 3.48 – 
3.30 (2 H, m, H-21), 3.17 (1 H, s, H-23), 2.49 – 2.39 (1 H, m, H-7a), 2.33 (1 H, ddd, J 13.6, 9.7, 6.1, H-
15a), 2.24 – 2.15 (1 H, m, H-15b), 1.95 – 1.85 (2 H, m, H-8), 1.84 – 1.74 (1 H, m, H-7b), 1.63 – 1.54 (2 
H, m, H-16), 1.25 (3 H, s, H-18); δ C (101 MHz, CDCl3) 172.7 (C-1), 161.7 (C-3), 161.0 (C-4), 138.4 (C-
11), 128.6 (C-Ar), 127.5 (C-Ar), 127.3 (C-14), 109.5 (C-17), 73.0 (C-6), 64.7 (C-19), 64.6 (C-19’), 61.3 
(C-22), 51.3 (C-9), 43.7 (C-10), 42.1 (C-21), 34.9 (C-7), 33.5 (C-16), 27.9 (C-15), 24.0 (C-8), 23.8 (C-18); 
m/z 434.2 ([MH]+, 100); HRMS (ESI/[MH]+) Calcd. For C22H32N3O6: 434.2135, Found 434.2137. 
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Experimental for Chapter 3 
Enantioselective Michael Addition–Ring-Closure Reactions of TKPs 
Hydroxy DKP 159 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), chalcone (60 mg, 0.29 mmol) and 
144 (6 mg, 0.012 mmol) as base. Flash chromatography (40–50% EtOAc in hexane) gave Michael adduct 
159 (52 mg, 0.11 mmol, 96%) as a colourless solid in 1:99 er [Cellulose-3, MeCN:H2O 60:40, 1.0   
mLmin-1, t1= 4.37 mins, t2= 7.40 mins]; m.p. 93 – 95 °C; IR (thin film) νmax /cm-1: 3323 (br), 3029, 1683, 
1449, 1395, 1321, 1216, 1070, 750, 702; δ H (400 MHz, CDCl3) 7.69 – 7.57 (4 H, m, H-Ar), 7.56 – 7.49 
(1 H, m, H-Ar), 7.48 – 7.31 (5 H, m, H-Ar), 7.25 – 7.19 (1 H, m, H-Ar), 7.18 – 7.11 (2 H, m, H-Ar), 6.76 
– 6.70 (2 H, m, H-Ar), 5.08 (1 H, s, H-15), 4.91 (1 H, d, J 14.2, H-10a), 4.75 (1 H, d, J 14.2, H-10b), 4.31 
(1 H, d, J 6.1, H-17), 3.80 – 3.64 (2 H, m, H-9), 3.45 (1 H, d, J 6.1, H-16), 2.52 – 2.43 (1 H, m, H-7a), 2.16 
– 1.96 (2 H, m, H-8), 1.83 – 1.73 (1 H, m, H-7b); δ C (101 MHz, CDCl3) 198.2 (C-18), 168.2 (C-1), 166.2 
(C-4), 137.4 (C-11), 137.1 (C-23), 136.7 (C-19), 133.7 (C-Ar), 129.9 (C-Ar), 128.9 (C-Ar), 128.6 (C-Ar), 
128.5 (C-Ar), 128.0 (C-Ar), 84.9 (C-3), 70.8 (C-6), 58.0 (C-17), 52.5 (C-16), 44.8 (C-9), 43.1 (C-10), 28.2 
(C-7), 24.6 (C-8); m/z (ESI) 259.1 ([M(–Chalcone)H]+, 100), 467.2 ([MH]+, 42), 933.4 ([2MH]+, 63); 
HRMS (ESI/[MH]+) Calcd. For C29H27N2O4: 467.1971, Found 467.1964; [𝛼]𝐷
21= 69.4 (c 0.64, CH2Cl2). 
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PMB Hydroxy DKP 180 
 
General procedure A was followed with TKP 125 (30 mg, 0.104 mmol), chalcone (60 mg, 0.29 mmol) 
and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (50–60% EtOAc in hexane) gave Michael 
adduct 180 (43 mg, 0.087 mmol, 84%) as a colourless solid in 1:99 er [Cellulose-3, MeCN:H2O 55:45, 
1.0 mLmin-1, t1= 4.86 mins, t2= 6.29 mins]; m.p. 150 – 152 °C; IR (thin film) νmax /cm-1: 3334 (br), 3010, 
1677, 1611, 1596, 1582, 1511, 1448, 1245, 748, 702; δ H (400 MHz, CDCl3) 7.62 – 7.54 (4 H, m), 7.50 (1 
H, ddt, J 8.6, 7.3, 1.3), 7.35 – 7.28 (2 H, m), 7.23 – 7.17 (1 H, m), 7.15 – 7.10 (2 H, m), 6.97 – 6.91 (2 H, 
m), 6.75 – 6.68 (2 H, m), 5.03 (1 H, s), 4.84 (1 H, d, J 14.2), 4.64 (1 H, d, J 14.2), 4.28 (1 H, d, J 6.1), 3.85 
(3 H, s), 3.74 – 3.63 (2 H, m), 3.41 (1 H, d, J 6.1), 2.44 (1 H, ddd, J 13.3, 7.2, 5.2), 2.14 – 1.93 (2 H, m), 
1.74 (1 H, ddd, J 13.4, 8.5, 7.3); δ C (101 MHz, CDCl3) 168.1, 166.2, 159.3, 137.1, 136.7, 133.7, 131.3, 
129.7, 128.9, 128.9, 128.5, 128.1, 128.0, 113.9, 84.9, 70.8, 58.1, 55.4, 52.5, 44.8, 42.4, 28.2, 24.5; m/z 
(ESI) 519.2 ([MNa]+, 100); HRMS (ESI/[MH]+) Calcd. For C30H28N2O5Na: 519.1896, Found 519.1893; 
[𝛼]𝐷
21= 41.2 (c 1.01, CH2Cl2). 
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Hydroxy DKP 182 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), 2’-bromo chalcone (86 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (40% EtOAc in hexane) gave Michael 
adduct 182 (49 mg, 0.090 mmol, 75%) as a colourless solid in 97:3 er [Cellulose-3, MeCN:H2O 45:55, 
1.0 mLmin-1, t1= 10.77 mins, t2= 15.05 mins]; m.p. 94 – 96 °C; IR (thin film) νmax /cm-1: 3257 (br), 3030, 
1685, 1429, 1393, 1319, 1209, 1070, 751, 702; δ H (300 MHz, CDCl3) 7.55 – 7.44 (3 H, m), 7.40 – 7.07 
(10 H, m), 6.79 – 6.67 (2 H, m), 5.11 (1 H, s), 4.86 – 4.71 (2 H, m), 4.29 (1 H, d, J 6.0), 3.85 – 3.65 (2 H, 
m), 3.61 (1 H, d, J 6.0), 2.54 – 2.37 (1 H, m), 2.24 – 1.94 (2 H, m), 1.90 – 1.74 (1 H, m); δ C (101 MHz, 
CDCl3) 201.3, 168.1, 165.6, 141.1, 137.1, 136.9, 133.7, 132.2, 129.7, 129.4, 128.8, 128.6, 128.2, 127.9, 
127.8, 127.2, 119.2, 85.3, 70.8, 61.8, 52.2, 44.8, 43.0, 28.1, 24.6; m/z 259.1 ([M(–2-BrChalcone)H]+, 100), 
547.1([MH]+, 38); HRMS (ESI/[MH]+) Calcd. For C29H26N2O4Br: 547.1055, Found 547.1061; [𝛼]𝐷
21= 
50.9 (c 0.99, CH2Cl2). 
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Hydroxy DKP 183 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), 4-methoxy-chalcone (71 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (40–50% EtOAc in hexane) gave 
Michael adduct 183 (42 mg, 0.084 mmol, 70%) as a colourless solid in 1:99 er [Cellulose-3, MeCN:H2O 
60:40, 1.0 mLmin-1, t1= 4.20 mins, t2= 5.64 mins]; m.p. 92 – 94 °C; IR (thin film) νmax /cm-1: 3312 (br), 
3010, 1679, 1514, 1395, 1251, 1181, 1031, 753, 702; δ H (300 MHz, CDCl3) 7.73 – 7.30 (11 H, m), 6.71 
– 6.56 (4 H, m), 5.05 (1 H, s), 4.89 (1 H, d, J 14.2), 4.74 (1 H, d, J 14.2), 4.27 (1 H, d, J 6.1), 3.79 – 3.65 
(5 H, m), 3.37 (1 H, d, J 6.1), 2.54 – 2.38 (1 H, m), 2.18 – 1.92 (2 H, m), 1.82 – 1.72 (1 H, m); δ C (101 
MHz, CDCl3) 198.3, 168.3, 166.2, 159.2, 137.4, 136.7, 133.7, 129.9, 129.1, 128.9, 128.6, 128.5, 128.0, 
114.3, 84.82, 71.0, 58.2, 55.2, 51.8, 44.8, 43.1, 28.2, 24.5; m/z 519.18 ([MNa]+, 100); HRMS 
(ESI/[MNa]+) Calcd. For C30H28N2O5Na: 519.1896, Found 519.1893; [𝛼]𝐷
21= 93.7 (c 1.34, CH2Cl2). 
  
Chapter 5  Experimental 
 
121 
 
Hydroxy DKP 184 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), 4-fluoro-chalcone (68 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (50% EtOAc in hexane) gave Michael 
adduct 184 (55 mg, 0.11 mmol, 95%) as a colourless solid in 6:94 er [Cellulose-3, MeCN:H2O 50:50, 1.0 
mLmin-1, t1= 6.29 mins, t2= 11.69 mins]; m.p. 150 – 152 °C; IR (thin film) νmax /cm-1: 3312, 3010, 1682, 
1511, 1395, 1215, 761, 703; δ H (300 MHz, CDCl3) 7.70 – 7.52 (5 H, m), 7.51 – 7.31 (5 H, m), 6.87 – 6.75 
(2 H, m), 6.71 – 6.59 (2 H, m), 4.98 (1 H, s), 4.89 (1 H, d, J 14.2), 4.72 (1 H, d, J 14.2), 4.23 (1 H, d, J 6.1), 
3.78 – 3.67 (2 H, m), 3.43 (1 H, d, J 6.1), 2.55 – 2.39 (1 H, m), 2.17 – 1.91 (2 H, m), 1.80 – 1.65 (1 H, m); 
δ C (101 MHz, CDCl3) 198.0, 168.0, 166.1, 162.3 (d, J 247.6), 137.3, 136.6, 133.9, 132.9 (d, J 2.1), 130.0, 
129.7 (d, J 8.0), 128.9, 128.7, 128.6, 128.1, 115.9 (d, J 21.5), 84.9, 70.8, 58.2, 51.7, 44.8, 43.1, 28.2, 24.5; 
m/z 507.17 ([MNa]+, 100), 485.18 ([MH]+, 5); HRMS (ESI/[MNa]+) Calcd. For C29H25N2O4NaF: 
507.1696, Found 507.1691; [𝛼]𝐷
21= 45.9 (c 1.05, CH2Cl2). 
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Hydroxy DKP 185 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), cinnamoyl-2-oxazolidinone (65 
mg, 0.30 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (85% EtOAc in hexane) 
gave Michael adduct 185 (46 mg, 0.097 mmol, 81%) as a colourless solid in 3:97 er [Cellulose-1, 
MeCN:H2O 50:50, 1.0 mLmin
-1, t1= 5.64 mins, t2= 8.27 mins]; m.p. 166 – 168 °C; IR (thin film)                
νmax /cm-1: 3332 (br), 3029, 1782, 1688, 1393, 1359, 1203, 1114, 1041, 752, 702; δ H (300 MHz, CDCl3) 
7.52 – 7.43 (2 H, m), 7.43 – 7.29 (3 H, m), 7.26 – 7.12 (3 H, m), 6.86 – 6.73 (2 H, m), 5.39 (1 H, d, J 5.7), 
4.99 (1 H, s), 4.93 (1 H, d, J 14.6), 4.68 (1 H, d, J 14.6), 4.48 – 4.21 (2 H, m), 4.18 – 3.85 (2 H, m), 3.76 – 
3.63 (2 H, m), 3.56 (1 H, d, J 5.8), 2.49 – 2.33 (1 H, m), 2.20 – 1.93 (2 H, m), 1.86 – 1.74 (1 H, m); δ C 
(101 MHz, CDCl3) 170.9, 168.1, 165.9, 152.8, 137.1, 136.2, 128.9, 128.8, 128.6, 128.3, 128.1, 127.6, 85.0, 
70.8, 61.7, 52.7, 51.8, 44.8, 43.3, 42.8, 28.1, 24.5; m/z (ESI) 476.18 ([MH]+, 100), 498.16 ([MNa]+, 82); 
HRMS (ESI/[MH]+) Calcd. For C26H26N3O6: 476.1822, Found 476.1809; [𝛼]𝐷
21= 67.9 (c 1.16, CH2Cl2). 
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Hydroxy DKP 186 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), 4-phenyl-3-buten-2-one (44 mg, 
0.30 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (50% EtOAc in hexane) gave 
Michael adduct 186 (47 mg, 0.12 mmol, 98%) as a colourless solid in 2:98 er [Cellulose-3, MeCN:H2O 
40:60, 1.0 mLmin-1, t1= 5.76 mins, t2= 9.47 mins]; m.p. 142 – 144 °C; IR νmax /cm-1: 3309 (br), 3035, 1685, 
1495, 1395, 1354, 1189, 1071, 749, 702; δ H (300 MHz, CDCl3) 7.62 – 7.52 (2 H, m), 7.47 – 7.30 (3 H, 
m), 7.26 – 7.07 (3 H, m), 6.76 – 6.66 (2 H, m), 4.91 – 4.72 (2 H, m), 3.71 – 3.60 (2 H, m), 3.52 (1 H, d, J 
5.9), 3.43 (1 H, d, J 5.9), 2.48 – 2.35 (1 H, m), 2.20 (3 H, s), 2.13 – 1.93 (2 H, m), 1.81 – 1.63 (1 H, m); δ 
C (101 MHz, CDCl3) 206.0, 168.1, 165.7, 137.3, 129.4, 128.9, 128.7, 128.1, 128.0, 127.9, 84.6, 70.7, 63.1, 
50.8, 44.7, 43.0, 33.0, 28.0, 24.5; m/z 427.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For 
C24H24N2O4Na: 427.1634, Found 427.1619; [𝛼]𝐷
21= 2.4 (c 1.16, CH2Cl2). 
Hydroxy DKP 187 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), phenyl crotonone (45 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (50–55% EtOAc in hexane) gave 
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Michael adduct 187 (48 mg, 0.12 mmol, 99%) as a colourless solid in 1:99 er [Cellulose-3, MeCN:H2O 
50:50, 1.0 mLmin-1, t1= 5.39 mins, t2= 6.77 mins]; m.p. 158 – 159 °C; IR (thin film) νmax /cm-1: 3314 (br), 
2970, 1679, 1448, 1395, 1355, 1215, 753, 702; δ H (300 MHz, CDCl3) 7.72 – 7.47 (5 H, m), 7.49 – 7.32 
(5 H, m), 5.00 (1 H, d, J 14.2), 4.82 (1 H, s), 4.44 (1 H, d, J 14.2), 2.98 – 2.79 (1 H, m), 2.43 – 2.27 (1 H, 
m), 2.20 – 1.97 (2 H, m), 1.90 – 1.75 (1 H, m), 0.92 (3 H, d, J 7.2); δ C (101 MHz, CDCl3) 198.3, 168.6, 
165.7, 138.2, 137.0, 133.7, 129.6, 128.9, 128.6, 128.5, 127.8, 85.0, 70.7, 57.3, 44.5, 42.9, 41.2, 28.3, 24.8, 
17.0; m/z 427.16 ([MNa]+, 100), 405.17 ([MH]+, 10); HRMS (ESI/[MNa]+) Calcd. For C24H24N2O5: 
427.1634, Found 427.1632; [𝛼]𝐷
21= 39.1 (c 0.92, CH2Cl2). 
Hydroxy DKP 188  
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), 4-hexen-3-one (29 mg, 35 μL, 
0.30 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (40–50% EtOAc in hexane) gave 
Michael adduct 188 (41 mg, 0.12 mmol, 96%) as a colourless solid in 1:99 er [Cellulose-3, MeCN:H2O 
35:65, 1.0 mLmin-1, t1= 7.41 mins, t2= 8.99 mins]; m.p. 110 – 111 °C; IR (thin film) νmax /cm-1: 3243 (br), 
2973, 1680, 1456, 1394, 1356, 1187, 702; δ H (400 MHz, CDCl3) 7.38 – 7.32 (2 H, m), 7.29 – 7.20 (3 H, 
m), 4.77 (1 H, s), 4.70 (1 H, d, J 14.4), 4.46 (1 H, d, J 14.4), 3.60 (1 H, ddd, J 11.5, 7.8, 3.9), 3.44 (1 H, 
ddd, J 11.3, 8.8, 6.8), 2.76 (1 H, ddd, J 13.0, 7.0, 4.1), 2.63 – 2.49 (2 H, m), 2.32 – 2.22 (1 H, m), 2.10 – 
2.20 (1 H, m), 2.04 – 1.89 (2 H, m), 1.71 (1 H, ddd, J 13.1, 9.5, 7.3), 0.92 (3 H, t, J 7.2), 0.81 (3 H, d, J 
7.2); δ C (101 MHz, CDCl3) 208.9, 168.5, 165.6, 137.9, 128.9, 128.5, 127.6, 84.6, 70.6, 62.0, 44.4, 42.8, 
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39.9, 38.9, 28.2, 24.7, 17.3, 7.2; m/z 379.2 ([MNa]+, 100), 301.1 ([MH(–C3H4O)]+, 75); HRMS 
(ESI/[MNa]+) Calcd. For C20H24N2O4Na: 379.1634, Found 379.1636; [𝛼]𝐷
21= –63.2 (c 0.88, CH2Cl2). 
Carbonate adduct 193 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), methylacrylate (27 μL, 0.30 
mmol) and 195 (7 mg, 0.012 mmol) as base. The volatiles were then removed under reduced pressure and 
the residue was dissolved in THF (1.0 mL) and K2CO3 (20 mg) was then added and the mixture was stirred 
for 30 mins. Methyl chloroformate (40 l, 0.50 mmol) was then added and the mixture was stirred for 2 
hours. H2O (5 mL) and EtOAc (10 mL) were then added and extracted with EtOAc (3 × 10 mL). The 
organic layers were combined, dried over magnesium sulphate and then purified by flash chromatography 
(60–70% EtOAc in hexane) gave carbonate adduct 193 (23 mg, 0.058 mmol, 48%) as a colourless solid 
in 5:95 er [Cellulose-3, MeCN:H2O 25:75, 1.0 mLmin
-1, t1= 9.38 mins, t2= 10.56 mins]; m.p. 120 – 122 
°C; IR (thin film) νmax /cm-1: 1771, 1721, 1668, 1644, 1518, 1431, 1262, 1189, 731, 699; δ H (300 MHz, 
CDCl3) 7.33 – 7.02 (5 H, m), 6.83 (1 H, t, J 5.4), 4.50 (1 H, dd, J 14.7, 6.8), 4.20 (1 H, dd, J 14.7, 5.2), 
3.78 (3 H, s), 3.72 (3 H, s), 3.62 (2 H, ddd, J 11.9, 6.3, 3.4), 3.53 (1 H, d, J 17.1), 2.77 – 2.50 (2 H, m), 2.05 
– 1.68 (3 H, m); δ C (101 MHz, CDCl3) 171.7, 163.9, 158.3, 153.0, 143.7, 137.9, 128.7, 127.8, 127.6, 
122.2, 68.3, 56.2, 52.8, 46.2, 44.4, 39.0, 33.9, 29.8, 22.4; m/z 425.1 ([MNa]+, 100), 403.1 ([MH]+, 6); 
HRMS (ESI/[MNa]+) Calcd. For C23H28N2O7Na: 425.1427, Found 425.1424 [𝛼]𝐷
21= –152.3 (c 0.68, 
CH2Cl2). 
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Carbonate adduct 194 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), tert-butylacrylate (44 μL, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. The volatiles were then removed under reduced pressure and 
the residue was dissolved in THF (1 mL) and K2CO3 (20 mg) was then added and the mixture was stirred 
for 30 mins. Methyl chloroformate (40 l, 0.50 mmol) was then added and the mixture was stirred for 2 
hours. H2O (5 mL) and EtOAc (10 mL) were then added and extracted with EtOAc (3 × 10 mL). The 
organic layers were combined, dried over magnesium sulphate and then purified by flash chromatography 
(60–70% EtOAc in hexane) gave carbonate adduct 194 (26 mg, 0.058 mmol, 48%) as a colourless solid 
in 15:85 er [Cellulose-3, MeCN:H2O 40:60, 1.0 mLmin
-1, t1= 14.98 mins, t2= 18.49 mins]; m.p. 120 – 122 
°C; IR (thin film) νmax /cm-1: 1772, 1706, 1665, 1640, 1523, 1440, 1262, 1212, 1142, 732, 698; δ H (400 
MHz, CDCl3) 7.26 – 7.10 (5 H, m), 6.83 (1 H, t, J 5.7), 4.47 (1 H, dd, J 14.7, 6.6), 4.25 (1 H, dd, J 14.7, 
5.3), 3.76 (3 H, s), 3.64 – 3.55 (2 H, m), 3.43 (1 H, d, J 17.3), 2.72 – 2.66 (1 H, m), 2.63 (1 H, d, J 17.3), 
1.99 – 1.88 (1 H, m), 1.88 – 1.66 (2 H, m), 1.41 (9 H, s); δ C (101 MHz, CDCl3) 171.6, 162.4, 158.5, 153.0, 
142.3, 137.9, 128.6, 127.7, 127.4, 124.3, 83.1, 68.1, 55.9, 46.0, 44.2, 39.0, 33.9, 28.0, 22.2; m/z 467.2 
([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C23H28N2O7Na: 467.1794, Found 467.1795;            
[𝛼]𝐷
21= –89.7 (c 0.78, CH2Cl2). 
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Ester adduct 196 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), methyl crotonate (32 μL, 0.30 
mmol) and 195 (7 mg, 0.012 mmol) as base. Flash chromatography (40–50% EtOAc in hexane) gave 
Michael adduct 196 (37 mg, 0.10 mmol, 85%) as a colourless solid in 4:96 er [Cellulose-3, MeCN:H2O 
35:65, 1.0 mLmin-1, t1= 7.75 mins, t2= 9.74 mins]; m.p. 140 – 142 °C; IR (thin film) νmax /cm-1: 3316 (br), 
1739, 1683, 1396, 1358, 199, 702; δ H (400 MHz, CDCl3) 7.39 – 7.14 (5 H, m), 4.96 (1 H, s), 4.69 (1 H, 
d, J 14.5), 4.53 (1 H, d, J 14.5), 3.72 – 3.59 (4 H, m), 3.46 (1 H, ddd, J 11.3, 9.1, 6.9), 2.82 (1 H, ddd, J 
12.9, 6.9, 3.9), 2.50 (1 H, d, J 5.0), 2.20 (1 H, dd, J 7.2, 5.0), 2.11 – 1.90 (2 H, m), 1.77 – 1.67 (1 H, m), 
0.93 (3 H, d, J 7.2); δ C (101 MHz, CDCl3) 171.2, 168.2, 165.9, 137.8, 128.7, 128.6, 127.5, 84.0, 70.6, 
56.7, 52.5, 44.5, 42.8, 41.3, 28.3, 24.8, 17.3; m/z 381 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For 
C19H22N2O5Na: 381.1426, Found 381.1424; [𝛼]𝐷
21= 53.7 (c 1.30, CH2Cl2). 
Ester adduct 197 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), ethyl cinnamate (50 μL, 0.30 
mmol) and 195 (7 mg, 0.012 mmol) as base. Flash chromatography (50–55% EtOAc in hexane) gave 
Michael adduct 197 (35 mg, 0.080 mmol, 67%) as a colourless solid in 4:96 er [Cellulose-3, MeCN:H2O 
50:50, 1.0 mLmin-1, t1= 5.22 mins, t2= 7.21 mins]; m.p. 140 – 141 °C; IR (thin film) νmax /cm-1: 3309 
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(br),1731, 1681, 1454, 1393, 1302, 1267, 1186, 1070, 732, 701; δ H (400 MHz, CDCl3) 7.54 – 7.43 (2 H, 
m), 7.41 – 7.28 (3 H, m), 7.24 – 7.06 (3 H, m), 6.76 – 6.64 (2 H, m), 5.08 (1 H, s), 4.82 (1 H, d, J 14.4), 
4.71 (1 H, d, J 14.4), 4.22 – 4.05 (2 H, m), 3.70 – 3.56 (2 H, m), 3.35 (1 H, d, J 5.9), 3.29 (1 H, d, J 5.9), 
2.41 (1 H, ddd, J 13.0, 7.1, 5.2), 2.13 – 1.89 (2 H, m), 1.81 – 1.60 (1 H, m), 1.21 (3 H, t, J 7.1); δ C (101 
MHz, CDCl3) 170.7, 167.9, 166.0, 137.2, 136.8, 129.2, 128.9, 128.7, 128.0, 127.7, 84.2, 70.7, 61.7, 57.5, 
52.2, 44.7, 43.1, 28.1, 24.5, 14.1; m/z 457.2 ([MNa]+, 100), 435.2 ([MH]+, 12); HRMS (ESI/[MNa]+) 
Calcd. For C25H26N2O5Na: 457.1739, Found 457.1742; [𝛼]𝐷
21= –31.5 (c 0.88, CH2Cl2). 
Maleimide adduct 199 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), N-phenyl maleimide (52 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (50–55% EtOAc in hexane) gave 
Michael adduct 199 (25 mg, 0.058 mmol, 48%) as a colourless solid in 65:35 er [Cellulose-3, MeCN:H2O 
30:70, 1.0 mLmin-1, t1= 15.04 mins, t2= 18.07 mins]; m.p. decomp. 210 – 212 °C; IR (thin film)                   
νmax /cm-1: 3302 (br), 1716, 1697, 1685, 1675, 1498, 1452, 1394, 1195, 967, 772, 729, 692; δ H (400 MHz, 
CDCl3) 7.43 – 7.30 (5 H, m), 7.30 – 7.16 (3 H, m), 7.09 – 7.00 (2 H, m), 4.99 (1 H, s), 4.76 (1 H, d, J 14.5), 
4.53 (1 H, d, J 14.5), 3.59 (1 H, ddd, J 11.8, 7.9, 4.3), 3.34 – 3.22 (2 H, m), 3.15 (1 H, d, J 8.8), 2.93 (1 H, 
ddd, J 13.6, 7.8, 4.5), 2.82 (1 H, ddd, J 13.6, 9.1, 7.6), 2.11 – 1.98 (1 H, m), 1.98 – 1.86 (1 H, m); δ C (101 
MHz, CDCl3) 172.2, 170.2, 167.2, 164.7, 137.1, 134.2, 130.9, 129.4, 129.3, 128.8, 128.6, 127.9, 126.3, 
126.1, 84.1, 69.3, 50.3, 45.4, 44.4, 44.4, 43.4, 25.5, 24.7; [𝛼]𝐷
21= N.D. (poor solubility). 
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Amide 207 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), phenyl acrylamide (44 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (70–80% EtOAc in hexane) gave 
Michael adduct 207 (35 mg, 0.086 mmol, 72%) as a colourless solid in 97:3 er [Cellulose-3, MeCN:H2O 
30:70, 1.0 mLmin-1, t1= 9.49 mins, t2= 11.32 mins]; m.p. 134 – 136 °C; IR (thin film) νmax /cm-1: 3316 (br), 
1682, 1600, 1548, 1443, 1359, 755, 695; δ H (400 MHz, CDCl3) 7.60 (1 H, s), 7.48 – 7.39 (2 H, m), 7.39 
– 7.25 (7 H, m), 7.18 – 7.04 (1 H, m), 5.36 (1 H, s), 4.82 (1 H, d, J 14.8), 4.58 (1 H, d, J 14.8), 3.69 – 3.61 
(1 H, m), 3.60 – 3.52 (1 H, m), 2.95 – 2.79 (2 H, m), 2.60 (1 H, dd, J 13.4, 4.3), 2.21 – 1.87 (4 H, m); δ C 
(101 MHz, CDCl3) 169.7, 166.7, 165.0, 137.9, 137.2, 128.9, 128.7, 128.1, 127.6, 124.8, 120.1, 84.9, 66.7, 
50.3, 44.6, 43.0, 32.1, 29.2, 24.7; m/z 428.2 ([MNa]+, 100), 406.2 ([MH]+, 12); HRMS (ESI/[MNa]+) 
Calcd. For C23H23N3O4Na: 428.1586, Found 428.1587; [𝛼]𝐷
21= 78.7 (c 0.94, CH2Cl2). 
Amide 208 
 
General procedure A was followed with TKP 113 (30 mg, 0.12 mmol), benzyl acrylamide (47 mg, 0.29 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (80% EtOAc in hexane) gave Michael 
adduct 208 (31 mg, 0.074 mmol, 64%) as a colourless solid in 99:1 er [Chiralcel OD, IPA:Hexane 20:80, 
1.0 mLmin-1, t1= 13.99 mins, t2= 23.18 mins]; m.p. 104 – 106 °C; IR (thin film) νmax /cm-1: 3316 (br), 3030, 
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1674, 1539, 1397, 1357, 1219, 750, 699; δ H (300 MHz, CDCl3) 7.35 – 7.22 (10 H, m), 6.15 (1 H, s), 5.14 
(1 H, s), 4.76 (1 H, d, J 14.8), 4.54 (1 H, d, J 14.8), 4.40 (2 H, qd, J 14.8, 5.7), 3.73 – 3.51 (2 H, m), 2.88 
(1 H, dt, J 13.2, 6.7), 2.73 (1 H, dd, J 10.2, 4.2), 2.55 (1 H, dd, J 13.3, 4.3), 2.19 – 1.91 (4 H, m); δ C (101 
MHz, CDCl3) 169.8, 168.5, 165.2, 137.9, 137.7, 128.7, 128.7, 128.0, 127.7, 127.6, 127.5, 84.7, 66.8, 49.5, 
44.6, 44.0, 42.9, 32.3, 29.2, 24.7; m/z 442.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For 
C24H25N3O4Na: 442.1743, Found 442.1746; [𝛼]𝐷
21= 60.4 (c 1.06, CH2Cl2). 
Amide 209 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), methyl phenyl acrylamide (48 
mg, 0.30 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (EtOAc) gave Michael 
adduct 209 (42 mg, 0.10 mmol, 83%) as a colourless solid in 99:1 er [Cellulose-3, MeCN:H2O 20:80, 1.0 
mLmin-1, t1= 22.38, t2= 27.33]; m.p. 184 – 186 °C; IR (thin film) νmax /cm-1: 3321 (br), 3005, 1685, 1670, 
1455, 1396, 928, 698; δ H (300 MHz, CDCl3) 7.35 – 7.22 (10 H, m), 6.15 (1 H, s), 5.14 (1 H, s), 4.76 (1 
H, d, J 14.8), 4.54 (1 H, d, J 14.8), 4.40 (2 H, qd, J 14.8, 5.7), 3.73 – 3.51 (2 H, m), 2.88 (1 H, dt, J 13.2, 
6.7), 2.73 (1 H, dd, J 10.2, 4.2), 2.55 (1 H, dd, J 13.3, 4.3), 2.19 – 1.91 (4 H, m); δ C (101 MHz, CDCl3) 
170.4, 169.5, 166.4, 142.9, 137.7, 129.9, 128.4, 128.1, 127.9, 127.3, 127.1, 85.0, 66.4, 46.2, 44.7, 42.7, 
37.6, 34.3, 29.3, 24.7; m/z 442.3 ([MNa]+, 100), 303.1 (8); HRMS (ESI/[MNa]+) Calcd. For 
C24H25N3O4Na: 442.1743, Found 442.1734; [𝛼]𝐷
21= –46.5 (c 0.49, CH2Cl2). 
Scale up - General procedure A was followed with TKP 113 (500 mg, 1.94 mmol), methyl phenyl 
acrylamide (468 mg, 2.90 mmol) and 144 (47 mg, 0.097 mmol [5 mol %]) as base. Flash chromatography 
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(90–100% EtOAc in hexane) gave Michael adduct 209 (770 mg, 1.62 mmol, 84%) as a colourless solid, 
with data consistent to that above. 
Amide 210 
 
General procedure A was followed with TKP 113 (30 mg, 0.12 mmol), dimethyl acrylamide (29 mg, 0.29 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (0–10% MeOH in EtOAc) gave 
Michael adduct 210 (35 mg, 0.097 mmol, 81%) as a colourless gum in 99:1 er [Cellulose-3, MeCN:H2O 
15:85, 1.0 mLmin-1, t1= 8.13 mins, t2= 9.85 mins]; IR (thin film) νmax /cm-1: 3278 (br), 2938, 1680, 1641, 
1396, 922, 728, 703; δ H (300 MHz, CDCl3) 7.46 – 7.36 (2 H, m), 7.36 – 7.25 (3 H, m), 5.02 – 4.86 (2 H, 
m), 4.39 (1 H, d, J 14.4), 3.75 – 3.50 (2 H, m), 3.15 (1 H, dt, J 8.4, 4.2), 2.98 – 2.79 (4 H, m), 2.74 (3 H, 
s), 2.26 – 1.79 (5 H, m); δ C (101 MHz, CDCl3) 169.9, 169.7, 165.6, 138.1, 128.8, 128.6, 127.6, 85.4, 66.6, 
45.0, 44.5, 42.9, 37.5, 36.0, 33.8, 29.3, 24.6; m/z 380.2 ([MNa]+, 100), 358.2 ([MH]+, 7); HRMS 
(ESI/[MNa]+) Calcd. For C19H23N3O4Na: 380.1586, Found 380.1585; [𝛼]𝐷
21= 31.0 (c 0.98, CH2Cl2). 
Amide 211 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), diphenyl acrylamide (67 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (50–65% EtOAc in hexane) gave 
Michael adduct 211 (46 mg, 0.096 mmol, 80%) as a colourless solid in 4:96 er [Cellulose-3, MeCN:H2O 
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35:65, 1.0 mLmin-1, t1= 9.14 mins, t2= 10.21 mins]; m.p. 157 – 158 °C; IR (thin film) νmax /cm-1: 3252 
(br),  1676, 1593, 1491, 1387, 1325, 1268, 734, 700; δ H (400 MHz, CDCl3) 7.35 – 7.24 (6 H, m), 7.19 – 
7.08 (9 H, m), 5.21 (1 H, s), 4.54 (1 H, d, J 14.7), 4.40 (1 H, d, J 14.7), 3.69 – 3.53 (2 H, m), 3.18 (1 H, dd, 
J 10.4, 5.0), 2.81 (1 H, dt, J 13.2, 6.4), 2.17 (1 H, dd, J 13.0, 5.1), 2.12 – 1.90 (3 H, m), 1.81 (1 H, dt, J 
13.1, 7.4); δ C (101 MHz, CDCl3) 170.8, 169.5, 166.2, 142.1, 142.0, 137.6, 129.9, 128.9, 128.5, 128.5, 
128.1, 127.9, 127.2, 126.5, 126.3, 85.4, 66.4, 47.2, 44.5, 42.8, 34.5, 29.3, 24.6; m/z 504.2 ([MNa]+, 100), 
482.2 ([MH]+, 38); HRMS (ESI/[MNa]+) Calcd. For C29H27N3O4Na: 504.1899, Found 504.1901; [𝛼]𝐷
21= 
–123.2 (c 0.99, CH2Cl2). 
Amide 212 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), N-methoxymethyl acrylamide (35 
mg, 0.30 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (0–5% MeOH in EtOAc) 
gave Michael adduct 212 (44 mg, 0.12 mmol, 98%) as a colourless gum in 2:98 er [HPLC analysis was 
performed on 134 formed from the reaction of 212 with MeMgBr (3 eq) in THF followed by purification 
by flash chromatography; Cellulose-3, MeCN:H2O 30:70, 1.0 mLmin
-1, t1= 6.09 mins, t2= 7.58 mins]; IR 
(thin film) νmax /cm-1: 3319 (br),  1683, 1428, 1394, 1356, 1187, 703; δ H (400 MHz, CDCl3) 7.38 – 7.33 
(2 H, m), 7.32 – 7.21 (3 H, m), 4.96 (1 H, s), 4.89 (1 H, d, J 14.5), 4.38 (1 H, d, J 14.6), 3.69 – 3.53 (2 H, 
m), 3.46 (1 H, dd, J 10.2, 5.3), 3.38 (3 H, s), 3.10 (3 H, s), 2.86 (1 H, ddd, J 13.2, 7.1, 6.1), 2.15 – 1.95 (4 
H, m), 1.84 (1 H, dt, J 13.1, 7.5); δ C (101 MHz, CDCl3) 170.9, 169.6, 165.9, 138.1, 128.6, 128.6, 127.4, 
84.8, 66.6, 61.4, 44.5, 44.0, 42.9, 33.8, 31.9, 29.3, 24.7; m/z 374.2 ([MH]+, 100); HRMS (ESI/[MH]+) 
Calcd. For C19H24N3O5: 374.1716, Found 374.1721; [𝛼]𝐷
21= –14.4 (c 0.70, CH2Cl2). 
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Amide 213 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), piperidine acrylamide (42 mg, 
0.30 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (0–5% MeOH in EtOAc) gave 
Michael adduct 213 (38 mg, 0.096 mmol, 80%) as a colourless gum in 1:99 er [Amylose-2, MeCN:H2O 
40:60, 1.0 mLmin-1, t1= 6.38 mins, t2= 9.22 mins]; IR (thin film) νmax /cm-1: 3278 (br), 2937, 2857, 1681, 
1633, 1442, 1395, 1248, 750, 703; δ H (300 MHz, CDCl3) 7.40 – 7.28 (2 H, m), 7.28 – 7.13 (3 H, m), 4.98 
(1 H, s), 4.87 (1 H, d, J 14.3), 4.28 (1 H, d, J 14.3), 3.70 – 3.38 (3 H, m), 3.23 – 3.11 (1 H, m), 3.07 – 2.94 
(2 H, m), 2.93 – 2.68 (2 H, m), 2.17 – 1.71 (5 H, m), 1.58 – 1.24 (6 H, m); δ C (101 MHz, CDCl3) 169.7, 
168.1, 165.7, 138.2, 129.0, 128.5, 127.5, 85.3, 66.6, 47.3, 44.5, 44.5, 43.3, 42.9, 34.0, 29.3, 26.5, 25.6, 
24.6, 24.4; m/z 420.18 ([MNa]+, 100), 398.19 ([MH]+, 7); HRMS (ESI/[MNa]+) Calcd. For 
C22H27N3O4Na: 420.1899, Found 420.1903; [𝛼]𝐷
21= –24.3 (c 1.15, CH2Cl2). 
Amide 214 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), morpholine acrylamide (42 mg, 
0.30 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (0.5–1.5% MeOH in EtOAc) 
gave Michael adduct 214 (47 mg, 0.12 mmol, 98 %) as a colourless gum in 1:99 er [Cellulose-3, 
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MeCN:H2O 15:85, 1.0 mLmin
-1, t1= 12.13 mins, t2= 16.99 mins]; IR (thin film) νmax /cm-1: 3313 
(br),  2923, 1679, 1632, 1434, 1364, 1244, 1111, 731, 702; δ H (300 MHz, CDCl3) 7.42 – 7.35 (2 H, m), 
7.33 – 7.21 (3 H, m), 5.08 – 4.93 (2 H, m), 4.28 (1 H, d, J 14.3), 3.90 – 3.76 (1 H, m), 3.71 – 3.48 (6 H, 
m), 3.23 (1 H, ddd, J 13.4, 8.0, 3.5), 3.07 – 2.80 (4 H, m), 2.27 (1 H, dd, J 13.0, 4.8), 2.17 – 2.00 (2 H, m), 
1.95 – 1.82 (2 H, m); δ C (101 MHz, CDCl3) 169.5, 168.2, 165.2, 138.2, 129.0, 128.5, 127.7, 85.3, 66.8, 
66.7, 66.6, 46.5, 44.6, 44.4, 43.0, 42.6, 33.8, 29.3, 24.6; m/z 422.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) 
Calcd. For C21H25N3O5Na: 422.1692, Found 422.1690; [𝛼]𝐷
21= 9.6 (c 0.67, CH2Cl2). 
Amide 215 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), indoline acrylamide (52 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (60–65% EtOAc in hexane) gave 
Michael adduct 215 (49 mg, 0.11 mmol, 95%) as a colourless solid in 2:98 er [Cellulose-3, MeCN:H2O 
35:65, 1.0 mLmin-1, t1= 8.33 mins, t2= 9.66 mins]; m.p. 164 – 167 °C; IR νmax /cm-1: 3358 (br), 2943, 1680, 
1656, 1482, 1418, 1340, 757, 704; δ H (400 MHz, CDCl3) 8.19 – 8.11 (1 H, m), 7.47 – 7.38 (2 H, m), 7.35 
– 7.27 (3 H, m), 7.17 – 7.08 (2 H, m), 6.99 (1 H, td, J 7.4, 1.1), 5.16 (1 H, s), 4.97 (1 H, d, J 14.4), 4.38 (1 
H, d, J 14.4), 3.83 (1 H, td, J 10.0, 7.1), 3.70 (1 H, dt, J 11.3, 7.2), 3.58 (1 H, ddd, J 11.4, 7.5, 5.5), 3.49 (1 
H, td, J 10.1, 6.9), 3.13 – 2.96 (3 H, m), 2.88 (1 H, ddd, J 13.2, 7.2, 6.0), 2.32 (1 H, dd, J 13.0, 4.9), 2.15 – 
1.96 (3 H, m), 1.88 (1 H, dt, J 13.1, 7.5); δ C (101 MHz, CDCl3) 169.6, 167.9, 165.4, 142.4, 138.1, 131.6, 
129.0, 128.6, 127.6, 127.4, 124.5, 124.2, 117.6, 85.6, 66.7, 48.3, 48.2, 44.6, 43.0, 33.7, 29.3, 27.6, 24.7; 
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m/z 454.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C25H25N3O4Na: 454.1743, Found 454.1741; 
[𝛼]𝐷
21= 20.1 (c 0.89, CH2Cl2). 
Indole amide 217 
 
General procedure A was followed with TKP 113 (31 mg, 0.12 mmol), indole acrylamide (51 mg, 0.30 
mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (40–60% EtOAc in hexane) gave 
Michael adduct 217 (23 mg, 0.054 mmol, 45%) as a colourless solid [er not determined]; m.p. 188 – 190 
°C; IR νmax /cm-1: 2940, 1741, 1694, 1680, 1476, 1312, 754, 725; δ H (300 MHz, CDCl3) 8.32 (1 H, d, J 
8.0), 7.61 – 7.55 (1 H, m), 7.54 – 7.48 (2 H, m), 7.39 – 7.28 (3 H, m), 7.27 – 7.23 (1 H, m), 7.18 (1 H, ddd, 
J 7.4, 3.8, 1.2), 6.80 (1 H, d, J 3.3), 6.59 (1 H, dd, J 3.8, 0.6), 5.09 (1 H, d, J 13.5), 5.04 – 4.95 (1 H, m), 
3.98 (1 H, dt, J 13.1, 8.4), 3.71 (1 H, ddd, J 13.0, 7.8, 5.1), 2.51 – 2.31 (4 H, m), 2.31 – 2.09 (4 H, m); δ C 
(101 MHz, CDCl3) 170.8, 168.5, 157.8, 135.4, 130.3, 129.7, 128.8, 128.5, 127.6, 125.4, 124.0, 121.0, 
116.4, 109.8, 72.6, 68.6, 45.3, 44.4, 34.2, 33.8, 29.7, 22.0, 19.7; m/z 452.2 ([MNa]+, 100), 430.2 ([M]+, 
35); HRMS (ESI/[MNa]+) Calcd. For C25H23N3O4Na: 452.1586, Found 452.1585. 
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PMB Amide 221 
 
General procedure A was followed with TKP 125 (35 mg, 0.12 mmol), methyl phenyl acrylamide (48 
mg, 0.30 mmol) and 144 (6 mg, 0.012 mmol) as base. Flash chromatography (90% EtOAc in hexane- 
EtOAc) gave Michael adduct 221 (44 mg, 0.097 mmol, 81%) as a colourless solid in 99:1 er [Cellulose-
3, MeCN:H2O 20:80, 1.0 mLmin
-1, t1= 21.23, t2= 24.65]; m.p. 174 – 175 °C; IR (thin film) νmax /cm-1: 
3323 (br), 3001, 1683, 1671, 1456, 1401, 923, 691; δ H (300 MHz, CDCl3) 7.63 – 7.22 (9 H, m), 6.11 (1 
H, s), 5.18 (1 H, s), 4.71 (1 H, d, J 14.6), 4.51 (1 H, d, J 14.6), 4.43 (2 H, m), 3.87 (3 H, s), 3.70 – 3.54 (2 
H, m), 2.85 (1 H, dt, J 13.5, 6.3), 2.75 (1 H, dd, J 10.0, 4.5), 2.51 (1 H, dd, J 13.5, 4.5), 2.21 – 1.95 (4 H, 
m); δ C (101 MHz, CDCl3) 170.7, 168.5, 166.2, 142.5, 137.7, 134.5, 129.9, 128.4, 128.1, 127.5, 127.4, 
113.4, 85.4, 66.3, 46.0, 44.8, 42.5, 37.3, 34.0, 29.6, 24.9; m/z 472.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) 
Calcd. For C24H25N3O4Na: 472.1848, Found 472.1850; [𝛼]𝐷
21= –42.5 (c 0.65, CH2Cl2). 
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Further Transformations of Michael Addition–Ring-Closure Adducts 
Carbonate 242 
 
LiHMDS (1.0M solution in THF, 0.36 mL, 0.36 mmol) was added dropwise to a stirred solution of 
hydroxy DKP 209 (30 mg, 0.072 mmol) in THF (1 mL) at 40 °C and left for 10 minutes before addition 
of methyl chloroformate (56 l, 68 mg, 0.72 mmol) in one portion. The reaction mixture was allowed to 
slowly warm to 5 °C over 2 hours before being quenched with sat. aq. NH4Cl (5 mL). The mixture was 
extracted with EtOAc (3 × 10 mL) and the combined organic layers were washed with HCl (1.0 M, 10 
mL) and brine (10 mL), and then dried over MgSO4 before the solvent was removed under reduced 
pressure. The residue was then purified by flash chromatography (EtOAc) to give a mixture of carbonate 
242 and DKP 209 (approx. 9:1, 90% conversion) as a colourless solid; m.p. 69 – 71 °C; IR (thin film) νmax 
/cm-1: 2956, 2361, 1775, 1718, 1693, 1657, 1595, 1495, 1430, 1388, 1254, 1204, 1182, 729, 700; δ H (400 
MHz, CDCl3) 7.35 – 7.29 (3 H, m), 7.19 – 7.01 (5 H, m), 6.96 – 6.86 (2 H, m), 5.02 (1 H, d, J 15.3), 4.07 
(1 H, d, J 15.3), 3.95 (3 H, s), 3.82 – 3.70 (1 H, m), 3.62 – 3.50 (1 H, m), 3.22 (3 H, s), 3.04 (1 H, dd, J 
10.2, 4.4), 2.83 – 2.70 (1 H, m), 2.17 – 1.99 (3 H, m), 1.84 (1 H, ddd, J 8.7, 5.9, 3.0), 1.71 (1 H, dd, J 12.9, 
10.2). δ C (101 MHz, CDCl3) 169.3, 168.9, 160.9, 152.7, 142.8, 136.7, 129.9, 128.5, 128.1, 127.9, 127.5, 
127.5, 90.9, 77.4, 77.1, 76.7, 65.8, 55.9, 45.9, 45.2, 44.4, 38.3, 34.1, 29.4, 24.0; m/z 500.2 ([MNa]+, 100), 
478.2 ([M]+, 50); HRMS (ESI/[MNa]+) Calcd. For C26H27N3O6Na: 500.1798, Found 500.1794. 
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Carbonate 243 
 
NaH (60% on mineral oil, 9 mg, 0.22 mmol) was added to a solution of amide adduct 209 (30 mg, 0.072 
mmol) in THF (1.0 mL) at 0 °C and then was allowed to warm to rt over 30 minutes. Methyl chloroformate 
(68 mg, 56 L, 0.72 mmol) was then added and the mixture was stirred at rt for a further 90 minutes. The 
reaction mixture was quenched with NaHCO3, extracted with DCM and then washed with H2O. The 
organic layer was then dried over MgSO4 before the solvent was removed under reduced pressure. Flash 
chromatography (80% EtOAc in hexane) gave 243 (23 mg, 0.47 mmol, 65%) as a colourless solid; m.p. 
160 – 161 °C; IR (thin film) νmax /cm-1: 3365 (br), 2955, 1773, 1645, 1594, 1518, 1495, 1439, 1418, 1383, 
1229, 732, 699; δ H (400 MHz, CDCl3) 7.38 (2 H, t, J 7.4), 7.34 – 7.27 (5 H, m), 7.21 (2 H, d, J 6.8), 7.14 
(2 H, d, J 7.4), 6.63 (1 H, s), 4.77 (1 H, dd, J 14.6, 7.6), 3.96 (1 H, dd, J 14.6, 3.3), 3.75 (3 H, s), 3.63 – 
3.50 (2 H, m), 3.46 – 3.32 (4 H, m), 2.76 – 2.49 (2 H, m), 2.02 – 1.82 (2 H, m), 1.77 – 1.62 (1 H, m); δ C 
(101 MHz, CDCl3) 171.9, 164.5, 158.0, 152.3, 142.1, 137.7, 136.7, 129.4, 128.7, 127.8, 127.7, 127.5, 
127.3, 126.4, 67.9, 55.6, 45.9, 44.3, 39.3, 37.2, 35.0, 22.3; m/z 500.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) 
Calcd. For C26H27N3O6Na: 500.1798, Found 500.1790. 
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General procedure B – NaHMDS (1.0 M solution in THF) was added dropwise to a stirred solution of 
hydroxy DKP in THF or DMF at 40 °C and left for 5 mins before addition of O-phenyl 
chlorothionoformate in one portion. The reaction mixture was allowed to slowly warm to 5 °C over 2 
hours before being quenched with sat. aq. NH4Cl. The mixture was extracted with EtOAc (3×) and the 
combined organic layers were washed with HCl (1.0 M) and brine, and then dried over MgSO4 before the 
solvent was removed under reduced pressure. The residue was then purified by flash chromatography 
using the indicated solvent system. 
Thiocarbonate 244 
 
General procedure B was followed with Michael product 209 (192 mg, 0.458 mmol) in THF (5 mL), 
NaHMDS (1.0 M in THF, 0.92 mL, 0.92 mmol) and O-phenyl chlorothionoformate (316 mg, 0.25 mL, 
1.83 mmol). Flash chromatography (80–100% EtOAc in hexane) gave thiocarbonate 244 (182 mg, 0.328 
mmol, 72%) as a colourless solid; m.p. 192 – 194 °C; IR (thin film) νmax /cm-1: 3060, 1719, 1698, 1657, 
1491, 1426, 1385, 1276, 1196, 1142, 1124, 735, 699; δ H (400 MHz, CDCl3) 7.44 – 7.35 (5 H, m), 7.34 – 
7.27 (2 H, m), 7.25 – 7.15 (3 H, m), 7.15 – 7.09 (1 H, m), 7.05 – 6.95 (4 H, m), 4.97 (1 H, d, J 15.1), 4.22 
(1 H, d, J 15.1), 3.84 (1 H, ddd, J 11.2, 7.5, 5.6), 3.51 (1 H, dt, J 11.3, 7.3), 3.27 (3 H, s), 3.18 (1 H, dd, J 
10.0, 4.2), 2.74 (1 H, dt, J 13.3, 8.0), 2.22 (1 H, dd, J 12.9, 4.2), 2.13 – 2.03 (2 H, m), 1.87 (1 H, ddd, J 
13.0, 7.2, 5.4), 1.68 (1 H, dd, J 12.9, 10.0); δ C (101 MHz, CDCl3) 189.9, 169.5, 168.6, 159.9, 153.6, 142.9, 
136.2, 130.0, 129.8, 129.8, 129.6, 129.3, 129.1, 128.7, 128.4, 128.3, 127.9, 127.7, 127.2, 127.1, 127.0, 
126.6, 121.6, 94.4, 66.0, 46.1, 46.0, 44.6, 38.6, 33.9, 29.3, 23.8; m/z 578.2 ([MNa]+, 100); HRMS 
(ESI/[MNa]+) Calcd. For C31H29N3O5NaS: 578.1726, Found 578.1730.  
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Carbonate 248 
 
n-BuLi (2.7 M in PhMe, 31 L, 0.083 mmol) was added to a solution of  chalcone adduct 159 (32 mg, 
0.069 mmol) in THF (1.0 mL) at -78 °C for 5 minutes before addition of methyl chloroformate (20 mg, 
16 L, 0.21 mmol) and then the mixture was allowed to warm to room temperature over 2 hours. The 
reaction mixture was quenched with NH4Cl, extracted with EtOAc and then washed with H2O. The 
organic layer was then dried over MgSO4 before the solvent was removed under reduced pressure. Flash 
chromatography (60% EtOAc in hexane) gave 248 (27 mg, 0.052 mmol, 75%) as a colourless solid; m.p. 
174 – 175 °C; IR (thin film) νmax /cm-1: 2955, 1778, 1721, 1693, 1447, 1385, 1260, 1186, 701; δ H (400 
MHz, CDCl3) 7.52 – 7.49 (2 H, m), 7.46 – 7.40 (6 H, m), 7.35 – 7.30 (2 H, m), 7.12 – 7.09 (1 H, m), 7.05 
– 7.00 (2 H, m), 6.60 – 6.56 (2 H, m), 5.25 (1 H, d, J 15.0), 4.38 (1 H, d, J 15.0), 4.20 (1 H, d, J 5.9), 3.76 
– 3.70 (4 H, m), 3.61 – 3.57 (1 H, m), 3.47 (1 H, d, J 5.9), 2.52 – 2.48 (1 H, m), 2.04 – 1.95 (2 H, m), 1.75 
– 1.68 (1 H, m); δ C (101 MHz, CDCl3) 196.3, 168.3, 160.9, 152.6, 136.8, 136.7, 136.6, 133.7, 130.5, 
128.9, 128.8, 128.4, 127.9, 90.4, 70.0, 57.5, 55.9, 52.5, 45.9, 44.5, 28.1, 24.0; m/z 547.2 ([MNa]+, 100), 
525.2 ([MH]+, 44); HRMS (ESI/[MNa]+) Calcd. For C31H28N2O6Na: 547.1845, Found 547.1841. 
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Pentacycle 250 
 
Tris(trimethylsilyl)silane (TMSS) (29 mg, 35l, 0.115 mmol)  and 1,1′-Azobis(cyclohexane carbonitrile) 
(ACCN) (7 mg, 0.029 mmol) were added to a solution of thiocarbonate 244 (32 mg, 0.058 mmol) in dry 
toluene (2.0 mL, N2 degassed). The mixture was then degassed by three freeze-thaw cycles before it was 
heated under reflux for 4 hours. The reaction mixture was then cooled to room temperature and then 
directly purified by flash chromatography (80% EtOAc in hexane) to give pentacycle 250 (7–12 mg, 
0.017–0.029, 30–50%) as a colourless solid; m.p. 199 –200 °C;  IR (thin film) νmax /cm-1: 2924, 1684, 
1677, 1603, 1455, 1421, 1374, 1267, 1147, 760, 732, 700; δ H (400 MHz, CDCl3) 7.46 (1 H, ddd, J 8.6, 
7.4, 1.6), 7.30 (1 H, dd, J 7.8, 1.6), 7.24 – 7.16 (3 H, m), 7.16 – 7.05 (2 H, m), 6.98 – 6.86 (2 H, m), 4.98 
(1 H, d, J 15.3), 4.65 (1 H, d, J 15.2), 3.61 – 3.46 (2 H, m), 3.30 (3 H, s), 3.00 – 2.81 (2 H, m), 2.70 (1 H, 
dd, J 13.7, 5.8), 2.15 (1 H, dd, J 13.7, 10.5), 2.11 – 1.95 (3 H, m); δ C (101 MHz, CDCl3) 175.1, 166.6, 
164.4, 140.4, 137.2, 130.7, 130.2, 128.8, 127.8, 127.7, 122.5, 119.8, 115.8, 69.1, 66.2, 47.1, 45.0, 44.7, 
32.7, 30.4, 29.8, 24.2; m/z 424.2 ([MNa]+, 100), 402.2 ([MH]+, 22); HRMS (ESI/[MNa]+) Calcd. For 
C24H23N3O3Na: 424.1637, Found 424.1636.  
Nb. Improved yields can be obtained by performing the reaction under air. 
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Thiocarbonate 254 
 
General procedure B was followed with Michael product 210 (280 mg, 0.783 mmol) in DMF (10 mL), 
NaHMDS (1.0 M in THF, 1.18 mL, 1.18 mmol) and O-phenyl chlorothionoformate (405 mg, 0.32 mL, 
2.35 mmol). Flash chromatography (EtOAc) gave thiocarbonate 254 (290 mg, 0.588 mmol, 75%) as a 
colourless solid; m.p. 184 – 186 °C; IR (thin film) νmax /cm-1: 2948, 1717, 1696, 1646, 1489, 1380, 1278, 
1197, 1137, 1068, 910, 730, 703, 691; δ H (400 MHz, CDCl3) 7.56 – 7.50 (2 H, m), 7.49 – 7.43 (2 H, m), 
7.43 – 7.27 (6 H, m), 5.66 (1 H, d, J 14.8), 4.29 (1 H, d, J 14.8), 3.83 (1 H, ddd, J 11.3, 7.6, 5.3), 3.48 (1 
H, dt, J 11.3, 7.4), 3.09 (1 H, dd, J 9.8, 4.0), 2.92 (3 H, s), 2.82 (1 H, dt, J 13.3, 8.2), 2.44 (1 H, dd, J 12.9, 
4.0), 2.23 – 2.06 (2 H, m), 1.98 (1 H, ddd, J 12.7, 7.2, 5.0), 1.80 – 1.67 (1 H, m); δ C (101 MHz, CDCl3) 
189.7, 169.9, 167.9, 159.3, 153.6, 137.3, 129.7, 129.2, 129.0, 128.5, 127.0, 121.7, 94.5, 66.5, 46.0, 44.9, 
44.5, 37.8, 36.4, 33.7, 29.4, 23.7; m/z 516.16 ([MNa]+, 100), 595.30 (30); HRMS (ESI/[MNa]+) Calcd. 
For C26H27N3O5NaS: 516.1569, Found 516.1570. 
Thiocarbonate 255 
 
General procedure B was followed with Michael product 212 (246 mg, 0.66 mmol) in DMF (7.0 mL), 
NaHMDS (1.0 M in THF, 1.0 mL, 1.0 mmol) and O-phenyl chlorothionoformate (341 mg, 0.27 mL, 1.98 
mmol). Flash chromatography (80–100% EtOAc in hexane) gave thio-carbonate 255 (43 mg, 0.084 
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mmol, 75%) as a colourless solid; m.p. 187 – 189 °C; IR (thin film) νmax /cm-1: 2979, 1717, 1695, 1659, 
1489, 1427, 1381, 1269, 1193, 1141, 734, 699; δ H (400 MHz, CDCl3) 7.52 – 7.46 (2 H, m), 7.46 – 7.41 
(2 H, m), 7.40 – 7.34 (3 H, m), 7.34 – 7.29 (1 H, m), 7.28 – 7.26 (1 H, m), 7.26 – 7.23 (1 H, m), 5.58 (1 H, 
d, J 15.0), 4.31 (1 H, d, J 14.9), 3.80 (1 H, dt, J 11.3, 6.5), 3.56 – 3.41 (5 H, m), 3.13 (3 H, s), 2.81 (1 H, 
dt, J 13.3, 8.1), 2.18 – 2.03 (3 H, m), 1.94 (1 H, dt, J 12.8, 6.2), 1.85 (1 H, dd, J 13.0, 10.1); δ C (101 MHz, 
CDCl3) 189.9, 169.8, 169.1, 159.6, 153.6, 137.2, 129.7, 129.1, 128.9, 128.3, 127.0, 121.7, 93.9, 66.3, 61.8, 
46.1, 44.6, 43.7, 33.9, 32.3, 29.4, 23.8; m/z 532.1 ([MNa]+, 100), 611.29, 40); HRMS (ESI/[MNa]+) Calcd. 
For C26H27N3O6NaS: 532.1518, Found 532.1520. 
General procedure C – Tris(trimethylsilyl)silane (TTMS) and 1,1′-Azobis(cyclohexane carbonitrile) 
(ACCN) were added to a solution of thiocarbonate in dry toluene (N2 degassed). The mixture was then 
degassed by three freeze-thaw cycles before being heated under reflux for 1 hour. The reaction mixture 
was then cooled to room temperature and then directly purified by flash chromatography using the 
indicated solvent system. 
Amide DKP 256 
 
General procedure C was followed with thiocarbonate 254 (30 mg, 0.061 mmol), TTMS (76 mg, 94 L, 
0.30 mmol) and ACCN (22 mg, 0.091 mmol). Flash chromatography (3% MeOH in CH2Cl2 then 5% 
MeOH in 1:1 CH2Cl2:EtOAc) gave amide 256 (21 mg, 0.061 mmol, quant.) as a colourless solid; m.p. 
130 – 131 °C;  IR (thin film) νmax /cm-1: 3486 (br), 2926, 1679, 1639, 1495, 1417, 1217, 1145, 733, 702; δ 
H (400 MHz, CDCl3) 7.40 – 7.28 (5 H, m), 5.24 (1 H, d, J 14.4), 3.95 (1 H, d, J 14.4), 3.90 (1 H, d, J 3.3), 
3.62 – 3.54 (1 H, m), 3.52 – 3.45 (1 H, m), 2.89 (1 H, ddd, J 9.8, 4.6, 3.3), 2.85 – 2.76 (4 H, m), 2.48 – 
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2.39 (4 H, m), 2.13 – 2.00 (2 H, m), 1.99 – 1.87 (2 H, m); δ C (101 MHz, CDCl3) 171.1, 169.2, 165.1, 
136.2, 129.1, 128.9, 128.4, 67.2, 61.5, 48.4, 43.9, 41.4, 36.4, 36.0, 33.8, 29.3, 24.4; m/z 364.16 ([MNa]+, 
100; HRMS (ESI/[MNa]+) Calcd. For C19H23N3O3Na: 364.1637, Found 364.1639. 
Amide DKP 257 
 
General procedure C was followed with thiocarbonate 255 (25 mg, 0.049 mmol), TTMS (61 mg, 76 L, 
0.245 mmol) and ACCN (18 mg, 0.074 mmol). Flash chromatography (3% MeOH in CH2Cl2) gave 
amide 257 (15 mg, 0.046 mmol, 96%) as a colourless solid; m.p. 67 – 68 °C;  IR (thin film) νmax /cm-1: 
3315, 2940, 1671, 1555, 1417, 1225, 732, 700; δ H (400 MHz, CDCl3) 7.40 – 7.28 (3 H, m), 7.26 – 7.20 
(2 H, m), 5.60 (1 H, s), 4.86 (1 H, d, J 14.7), 4.27 (1 H, d, J 14.7), 4.00 (1 H, d, J 3.4), 3.58 – 3.44 (2 H, 
m), 2.80 (1 H, dt, J 13.5, 7.0), 2.71 (3 H, d, J 4.8), 2.59 (1 H, ddd, J 10.2, 4.9, 3.4), 2.28 (1 H, dd, J 13.3, 
5.0), 2.14 – 1.98 (3 H, m), 1.91 – 1.85 (1 H, m); δ C (101 MHz, CDCl3) 170.9, 170.1, 165.6, 136.0, 129.1, 
128.3, 128.2, 67.1, 62.4, 48.6, 45.0, 44.0, 34.1, 29.3, 26.7, 24.5; m/z 350.2 ([MNa]+, 100), 372.2 (44), 
328.2 ([MH]+, 15); HRMS (ESI/[MNa]+) Calcd. For C18H21N3O3Na: 350.1481, Found 350.1479. 
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Thiocarbonate 259 
 
General procedure B was followed with Michael product 258 (144 mg, 0.37 mmol) in DMF (4.0 mL), 
NaHMDS (1.0 M in THF, 0.48 mL, 0.48 mmol) and O-phenyl chlorothionoformate (192 mg, 0.15 mL, 
1.11 mmol). Flash chromatography (2–4% MeOH in DCM) followed by preparative HPLC 
[Phenomenex C-18, H2O:MeCN gradient 100:0–0:100, 45 minutes] gave 259 (58 mg, 0.11 mmol, 30%) 
as a colourless solid; m.p. 240 – 242 °C;  IR (thin film) νmax /cm-1: 2976, 1721, 1699, 1666, 1595, 1480, 
1421, 1276, 732, 699; δ H (400 MHz, CDCl3) 7.43 – 7.31 (4 H, m, H-12, H-22), 7.27 – 7.17 (3 H, m, H-
24, H-23), 6.85 – 6.77 (2 H, m, H-13), 5.50 (1 H, d, J 14.9, H-10a), 4.13 (1 H, d, J 14.9, H-10b), 3.77 – 
3.65 (4 H, m, H-9a, H-15), 3.37 (1 H, dt, J 11.3, 7.4, H-9b), 3.05 – 2.98 (1 H, m, H-17), 2.83 (3 H, s, H-
19), 2.76 – 2.62 (4 H, m, H-7a, H-19), 2.33 (1 H, dd, J 12.9, 4.0, H-16a), 2.12 – 1.94 (2 H, m, H-8), 1.87 
(1 H, ddd, J 11.8, 8.4, 4.8, H-7b), 1.62 (1 H, dd, J 12.9, 9.8, H-16b); δ C (101 MHz, CDCl3) 189.8 (C-20), 
169.8 (C-3), 167.9 (C-18), 159.7 (C-14), 159.4 (C-4), 153.6 (C-21), 130.6 (C-12), 129.7 (C-22), 129.4 (C-
11), 127.0 (C-24), 121.7 (C-23), 114.3 (C-13), 94.5 (C-3), 66.5 (C-6), 55.4 (C-15), 45.4 (C-10), 44.9 (C-
7), 44.5 (C-9), 38.0 (C-19), 36.4 (C-19), 33.8 (C-16), 29.3 (C-7), 23.7 (C-8); m/z 546.2 ([MNa]+, 100); 
HRMS (ESI/[MNa]+) Calcd. For C27H29N3O6Na: 546.1675, Found 546.16.77. 
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PMB amide DKP 260 
 
General procedure C was followed with thiocarbonate 259 (30 mg, 0.056 mmol), TTMS (70 
mg, 87 L, 0.28 mmol) and ACCN (21 mg, 0.084 mmol). Flash chromatography (4–6% MeOH in 
1:1 DCM:EtOAc) gave 260 (15 mg, 0.040 mmol, 72%) as a colourless solid; m.p. 75 – 76 °C;  IR (thin 
film) νmax /cm-1: 2931, 1680, 1634, 1611, 1511, 1413, 1245, 1175, 1030, 731; δ H (300 MHz, CDCl3) 7.07 
– 6.99 (2 H, m), 6.74 – 6.61 (2 H, m), 4.93 (1 H, t, J 13.7), 3.76 (2 H, t, J 8.8), 3.64 – 3.56 (3 H, m), 3.44 
– 3.24 (2 H, m), 2.71 (1 H, ddd, J 9.9, 4.7, 3.4), 2.66 – 2.50 (4 H, m), 2.32 (3 H, s), 2.22 (1 H, dd, J 12.9, 
4.8), 1.95 – 1.66 (4 H, m); δ C (75 MHz, CDCl3) 171.1, 159.7, 130.1, 128.1, 114.4, 67.1, 61.4, 55.4, 47.8, 
43.9, 41.5, 36.5, 36.0, 33.9, 29.3, 24.4; m/z 394.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For 
C20H25N3O4Na: 394.1743, Found 394.1742. 
Allylation Adducts 261 and 262 
 
A solution of thiocarbonate 254 (20 mg, 0.041 mmol), ACCN (15 mg, 0.61 mmol), and allyl tributyltin 
(134 mg, 126 L, 0.41 mmol) in toluene (2.0 mL) was freeze-thawed ×2 then heated under reflux for 1 
hour. Flash chromatography (2% MeOH in DCM) gave a mixture of 261/262 (7 mg, 0.017 mmol, 43%) 
as a colourless solid; m.p. 140 – 142 °C;  IR (thin film) νmax /cm-1: 2973, 2361, 1687, 1643, 1416, 1216; δ 
H (400 MHz, CDCl3) 7.42 – 7.30 (5 H, 5 H, m), 5.69 (1 H, ddt, J 17.1, 10.2, 6.9), 5.36 (1 H, ddt, J 17.2, 
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10.2, 7.1), 5.27 (1 H, 1 H, d, J 14.4), 5.07 – 4.90 (2 H, 2 H, m), 4.00 – 3.87 (2 H, 2 H, m), 3.62 – 5.57 (1 
H, 1 H, m), 3.56 – 3.46 (1 H, 1 H, m), 3.39 (1 H, dt, J 13.5, 7.4), 3.27 – 3.18 (1 H, m), 2.91 – 2.77 (4 H, 5 
H, m), 2.62 (1 H, dt, J 18.6, 5.6), 2.47 – 2.33 (3 H, 2 H, m), 2.21 – 2.18 (2 H, m), 2.12 – 1.86 (5 H, 5 H, 
m); δ C (101 MHz, CDCl3) 171.2, 171.1, 169.6, 169.1, 165.3, 165.0, 136.3, 136.2, 135.1, 133.4, 129.2, 
129.1, 128.9, 128.8, 128.4, 118.3, 116.8, 67.1, 61.9, 61.5, 48.7, 48.4, 48.4, 48.0, 43.9, 43.9, 41.6, 41.3, 
34.8, 34.3, 33.8, 33.8, 32.6, 31.6, 29.4, 24.4, 24.4; m/z 404.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. 
For C22H27N3O3Na: 404.1950, Found 404.1954. 
Indole Hydroxy DKP 267 
 
A solution of indoline adduct 215 (50 mg, 0.12 mmol) and DDQ (37 mg, 0.16 mmol) in toluene (2.0 mL) 
was heated to 80 °C for 2 hours. The solvent was then removed under reduced pressure and the residue 
taken up in DCM (10 mL) and filtered through celite before evaporating under reduced pressure.  Flash 
chromatography (40–50 EtOAc in hexane) gave 267 (45 mg, 0.10 mmol, 90%) as a colourless solid; m.p. 
190 – 192 °C;  IR (thin film) νmax /cm-1: 2926 (br), 2361, 2335, 1679, 1452, 1363, 1327, 1206, 747; δ H 
(400 MHz, CDCl3) 8.40 (1 H, s), 7.58 – 7.48 (3 H, m), 7.46 – 7.36 (3 H, m), 7.34 – 7.23 (2 H, m), 6.76 (1 
H, s), 6.54 (1 H, d, J 3.8), 5.12 – 5.00 (2 H, m), 4.42 (1 H, d, J 14.3), 3.74 (1 H, dt, J 11.4, 7.2), 3.69 – 3.60 
(1 H, m), 3.55 (1 H, dd, J 10.2, 4.7), 2.99 – 2.90 (1 H, m), 2.40 (1 H, dd, J 13.2, 4.8), 2.23 – 2.06 (3 H, m), 
1.94 (1 H, dt, J 13.3, 7.5); δ C (101 MHz, CDCl3) 169.3, 168.9, 165.0, 138.0, 135.7, 130.5, 129.1, 128.8, 
127.9, 125.3, 125.1, 124.2, 120.8, 117.0, 109.6, 85.3, 66.8, 48.3, 44.7, 43.1, 34.1, 29.3, 24.7; m/z 452.2 
([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C25H23N3O4Na: 452.1586, Found 452.1583. 
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Indoline thiocarbonate 268 
 
General procedure B was followed with Michael product 215 (160 mg, 0.37 mmol) in THF (8.0 
mL), NaHMDS (1.0M in THF, 0.48 mL, 0.48 mmol) and O-phenyl chlorothionoformate (160 
mg, 0.13 mL, 0.93 mmol).Flash chromatography (50–80% EtOAc in hexane) gave 268 (166 mg, 0.29 
mmol, 79%) as a colourless solid; m.p. 118 – 120 °C;  IR (thin film) νmax /cm-1: 2974, 1716, 1694, 1655, 
1598, 1481, 1416, 1279, 1194, 1141, 1070, 755, 734, 701; δ H (400 MHz, CDCl3) 8.06 (1 H, dd, J 6.0, 
2.7), 7.49 – 7.41 (2 H, m), 7.37 – 7.27 (4 H, m), 7.20 – 7.13 (4 H, m), 7.07 – 7.00 (2 H, m), 6.94 – 6.87 (1 
H, m), 5.61 (1 H, d, J 14.8), 4.23 (1 H, d, J 14.9), 3.85 – 3.67 (2 H, m), 3.51 – 3.34 (1 H, m), 3.12 – 2.91 
(3 H, m), 2.90 – 2.72 (2 H, m), 2.38 (1 H, dd, J 13.0, 4.2), 2.14 – 1.98 (2 H, m), 1.97 – 1.85 (1 H, m), 1.77 
(1 H, dd, J 13.0, 9.8); δ C (101 MHz, CDCl3) 189.1, 169.9, 165.8, 159.1, 153.5, 142.5, 137.4, 131.8, 129.7, 
129.3, 129.1, 128.6, 127.3, 127.0, 124.4, 124.3, 121.6, 118.0, 94.5, 66.5, 48.4, 48.1, 46.1, 44.6, 34.0, 29.4, 
27.8, 23.8; m/z 590.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C32H29N3O5Na: 590.1726, Found 
590.1728. 
Indole thiocarbonate 265 
 
A solution of indoline adduct 268 (75 mg, 0.13 mmol) and DDQ (60 mg, 0.26 mmol) in toluene (5.0 mL) 
was heated to reflux for 4 hours. The solvent was then removed under reduced pressure and the residue 
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taken up in DCM (10 mL) and filtered through celite before evaporating under reduced pressure.  Flash 
chromatography (30–50% EtOAc in hexane) gave 265 (70 mg, 0.12 mmol, 95%) as a colourless solid; 
m.p. 114 – 115 °C;  IR (thin film) νmax /cm-1: 1718, 1697, 1453, 1281, 1193, 1144; δ H (400 MHz, CDCl3) 
8.30 (1 H, d, J 7.6), 7.56 – 7.50 (2 H, m), 7.47 – 7.37 (4 H, m), 7.27 (2 H, dt, J 10.5, 2.1), 7.22 – 7.07 (5 H, 
m), 6.40 (2 H, dd, J 12.9, 3.8), 5.64 (1 H, d, J 14.8), 4.31 (1 H, d, J 14.8), 3.87 – 3.72 (1 H, m), 3.48 (1 H, 
dt, J 11.4, 7.3), 3.38 (1 H, dd, J 9.9, 4.2), 2.82 (1 H, dt, J 13.4, 7.9), 2.39 (1 H, dd, J 13.2, 4.3), 2.16 – 2.04 
(2 H, m), 2.00 – 1.82 (2 H, m); δ C (101 MHz, CDCl3) 189.0, 169.5, 167.1, 159.0, 153.4, 137.4, 135.9, 
130.5, 129.6, 129.4, 128.9, 127.0, 125.2, 125.1, 124.3, 121.5, 120.7, 117.2, 109.7, 93.7, 66.5, 48.2, 46.3, 
44.7, 34.5, 29.4, 23.9; m/z 588.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C32H27N3O5Na: 
588.1569, Found 588.1556. 
Hydroxy amide 269  
 
Cerium ammonium nitrate (CAN) (356 mg, 0.65 mmol) was added in one portion to a solution of hydroxy 
DKP 180 (80 mg, 0.16 mmol) in MeCN:H2O (3:1, 1.2 mL) at 0 °C. The reaction mixture was stirred for 
2 hours, warming to 10 °C, before pouring into ice-water (25 mL). The pale yellow precipitate was 
collected and then washed with chloroform to give deprotected DKP 269 as an off-white solid (31 mg, 
0.083 mmol, 51%); m.p. 87 – 88 °C; IR (thin film) νmax /cm-1: 3260 (br), 2926, 1693, 1597, 1449, 1364, 
1260, 1214, 751; δ H (400 MHz, DMSO-d6) 9.27 (1 H, s), 7.78 – 7.71 (2 H, m), 7.63 – 7.57 (1 H, m), 7.48 
– 7.41 (2 H, m), 7.34 – 7.27 (4 H, m), 7.20 (1 H, s), 4.48 (1 H, d, J 5.8), 3.57 – 3.42 (3 H, m), 2.09 – 1.98 
(2 H, m), 1.82 – 1.65 (2 H, m); δ C (101 MHz, DMSO-d6) 198.2, 169.8, 166.3, 138.1, 136.9, 128.7, 128.5, 
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128.2, 127.7, 84.0, 70.3, 58.9, 51.1, 43.9, 40.2, 39.9, 39.9, 39.7, 39.5, 39.3, 39.1, 38.9, 27.2, 24.0; m/z 399.1 
([MNa]+, 22), 269.0 (100); HRMS (ESI/[MNa]+) Calcd. For C22H20N2O4Na: 399.1321, Found 399.1320. 
Experimental for Chapter 4 
Synthesis of Methylene DKPs 
General procedure D - A microwave vial was charged with TKP, ylide and toluene and then heated in a 
microwave reactor as stated. Once the solution had cooled the solvent was removed under reduced 
pressure and the residue was purified by flash chromatography as specified. 
Cyano DKP 290 
 
General procedure D was followed with TKP 113 (100 mg, 0.39 mmol), ylide 289 (175 mg, 0.58 mmol) 
and toluene (3.0 mL) and then heated in a microwave reactor at 140 °C for 3 hours. Once the solution had 
cooled the solvent was removed under reduced pressure and the residue was purified by flash 
chromatography (2–3% acetone in CH2Cl2) to give DKPs Z-290 (67 mg, 0.24 mmol, 61%) and E-290 
(42 mg, 0.15 mmol, 38%) as colourless solids; Z-290 - m.p. 117 – 118 °C;  IR (thin film) νmax /cm-1: 2976, 
2211, 1704, 1677, 1604, 1454, 1442, 1363, 1188, 730, 696; δ H (400 MHz, CDCl3) 7.28 – 7.08 (5 H, m), 
5.90 (1 H, s), 5.56 (1 H, d, J 16.2), 5.22 (1 H, d, J 16.2), 4.24 (1 H, dt, J 6.5, 5.0), 3.73 – 3.50 (2 H, m), 
2.54 – 2.36 (1 H, m), 2.14 – 2.01 (2 H, m), 1.98 – 1.81 (1 H, m); δ C (101 MHz, CDCl3) 166.2, 156.0, 
145.1, 134.5, 132.2, 132.0, 128.9, 128.6, 128.5, 128.0, 127.2, 115.9, 84.5, 58.7, 46.5, 46.1, 29.1, 22.0;        
E-290 - m.p. 123 – 124 °C;  IR (thin film) νmax /cm-1: 2955, 2215, 1700, 1680, 1601, 1455, 1381, 1368, 
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1214, 730, 698; δ H (400 MHz, CDCl3) 7.37 – 7.29 (3 H, m), 7.20 – 7.07 (2 H, m), 5.27 (1 H, d, J 16.0), 
5.11 (1 H, s), 4.69 (1 H, d, J 16.0), 4.49 – 4.35 (1 H, m), 3.82 – 3.60 (2 H, m), 2.63 – 2.48 (1 H, m), 2.15 
– 2.03 (2 H, m), 2.03 – 1.87 (1 H, m); δ C (101 MHz, CDCl3) 165.9, 154.3, 147.3, 133.7, 132.9, 132.1, 
132.0, 129.3, 128.6, 128.5, 128.3, 126.5, 115.6, 85.9, 58.9, 47.4, 45.9, 29.4, 21.8; m/z 304.1 ([MNa]+, 100); 
HRMS (ESI/[MNa]+) Calcd. For C16H15N3O2Na: 304.1062, Found 304.1065. 
Ester DKP 291 
 
General procedure D was followed with TKP 113 (100 mg, 0.39 mmol), methyl (triphenyl 
phosphoranylidene)acetate (194 mg, 0.58 mmol) and toluene (2.0 mL) and then heated in a microwave 
reactor at 140 °C for 3 hours. Once the solution had cooled the solvent was removed under reduced 
pressure and the residue was purified by flash chromatography (50–100% EtOAc in hexane) to give DKP 
291 as a mixture of isomers (30–60% 1:1.8 E:Z) as a colourless gum; IR (thin film) νmax /cm-1: 2955, 1700, 
1674, 1624, 1434, 1369, 1340, 1195, 1170, 733, 700; Z-291 δ H (400 MHz, CDCl3) 7.23 – 7.13 (3 H, m), 
6.99 – 6.92 (2 H, m), 6.28 (1 H, s), 5.53 (1 H, d, J 15.6), 4.73 (1 H, d, J 15.6), 4.22 – 4.11 (1 H, m), 3.69 – 
3.52 (5 H, m), 2.36 (1 H, dtd, J 9.1, 6.8, 2.4), 2.18 – 1.97 (2 H, m), 1.95 – 1.81 (1 H, m); δ C (101 MHz, 
CDCl3) 167.3, 165.1, 159.2, 141.2, 135.5, 128.6, 127.6, 127.5, 109.1, 58.6, 52.1, 48.2, 45.6, 28.3, 22.5; 
m/z 337.1 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C17H18N2O4Na: 337.1164, Found 337.1168. 
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Cyano DKP 293 
 
General procedure D was followed with TKP 100a (150 mg, 0.49 mmol), ylide 289 (205 mg, 0.68 mmol) 
and toluene (5.0 mL) and then heated in a microwave reactor at 140 °C for 3 hours. Once the solution had 
cooled the solvent was removed under reduced pressure and the residue was purified by flash 
chromatography (35–60% EtOAc in hexane) to give DKP Z-293 (63 mg, 0.19 mmol, 39%) [E-293 
coeluted with starting material] as a colourless solid; m.p. 57 – 59 °C; IR (thin film) νmax /cm-1: 3047, 2211, 
1703, 1677, 1603, 1495, 1368, 1267, 1176, 730, 700; δ H (400 MHz, CDCl3) 7.34 – 7.12 (10 H, m), 6.11 
(1 H, s), 5.40 (2 H, s), 4.60 (2 H, s), 4.05 (2 H, s); δ C (101 MHz, CDCl3) 162.6, 156.6, 142.7, 134.2, 134.0, 
129.2, 128.9, 128.8, 128.7, 128.6, 128.0, 127.0, 115.9, 85.1, 50.8, 49.0, 46.6; m/z 354.1 ([MNa]+, 100); 
HRMS (ESI/[MNa]+) Calcd. For C20H17N3O2Na: 354.1218, Found 354.1220. 
Cyano DKP 294 
 
General procedure D was followed with TKP 100b (47 mg, 0.13 mmol), ylide 289 (58 mg, 0.19 mmol) 
and toluene (2.0 mL) and then heated in a microwave reactor at 140 °C for 3 hours. Once the solution had 
cooled the solvent was removed under reduced pressure and the residue was purified by flash 
chromatography (1-3% acetone in CH2Cl2) to give DKP Z-294 (17 mg, 0.044 mmol, 35%) [E-294 
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coeluted with starting material and glycine TKP 100a] as a colourless solid; m.p. 144 – 145 °C;  IR (thin 
film) νmax /cm-1: 2957, 2215, 1750, 1704, 1686, 1610, 1496, 1453, 1434, 1366, 1240, 1205, 1174, 731, 
699;        δ H (400 MHz, CDCl3) 7.44 – 7.18 (10 H, m), 6.22 (1 H, s), 5.59 (1 H, d, J 16.2), 5.32 (1 H, d, J 
16.2), 4.98 (1 H, d, J 14.7), 4.80 (1 H, s), 4.45 (1 H, d, J 14.7), 3.71 (3 H, s); δ C (101 MHz, CDCl3) 165.7, 
159.4, 158.3, 143.1, 134.0, 133.5, 129.2, 129.1, 128.9, 128.9, 128.2, 127.0, 115.5, 87.0, 62.9, 54.1, 50.1, 
47.2; m/z 412.1 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C22H19N3O4Na: 412.1273, Found 
412.1270. 
PMB cyano DKP 295 
 
General procedure D was followed with TKP 125 (200 mg, 0.77 mmol), ylide 289 (303 mg, 1.00 mmol) 
and toluene (5.0 mL) and then heated in a microwave reactor at 140 °C for 3 hours. Once the solution had 
cooled the solvent was removed under reduced pressure and the residue was purified by flash 
chromatography (1–3% acetone in CH2Cl2) to give DKPs Z-295 (130 mg, 0.46 mmol, 60%) and E-295 
(81 mg, 0.28 mmol, 37%) as a colourless solids;  Z-295 - m.p. 122 – 124 °C;  IR (thin film) νmax /cm-1: 
2961, 2211, 1705, 1678, 1605, 1513, 1444, 1363, 1246, 1179, 1028, 734; δ H (400 MHz, CDCl3) 7.14 – 
7.05 (2 H, m), 6.91 – 6.84 (2 H, m), 5.24 – 5.11 (2 H, m), 4.65 (1 H, d, J 15.7), 4.47 – 4.35 (1 H, m), 3.84 
– 3.74 (4 H, m), 3.72 – 3.60 (1 H, m), 2.57 (1 H, dt, J 17.7, 6.5), 2.21 – 1.91 (3 H, m); δ C (101 MHz, 
CDCl3) 165.9, 159.5, 154.4, 147.3, 128.1, 125.7, 115.6, 114.7, 85.9, 58.9, 55.4, 47.0, 45.9, 29.4, 21.8;         
E-295 - m.p. 128 – 129 °C;  IR (thin film) νmax /cm-1 :2961, 2214, 1699, 1678, 1600, 1513, 1458, 1373, 
1247, 1213, 1179, 1030, 733; δ H (400 MHz, CDCl3) 7.24 – 7.15 (2 H, m), 6.93 – 6.81 (2 H, m), 5.99 (1 
H, s), 5.60 (1 H, d, J 15.9), 5.21 (1 H, d, J 15.9), 4.31 (1 H, dd, J 9.7, 6.8), 3.79 (3 H, s), 3.76 – 3.56 (2 H, 
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m), 2.60 – 2.42 (1 H, m), 2.22 – 2.07 (2 H, m), 2.05 – 1.88 (1 H, m); δ C (101 MHz, CDCl3) 166.2, 159.3, 
156.1, 145.1, 128.9, 126.5, 116.1, 114.2, 84.4, 58.7, 55.3, 46.1, 45.9, 29.1, 22.0; m/z 334.1 ([MNa]+, 100); 
HRMS (ESI/[MNa]+) Calcd. For C17H17N3O3Na: 334.1168, Found 334.1170. 
Homo-proline cyano DKP 296 
 
General procedure D was followed with TKP 133 (100 mg, 0.37 mmol), ylide 289 (155 mg, 0.51 mmol) 
and toluene (3.0 mL) and then heated in a microwave reactor at 140 °C for 3 hours. Once the solution had 
cooled the solvent was removed under reduced pressure and the residue was purified by flash 
chromatography (40–60% EtOAc in hexane) to give DKPs Z-296 (54 mg, 0.18 mmol, 50%) and E-296 
(35 mg, 0.12 mmol, 32%) as off colourless solids; m.p.155 – 156 °C;  IR (thin film) νmax /cm-1: 2942, 2209, 
1697, 172, 1601, 1442, 1362, 1271, 1253, 730, 696; Z-296 δ H (400 MHz, CDCl3) 7.37 – 7.31 (2 H, m, H-
Ar), 7.31 – 7.26 (1 H, m, H-Ar), 7.25 – 7.19 (2 H, m, H-Ar), 6.17 (1 H, s, H-16), 5.55 (1 H, d, J 16.5, H-
11a), 5.49 (1 H, d, J 16.4, H-11b), 4.74 – 4.67 (1 H, m, H-10a), 4.16 (1 H, dd, J 11.5, 3.0, H-6), 2.68 (1 H, 
app. td, J 13.0, 2.9, H-10b), 2.45 – 2.36 (1 H, m, H-7a), 2.09 – 2.02 (1 H, m, H-8a), 1.84 – 1.76 (1 H, m, 
H-9a), 1.69 – 1.51 (3 H, m, H-7b, H-8b, H-9b); δ C (101 MHz, CDCl3) 165.3 (C-1), 154.7 (C-4), 141.6 
(C-3), 134.4 (C-12), 128.8 (C-Ar), 127.9 (C-Ar), 126.7 (C-Ar), 116.2 (C-17), 83.5 (C-16), 59.5 (C-6), 46.5 
(C-11), 44.1 (C-10), 32.3 (C-7), 24.5 (C-9), 24.1 (C-8); E-296 δ H (400 MHz, CDCl3) 7.39 – 7.29 (3 H, 
m), 7.14 – 7.09 (2 H, m), 5.11 (1 H, d, J 16.1), 5.08 (1 H, s), 4.90 (1 H, d, J 16.0), 4.82 – 4.76 (1 H, m), 
4.19 (1 H, dd, J 11.5, 3.0), 2.65 (1 H, app. td, J 12.9, 3.0), 2.49 – 2.43 (1 H, m), 2.12 – 2.02 (1 H, m), 1.85 
– 1.77 (1 H, m), 1.68 – 1.53 (3 H, m); δ C (101 MHz, CDCl3) 165.4, 153.3, 144.1, 133.1, 129.3, 128.3, 
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126.3, 116.0, 86.2, 59.4, 47.0, 43.3, 32.6, 24.6, 24.2; m/z 295.2  ([MH]+, 45), 204.1 (87), 91.1 (100); 
HRMS (ESI/[MNa]+) Calcd. For C17H17N3O2: 295.1321, Found 295.1320. 
Michael Additions and Michael–Michael Cascade 
Michael adduct 297 
 
General procedure A was followed with DKP Z-290 (31 mg, 0.11 mmol), MVK (23 mg, 25 L, 0.32 
mmol) and 101 (8 mg, 0.021 mmol, 20 mol%) as base. Flash chromatography (40–60% EtOAc in hexane) 
gave 297 (33 mg, 0.095 mmol, 87%) as a colourless solid; m.p. 120 – 122 °C;  IR (thin film) νmax /cm-1: 
2965, 2211, 1702, 1673, 1605, 1453, 1437, 1353, 1172, 732, 698; δ H (400 MHz, CDCl3) 7.34 – 7.23 (5 
H, m), 6.00 (1 H, s), 5.61 (1 H, d, J 16.2), 5.27 (1 H, d, J 16.2), 4.85 – 4.78 (1 H, m), 3.70 – 3.62 (1 H, m), 
2.50 – 2.35 (2 H, m), 2.30 – 1.95 (9 H, m); δ C (101 MHz, CDCl3) 205.7, 168.7, 155.9, 144.6, 134.7, 128.8, 
128.0, 127.4, 115.9, 84.2, 67.2, 46.7, 45.7, 37.9, 33.4, 32.0, 30.0, 20.1; m/z 374.2 ([MNa]+, 100); HRMS 
(ESI/[MNa]+) Calcd. For C20H21N3O3Na: 374.1481, Found 374.1483. 
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Michael adduct 299 
 
General procedure A was followed with DKP Z-291 (22 mg, 0.070 mmol), MVK (15 mg, 16 L, 0.21 
mmol) and DBU (1 mg, 1 L, 0.007 mmol) as base. Flash chromatography (55–65% EtOAc in hexanes) 
gave 299 (8 mg, 0.021 mmol, 30%) as a colourless gum; IR (thin film) νmax /cm-1: 2954, 1713, 1698, 1672, 
1626, 1435, 1195, 1171; δ H (400 MHz, CDCl3) 7.24 – 7.11 (3z H, m), 6.98 – 6.91 (2 H, m), 6.28 (1 H, s), 
5.49 (1 H, d, J 15.5), 4.72 (1 H, d, J 15.5), 3.74 – 3.64 (4 H, m), 3.53 (1 H, ddd, J 12.4, 8.5, 4.2), 2.41 (2 
H, dt, J 11.1, 5.6), 2.23 – 2.10 (1 H, m), 2.09 – 1.85 (7 H, m); δ C (101 MHz, CDCl3) 206.1, 169.6, 165.0, 
158.9, 140.8, 135.6, 128.6, 127.7, 127.5, 108.8, 67.3, 52.1, 48.5, 45.4, 38.3, 33.6, 31.6, 30.0, 20.6; m/z 
407.2 ([MNa]+, 100) , 385.2 ([MH]+, 55); HRMS (ESI/[MNa]+) Calcd. For C21H24N2O5Na: 407.1583, 
Found 407.1588. 
Michael–Michael adduct 300 
 
General procedure A was followed with DKP 291 (25 mg, 0.080 mmol), MVK (17 mg, 18 L, 0.24 
mmol) and DBU (3L, 0.020 mmol). Flash chromatography (80–90% EtOAc in hexane) gave adduct 
300 (21 mg, 0.055 mmol, 69%, 7:1 dr) as a colourless solid; m.p. 131 – 133 °C;  IR (thin film) νmax /cm-1: 
2952, 1731, 1716, 1682, 1435, 1390, 1359, 1198, 1173, 731, 699; δ H (400 MHz, CDCl3) 7.31 – 7.26 (2 
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H, m), 7.25 – 7.18 (1 H, m), 7.02 (2 H, d, J 7.0), 4.93 (1 H, d, J 16.6), 4.45 (1 H, d, J 16.6), 4.06 (1 H, dd, 
J 11.3, 5.9), 3.61 – 3.49 (5 H, m), 3.40 (1 H, d, J 18.3), 2.96 – 2.84 (2 H, m), 2.43 (1 H, dd, J 12.8, 11.4), 
2.17 (3 H, s), 2.06 – 1.97 (2 H, m), 1.90 – 1.78 (2 H, m); δ C (101 MHz, CDCl3) 206.9, 172.0, 171.2, 166.1, 
137.4, 128.8, 127.5, 126.2, 126.0, 65.2, 65.1, 52.5, 52.0, 45.4, 44.6, 34.1, 31.9, 30.0, 29.7, 24.3; m/z 407.2 
([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C21H24N2O5Na: 407. 1583, Found 407.1592. 
Michael adduct 301 
 
General procedure A was followed with DKP 290 (27 mg, 0.097 mmol), chalcone (51 mg, 0.24 mmol) 
and 101 (8 mg, 0.02 mmol) as base. Flash chromatography (35–50% EtOAc in hexane) gave 301 (37 mg, 
0.076 mmol, 78%) as a colourless solid; m.p. 144 – 145 °C;  IR (thin film) νmax /cm-1: 2965, 2211, 1702, 
1673, 1605, 1453, 1437, 1353, 1172, 732, 698; δ H (400 MHz, CDCl3) 7.65 – 7.54 (4 H, m), 7.34 – 7.23 
(6 H, m), 7.18 – 7.10 (5 H, m), 6.05 (1 H, s), 5.56 (1 H, d, J 15.8), 5.31 (1 H, d, J 15.8), 4.85 – 4.78 (1 H, 
m), 3.70 – 3.62 (1 H, m), 2.50 – 2.35 (2 H, m), 2.30 – 1.95 (5 H, m); δ C (101 MHz, CDCl3) 198.3, 168.7, 
155.9, 144.6, 137.5, 137.1, 136.4, 135.2, 134.7, 128.8, 128.0, 127.4, 126.2 115.9, 84.2, 64.5, 58.3, 54.5, 
45.7, 44.8, 29.3, 24.0, 18.0; m/z 512.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C31H27N3O3Na: 
512.1950, Found 512.1951. 
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Michael–Michael adduct 302 
 
General procedure A was followed with DKP 290 (21 mg, 0.075 mmol), chalcone (31 mg, 0.15 mmol) 
and 101 (6 mg, 0.015 mmol, 20 mol%). After 4 days DBU (5 mg, 5 L, 0.030 mmol) was added and the 
flask was moved to the fridge for 1 day. Flash chromatography (40–45% EtOAc in hexane) gave 302 (26 
mg, 0.053 mmol, 70%) as a colourless solid [Cellulose-3, MeCN:H2O 45:55, 1.0 mLmin
-1, t1= 8.53 mins, 
t2= 11.39 mins]; m.p. 213 – 216 °C;  IR (thin film) νmax /cm-1: 2930, 1690, 1673, 1650, 1634, 1594, 1451, 
1436, 1391, 1359, 703; δ H (400 MHz, CDCl3) 7.60 – 7.48 (3 H, m), 7.42 – 7.23 (9 H, m), 7.19 (2 H, d, J 
7.2), 7.07 (2 H, dt, J 7.5, 3.9), 5.75 (1 H, d, J 16.5), 4.73 – 4.61 (2 H, m), 3.83 – 3.74 (1 H, m), 3.67 (1 H, 
dt, J 11.4, 7.4), 3.48 (1 H, d, J 18.8), 3.17 (1 H, d, J 6.4), 2.94 (1 H, d, J 18.8), 2.57 – 2.48 (1 H, m), 2.11 – 
2.02 (2 H, m), 1.78 (1 H, dt, J 13.5, 7.9); δ C (101 MHz, CDCl3) 198.6, 170.7, 165.4, 136.7, 134.9, 134.4, 
129.4, 129.4, 129.1, 128.7, 128.1, 126.3, 116.9, 70.0, 64.2, 58.2, 54.1, 45.1, 45.0, 29.0, 24.3, 18.2; m/z 
512.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C31H27N3O3Na: 512.1950, Found 512.1946. 
Michael adduct 303 
 
General procedure A was followed with DKP 294 (35 mg, 0.090 mmol), MVK (19 mg, 22 L, 0.27 
mmol) and 101 (7 mg, 0.018 mmol, 20 mol%) as base. Flash chromatography (25–33% EtOAc in hexane) 
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gave 303 (40 mg, 0.086 mmol, 96%) as a colourless solid in 85:15 er [Cellulose-3, MeCN:H2O 45:55, 1.0 
mLmin-1, t1= 11.37 mins, t2= 12.31 mins]; m.p. 139 – 140 °C;  IR (thin film) νmax /cm-1: 3067, 2213, 1758, 
1695, 1608, 1437, 1419, 1360, 1264, 1227, 731, 697; δ H (400 MHz, CDCl3) 7.34 – 7.12 (10 H, m), 6.26 
(1 H, s), 5.51 (1 H, d, J 16.3), 5.37 (1 H, d, J 16.3), 4.64 (1 H, d, J 15.2), 4.51 (1 H, d, J 15.2), 3.37 (3 H, 
s), 2.71 – 2.53 (1 H, m), 2.53 – 2.40 (1 H, m), 2.24 – 2.09 (1 H, m), 2.06 – 1.92 (1 H, m), 1.86 (3 H, s); δ 
C (101 MHz, CDCl3) 205.3, 166.7, 162.7, 158.2, 141.4, 135.2, 134.2, 129.2, 128.9, 128.7, 128.2, 128.1, 
127.0, 126.9, 115.8, 85.2, 77.4, 77.1, 76.7, 71.4, 53.7, 48.3, 47.6, 37.0, 29.7, 27.6; m/z 498.1 ([MK]+, 100), 
482.1 ([MNa]+, 60); HRMS (ESI/[MNa]+) Calcd. For C26H25N3O5Na: 482.1692, Found 482.1693. 
Michael adducts 304 and 305 
 
General procedure A was followed with DKP 293 (15 mg, 0.045 mmol), MVK (8 mg, 9 L, 0.11 mmol) 
and 101 (7 mg, 0.018 mmol, 40 mol%) as base . Flash chromatography (0.5–1.5% MeOH in DCM) gave 
304 (2 mg, 0.0045 mmol, 10%) as a colourless gum; IR 304 (thin film) νmax /cm-1: 2933, 2212, 1701, 1675, 
1606, 1452, 1362, 1260, 1161, 734, 699; δ H (400 MHz, CDCl3) 7.33 – 7.19 (8 H, m), 7.13 – 7.08 (2 H, 
m), 6.03 (1 H, s), 5.50 (1 H, d, J 16.1), 5.18 (1 H, d, J 16.1), 5.16 (1 H, d, J 14.7), 4.14 (1 H, d, J 14.7), 
3.99 (1 H, dd, J 10.6, 3.9), 2.56 – 2.35 (2 H, m), 2.29 – 2.18 (1 H, m), 2.07 (3 H, s), 1.75 (1 H, ddt, J 14.0, 
10.9, 5.5).; δ C (101 MHz, CDCl3) 206.3, 165.5, 157.5, 143.6, 135.0, 134.4, 129.1, 128.9, 128.5, 128.4, 
128.1, 127.1, 115.8, 85.8, 58.5, 48.5, 46.6, 37.8, 30.0, 27.2; m/z 424.2 ([MNa]+, 100); HRMS 
(ESI/[MNa]+) Calcd. For C24H23N3O3Na: 424.1637, Found 424.1640; and 305 (17 mg, 0.037 mmol, 82%) 
as a colourless solid; m.p. 116 – 118 °C; IR 305 (thin film) νmax /cm-1: 2968, 2210, 1715, 1696, 1605, 1422, 
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1361, 1268, 734, 699; δ H (400 MHz, CDCl3) 7.33 –7.20 (10 H, m), 6.30 (1 H, s), 5.45 (2 H, s), 4.62 (2 H, 
s), 2.21 – 2.05 (4 H, m), 2.04 – 1.84 (4 H, m), 1.82 (6 H, s); δ C (101 MHz, CDCl3) 205.4, 166.9, 158.6, 
141.9, 136.8, 134.7, 129.1, 129.0, 128.9, 128.5, 128.5, 128.2, 127.4, 116.0, 83.8, 68.6, 47.6, 46.9, 37.5, 
32.3, 29.7; m/z 494.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C28H29N3O4Na: 494.2056, Found 
494.2051. 
Indole vinyl ketones 311-314 
 
Et3N (0.87 mL, 628 mg, 6.21 mmol) was added to a suspension of indole-2-carboxylic acid (1.00 g, 6.21 
mmol), DCC (1.28 g, 6.21 mmol) and N,O-dimethylhydroxylamine hydrochloride (605 mg, 6.21 mmol) 
in DCM (20 mL) cooled to 0 °C and was stirred for 3 hours and allowed to warm to room temperature. 
The reaction mixture was then filtered through a plug of celite and then washed with sat. NH4Cl (20 mL) 
and brine (20 mL) before being evaporated under reduced pressure. The residue was then dry-loaded onto 
a silica gel column (10-30% EtOAc in Hex) to give Weinreb adduct 310 (859 mg, 4.21 mmol, 68%) as a 
colourless solid. The 1H, 13C and m/z data was consistent with the literature.128 
Weinreb adduct 310 was then reacted with MeI (2 eq) and NaH (1.5 eq) in DMF followed by vinyl 
magnesium bromine (4 eq) in THF to give indole vinyl ketone 311 (45% w.r.t 310). The 1H, 13C and m/z 
data was consistent with the literature.129 Alternatively, reaction of Weinreb adduct 310 with Tosyl 
chloride (1.2 eq), NaOH (1.8 eq), BnEt3NCl (0.1 eq) in DCM followed by vinyl magnesium bromine (5 
eq) in THF gave indole vinyl ketone 312 (20% w.r.t 310). The 1H, 13C and m/z data was consistent with 
the literature.129 Reaction of Weinreb adduct 310 with 4-methoxy benzyl chloride (1.5 eq) and NaH (2 eq) 
in DMF followed by vinyl magnesium bromine (5 eq) in THF gave indole vinyl ketone 313 (49% w.r.t 
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310). The 1H, 13C and m/z data was consistent with the literature.129 Finally, reaction of Weinreb adduct 
310 with vinyl magnesium bromine (7 eq) in THF followed by Boc2O (2 eq) and DMAP (0.2 eq) in DCM 
gave indole vinyl ketone 314 (approx. 80% (crude) w.r.t 310). The 1H, 13C and m/z data was consistent 
with the literature.129 
Michael–Michael adduct 315 
 
General procedure A was followed with DKP 290 (29 mg, 0.10 mmol), 314 (approx.. 85 mg used crude) 
and DBU (3L, 0.020 mmol). Flash chromatography (40–50% EtOAc in hexane) gave adduct 315 (51 
mg, 0.091 mmol, 89%, 1.1:1 dr) as colourless gum; IR (thin film) νmax /cm-1: 2980, 1739, 1689, 1386, 
1322, 1152, 740; major diastereoisomer δ H (400 MHz, CDCl3) 7.98 (1 H, dq, J 8.4, 0.8), 7.64 (1 H, dt, J 
7.8, 1.0), 7.46 (1 H, ddd, J 8.4, 7.2, 1.3), 7.39 – 7.26 (4 H, m), 7.19 (1 H, d, J 0.9), 7.18 – 7.11 (2 H, m), 
5.33 (1 H, d, J 16.6), 4.67 (1 H, d, J 16.6), 4.17 (1 H, dd, J 10.9, 5.5), 3.71 – 3.64 (1 H, m), 3.63 – 3.55 (1 
H, m), 3.31 (1 H, d, J 18.5), 2.94 (1 H, app. dt, J 13.1, 6.6), 2.86 (1 H, d, J 18.5), 2.48 (1 H, dd, J 13.3, 
10.9), 2.24 (1 H, dd, J 13.4, 5.6), 2.14 – 2.05 (2 H, m), 1.91 (1 H, app. dt, J 13.1, 7.5), 1.61 (9 H, s); δ C 
(101 MHz, CDCl3) 189.4, 171.9, 164.4, 149.4, 139.0, 137.0, 136.8, 129.3, 128.5, 128.1, 127.1, 126.3, 
123.7, 123.1, 117.8, 116.8, 114.9, 85.4, 65.9, 64.5, 51.8, 44.9, 44.7, 35.2, 29.8, 27.9, 27.8, 24.4, 18.4; minor 
diastereoisomer δ H (400 MHz, CDCl3) 8.00 (1 H, dd, J 8.5, 0.8), 7.64 (1 H, dt, J 7.8, 1.0), 7.47 (1 H, ddd, 
J 8.5, 7.2, 1.2), 7.34 – 7.22 (5 H, m), 7.05 (2 H, d, J 7.5), 5.53 (1 H, d, J 17.0), 4.34 (1 H, d, J 16.9), 4.18 
(1 H, dd, J 10.9, 5.7), 3.64 (2 H, t, J 6.8), 3.38 (1 H, d, J 15.8), 3.00 – 2.86 (2 H, m), 2.43 (1 H, dd, J 13.3, 
11.0), 2.27 (1 H, dd, J 13.2, 5.7), 2.17 – 2.02 (2 H, m), 1.92 (1 H, dt, J 13.3, 7.1), 1.64 (9 H, s); δ C (101 
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MHz, CDCl3) 189.5, 170.9, 165.5, 149.4, 139.2, 137.3, 137.0, 129.1, 128.5, 127.7, 127.0, 126.2, 123.7, 
123.3, 118.2, 115.7, 114.7, 85.4, 66.1, 64.5, 47.9, 45.7, 44.7, 34.7, 29.8, 28.0, 27.8, 24.5, 24.4, 18.7; m/z 
575.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C32H32N4O5Na: 575.2270, Found 575.2280. 
Michael–Michael adduct 316 
 
General procedure A was followed with DKP 290 (21 mg, 0.075 mmol), 313 (approx.. 50 mg) and DBU 
(3L, 0.015 mmol). Flash chromatography (50–70% EtOAc in hexane) gave adduct 316 (29 mg, 0.051 
mmol, 68%, 1.5:1 dr) as a colourless solid; m.p. 123 – 125 °C; IR (thin film) νmax /cm-1: 2961, 1693, 1655, 
1613, 1512, 1389, 1249, 1176, 741; Major; minor - δ H (400 MHz, CDCl3) 7.73 (1 H, d, J 8.1, H-Ar), 7.69 
(1 H, d, J 8.1, H-Ar), 7.48 – 7.27 (11 H, m, H-Ar, H-Ar), 7.25 – 7.11 (6 H, m, H-Ar, H-Ar), 6.97 – 6.84 
(5 H, m, H-Ar, H-Ar), 6.83 – 6.77 (2 H, m, H-Ar), 6.77 – 6.71 (2 H, m, H-Ar), 5.82 (1 H, d, J 15.7, H-
28a), 5.77 – 5.64 (3 H, m, H-28, H-28b), 5.39 (1 H, d, J 17.0, H-10a), 5.20 (1 H, d, J 16.5, H-10a), 4.77 (1 
H, d, J 16.5, H-10b), 4.24 – 4.15 (2 H, m, H-19, H-19), 3.83 (1 H, d, J 17.0, H-10b), 3.74 (3 H, s, H-33), 
3.72 (3 H, s, H-33), 3.69 – 3.53 (4 H, m, H-9, H-9), 3.02 (1 H, d, J 18.3, H-15a), 2.94 – 2.83 (2 H, m, H-
7a, H-7a), 2.76 (2 H, ABq, J 16.0, H-15), 2.64 (1 H, d, J 18.3, H-15b), 2.47 – 2.31 (2 H, m, H-18a, H-18a), 
2.16 – 1.94 (4 H, m, H-8, H-8), 1.91 – 1.75 (4 H, m, H-7b, H-7b, H-18b, H-18b); δ C (101 MHz, CDCl3) 
190.6 (C-19), 190.3 (C-19), 171.9 (C-1), 170.8 (C-1), 165.5 (C-4), 164.5 (C-4), 159.0 (C-Ar), 158.9 (C-
Ar), 141.0 (C-Ar), 137.2 (C-Ar), 137.1 (C-Ar), 133.5 (C-Ar), 133.2 (C-Ar), 130.2 (C-Ar), 130.0 (C-Ar), 
129.4 (C-Ar), 129.1 (C-Ar), 128.1 (C-Ar), 127.9 (C-Ar), 127.7 (C-Ar), 127.6 (C-Ar), 127.5 (C-Ar), 126.6 
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(C-Ar), 126.1 (C-Ar), 125.9 (C-Ar), 123.6 (C-Ar), 123.5 (C-Ar), 121.6 (C-Ar), 116.8 (C-16), 115.6 (C-
16), 114.9 (C-Ar), 114.7 (C-Ar), 114.1 (C-Ar), 113.9 (C-Ar), 111.0 (C-Ar), 110.8 (C-Ar), 66.1 (C-6), 65.8 
(C-6), 64.7 (C-3), 64.6 (C-3), 55.2 (C-33, C-33), 51.1 (C-19), 47.7 (C-28), 47.5 (C-28), 46.9 (C-19), 
45.7(C-10), 44.9 (C-10), 44.6 (C-9, C-9), 36.2 (C-17), 36.0 (C-17), 29.8 (C-7), 29.7 (C-7), 24.5 (C-8), 24.3 
(C-8), 18.6 (C-17), 18.3 (C-17); m/z 595.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For 
C35H32N4O4Na: 595.2321, Found 595.2324. 
Michael–Michael adduct 317 
 
General procedure A was followed with DKP 291 (25 mg, 0.080 mmol), 311 (50 mg, 0.24 mmol) and 
DBU (2L, 0.016 mmol). Flash chromatography (50–70% EtOAc in hexane) gave adduct 317 (33 mg, 
0.071 mmol, 74%, >10:1 dr) as a colourless solid; m.p. 168 – 170 °C (decomp);  IR (thin film) νmax /cm-1: 
2964, 1735, 1690, 1657, 1510, 1392, 1195, 1175, 740; major diastereoisomer δ H (400 MHz, CDCl3) 7.63 
(1 H, d, J 8.1), 7.42 – 7.31 (5 H, m), 7.21 – 7.11 (3 H, m), 6.79 (1 H, s), 4.95 (1 H, d, J 16.3), 4.87 (1 H, d, 
J 16.3), 4.41 (1 H, dd, J 10.8, 5.6), 4.01 (3 H, s), 3.72 – 3.62 (2 H, m), 3.51 (3 H, s), 3.24 (1 H, d, J 18.2), 
2.93 (1 H, dt, J 13.5, 6.9), 2.86 (1 H, d, J 18.2), 2.40 (1 H, dd, J 13.0, 10.8), 2.07 (3 H, ddt, J 10.3, 6.9, 3.6), 
1.90 (1 H, dt, J 14.4, 7.2); δ C (101 MHz, CDCl3) 191.6, 172.4, 170.9, 165.7, 140.7, 138.2, 134.0, 129.1, 
127.7, 127.1, 126.8, 125.6, 123.2, 121.1, 113.0, 110.5, 66.3, 65.6, 52.0, 50.1, 45.7, 44.6, 36.1, 32.9, 32.4, 
29.9, 24.2; m/z 522.2 ([MNa]+, 100), 500.2 ([MH]+, 10); HRMS (ESI/[MNa]+) Calcd. For C29H29N3O5Na: 
522.2005, Found 522.2008. 
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Michael–Michael adduct 318 
 
General procedure A was followed with DKP 291 (20 mg, 0.064 mmol), 314 (approx. 85 mg of crude) 
and DBU (2L, 0.016 mmol). Flash chromatography (40–70% EtOAc in hexane) gave adduct 318 (16 
mg, 0.027 mmol, 68%, 4.0:1 dr) as a colourless solid; m.p. 155 – 257 °C;  IR (thin film) νmax /cm-1: 2979, 
1735, 1686, 1390, 1370, 1320, 1158, 1135, 734; major diastereoisomer δ H (400 MHz, CDCl3) 7.97 (1 H, 
dd, J 8.5, 0.9), 7.61 (1 H, dt, J 7.9, 1.1), 7.44 (1 H, ddd, J 8.5, 7.2, 1.3), 7.35 – 7.24 (4 H, m), 7.10 – 7.04 
(2 H, m), 6.97 (1 H, s), 5.01 (1 H, d, J 16.5), 4.64 – 4.52 (2 H, m), 3.68 – 3.57 (2 H, m), 3.35 – 3.25 (4 H, 
m), 2.97 – 2.85 (2 H, m), 2.39 (1 H, dd, J 13.2, 10.8), 2.23 (1 H, dd, J 13.2, 5.8), 2.11 – 2.02 (2 H, m), 1.91 
(1 H, dt, J 13.1, 7.4), 1.61 (9 H, s); δ C (101 MHz, CDCl3) 190.8, 172.5, 171.0, 165.7, 149.6, 138.5, 137.9, 
137.5, 129.0, 127.9, 127.5, 127.2, 126.5, 123.5, 122.8, 116.7, 114.8, 85.3, 65.9, 65.5, 51.7, 50.4, 45.6, 44.6, 
35.4, 32.3, 29.9, 27.8, 24.2; minor diastereoisomer - δ H (400 MHz, CDCl3) 8.02 (1 H, d, J 8.5), 7.65 (1 H, 
app dt, J 7.9, 1.1), 7.45 (1 H, ddd, J 8.5, 7.2, 1.3), 7.36 – 7.18 (5 H, m), 7.07 (2 H, d, J 7.1), 5.40 (1 H, d, J 
16.9), 4.97 (1 H, dd, J 11.2, 5.9), 4.42 (1 H, d, J 16.9), 3.62 – 3.57 (2 H, m), 3.54 (3 H, s), 3.25 (1 H, d, J 
16.0), 2.98 – 2.86 (2 H, m), 2.40 (1 H, dd, J 13.1, 11.3), 2.21 (1 H, dd, J 13.1, 6.0), 2.13 – 1.99 (2 H, m), 
1.88 (1 H, dt, J 13.2, 7.2), 1.61 (9 H, s); δ C (101 MHz, CDCl3) 190.9, 171.3, 170.5, 167.1, 149.4, 139.0, 
138.0, 137.6, 128.9, 128.0, 127.2, 127.1, 126.1, 123.5, 123.0, 117.4, 114.6, 114.3, 85.1, 66.0, 65.7, 51.8, 
46.9, 46.0, 44.5, 34.7, 31.8, 29.8, 27.9, 24.5; m/z 608.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For 
C33H35N3O7Na: 608.2373, Found 608.2374. 
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Michael–Michael adduct 319 
 
General procedure A was followed with DKP 291 (20 mg, 0.064 mmol), 313 (50 mg, 0.24 mmol) and 
DBU (2L, 0.013 mmol). Flash chromatography (50–70% EtOAc in hexane) gave adduct 319 (24 mg, 
0.040 mmol, 64%, 4.5:1 dr) as colourless gum; IR (thin film) νmax /cm-1: 2964, 1735, 1690, 1657, 1510, 
1392, 1195, 1175, 740; major; minor - δ H (400 MHz, CDCl3) 7.73 (1 H, d, J 8.1, H-Ar), 7.65 (1 H, d, J 
8.1, H-Ar), 7.48 – 7.23 (10 H, m, H-Ar, H-Ar), 7.22 – 7.12 (6 H, m, H-Ar, H-Ar), 6.98 – 6.85 (6 H, m, H-
Ar, H-Ar), 6.80 – 6.68 (4 H, m, H-Ar, H-Ar), 5.80 (1 H, d, J 15.7, H-29a), 5.73 – 5.64 (3 H, m, H-29b, H-
29), 5.22 (1 H, d, J 17.0, H-10a), 4.94 (1 H, dd, J 11.0, 5.4, H-19), 4.86 (2 H, s, H-10), 4.43 (1 H, dd, J 
10.9, 5.6, H-19), 3.81 (1 H, d, J 17.0, H-10b), 3.73 (3 H, s, H-34), 3.72 (3 H, s, H-34), 3.62 (2 H, t, J 6.9, 
H-9), 3.59 – 3.52 (5 H, m, H-9, H-17), 3.48 – 3.44 (4 H, m, H-15a, H-17), 3.16 (1 H, d, J 18.2, H-15a), 
2.93 – 2.83 (2 H, m, H-7a, H-7a), 2.81 – 2.74 (2 H, m, H-15b, H-15b), 2.37 – 2.26 (2 H, m, H-18a, H-
18b), 2.10 – 1.92 (4 H, m, H-8, H-8), 1.87 – 1.74 (4 H, m, H-7b, H-7b, H-18b, H-18b); δ C (101 MHz, 
CDCl3) 192.5 (C-20), 191.4 (C-20), 172.3 (C-1), 171.4 (C-1), 170.9 (C-16), 170.2 (C-16), 167.0 (C-4), 
165.7 (C-4), 158.9 (C-Ar), 158.8 (C-Ar), 140.7 (C-Ar), 140.6 (C-Ar), 138.1 (C-Ar), 138.1 (C-Ar), 134.2 
(C-Ar), 133.7 (C-Ar), 130.4 (C-Ar), 130.2 (C-Ar), 129.0 (C-Ar), 128.8 (C-Ar), 128.1 (C-Ar), 127.7 (C-
Ar), 127.7 (C-Ar), 127.1 (C-Ar), 127.0 (C-Ar), 126.9 (C-Ar), 126.0 (C-Ar), 125.9 (C-Ar), 123.4 (C-Ar), 
123.2 (C-Ar), 121.3 (C-Ar), 114.3 (C-Ar), 114.3 (C-Ar), 114.0 (C-Ar), 113.9 (C-Ar), 113.8 (C-Ar), 111.1 
(C-Ar), 110.7 (C-Ar), 66.1 (C-6), 66.1 (C-6), 65.5 (C-3), 55.2 (C-34), 51.9 (C-17), 51.8 (C-17), 50.1 (C-
19), 47.5 (C-29), 47.4 (C-29), 46.0  (C-10), 45.9 (C-19), 45.7 (C-10), 44.5 (C-17, C-17), 36.2 (C-18), 35.9 
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(C-18), 32.7 (C-15), 32.1 (C-15), 29.8 (C-7), 29.7 (C-7), 24.4 (C-8), 24.2 (C-8); m/z 628.2 ([MNa]+, 100); 
HRMS (ESI/[MNa]+) Calcd. For C36H35N3O6Na: 628.2424, Found 628.2422. 
Michael–Michael adduct 320 
 
General procedure A was followed with DKP 291 (18 mg, 0.057 mmol), 312 (approx. 14 mg) and DBU 
(2L, 0.013 mmol). Flash chromatography (50–67% EtOAc in hexane) gave adduct 320 (24 mg, 0.039 
mmol, 69%, 5.0:1 dr) as a colourless solid; m.p. 114 – 116 °C;  IR (thin film) νmax /cm-1: 2949, 1737, 1687, 
1438, 1394, 1363, 1173, 734, 578; major diastereoisomer - δ H (400 MHz, CDCl3) 8.17 – 8.11 (1 H, m), 
8.02 (1 H, s), 8.00 (1 H, s), 7.63 (1 H, d, J 7.8), 7.50 (1 H, ddd, J 8.5, 7.3, 1.2), 7.39 – 7.27 (6 H, m), 7.22 
(1 H, t, J 7.3), 7.09 (2 H, d, J 7.2), 5.37 (1 H, d, J 17.0), 4.99 (1 H, dd, J 10.4, 5.6), 4.32 (1 H, d, J 16.9), 
3.62 – 3.51 (2 H, m), 3.48 (3 H, s), 3.14 (1 H, d, J 16.2), 2.98 – 2.87 (2 H, m), 2.43 (3 H, s), 2.35 – 2.22 (2 
H, m), 2.10 – 2.01 (2 H, m), 1.89 (1 H, dt, J 13.3, 7.3); δ C (101 MHz, CDCl3) 191.6 (C-20), 171.6 (C-1), 
170.3 (C-16), 166.7 (C-4), 145.1 (C-32), 139.6 (C-Ar), 138.9 (C-Ar), 138.2 (C-11), 136.1 (C-Ar), 129.6 
(C-Ar), 128.9 (C-Ar), 128.3 (C-13), 127.7 (C-Ar), 127.6 (C-Ar), 127.2 (C-Ar), 126.3 (C-12), 124.1 (C-
Ar), 123.4 (C-Ar), 119.4 (C-Ar), 115.5 (C-Ar), 66.4 (C-6), 66.2 (C-3), 51.8 (C-17), 47.0 (C-19), 46.0 (C-
10), 44.5 (C-9), 35.0 (C-18), 32.1 (C-15), 29.8 (C-7), 24.5 (C-8), 21.7 (C-33); minor diastereoisomer - δ H 
(400 MHz, CDCl3) 8.07 – 8.00 (1 H, m, H-Ar), 7.82 – 7.76 (2 H, m, H-Ar), 7.54 (1 H, d, J 7.8, H-Ar), 
7.44 (1 H, ddd, J 8.5, 7.3, 1.2, H-Ar), 7.37 – 7.18 (6 H, m, H-Ar), 7.06 – 7.01 (3 H, m, H-Ar), 5.02 (1 H, 
d, J 16.6, H-10a), 4.86 (1 H, dd, J 10.6, 5.5, H-19), 4.52 (1 H, d, J 16.6, H-10b), 3.74 – 3.67 (1 H, m, H-
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9a), 3.66 – 3.60 (1 H, m, H-9b), 3.34 – 3.21 (4 H, m, H-15, H-17), 2.95 – 2.85 (2 H, m, H-7a, H-15b), 2.52 
– 2.29 (5 H, m, H-18, H-33), 2.13 – 2.05 (2 H, m, H-8), 2.00 – 1.92 (1 H, m, H-7b); δ C (101 MHz, CDCl3) 
192.8 (C-20), 172.5 (C-1), 170.8 (C-16), 165.6 (C-4), 145.2 (C-32), 139.3 (C-Ar), 138.6 (C-Ar), 137.8 (C-
11), 134.4 (C-Ar), 129.6 (C-Ar), 128.9 (C-Ar), 128.4 (C-Ar), 127.8 (C-Ar), 127.7 (C-Ar), 127.5 (C-Ar), 
126.3 (C-Ar), 124.5 (C-Ar), 123.0 (C-Ar), 117.9 (C-Ar), 115.6 (C-Ar), 65.9 (C-3), 65.5 (C-6), 51.7 (C-
17), 51.7 (C-19), 45.6 (C-10), 44.6 (C-9), 35.2 (C-18), 32.1 (C-15), 29.8 (C-7), 24.2 (C-8), 21.6 (C-33); 
m/z 640.2 ([MH]+, 100), 662.2 ([MNa]+, 50); HRMS (ESI/[MNa]+) Calcd. For C35H34N3O7S: 640.2117, 
Found 640.2119. 
Michael–Michael adduct 322 
 
General procedure A was followed with DKP 296 (22 mg, 0.075 mmol), chalcone (50 mg, 0.024 mmol) 
and DBU (2 mg, 2 L, 0.015 mmol). Flash chromatography (30–50% EtOAc in hexane) gave adduct 322 
(31 mg, 0.062 mmol, 83%) as a colourless solid; m.p. 181 – 182 °C;  IR (thin film) νmax /cm-1: 2950, 1690, 
1449, 1383, 1351, 1216, 735, 701; δ H (400 MHz, CDCl3) 7.54 – 7.45 (3 H, m, H-Ar), 7.39 – 7.27 (6 H, 
m, H-Ar), 7.26 – 7.17 (4 H, m, H-Ar), 7.04 – 6.96 (2 H, m, H-Ar), 5.77 (1 H, d, J 16.6, H-11a), 4.65 (1 H, 
d, J 16.6, H-11b), 4.60 (1 H, d, J 6.6, H-19), 3.67 (2 H, app. t, J 6.3, H-10), 3.41 (1 H, d, J 18.8, H-16a), 
3.22 (1 H, d, J 6.6, H-18), 2.88 (1 H, d, J 18.8, m, H-16b), 2.06 – 1.97 (1 H, m, H-8a), 1.83 – 1.74 (2 H, 
m, H-9), 1.72 – 1.59 (2 H, m, H-7), 1.48 – 1.37 (1 H, m, H-8b); δ C (101 MHz, CDCl3) 199.0 (C-20), 170.5 
(C-4), 168.4 (C-1), 136.9 (C-25), 136.8 (C-12), 135.1 (C-21), 134.4 (C-Ar), 129.3 (C-Ar), 129.1 (C- Ar), 
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128.6 (C- Ar), 128.5 (C- Ar), 128.3 (C- Ar), 128.1 (C- Ar), 126.2 (C- Ar), 116.9 (C-17), 62.8 (C-6), 62.6 
(C-3), 57.6 (C-19), 54.6 (C-18), 44.9 (C-11), 39.8 (C-10), 25.4 (C-8), 21.4 (C-9), 18.5 (C-16), 17.0 (C-7); 
m/z 526.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C32H29N3O3Na: 526.2107, Found 526.2101. 
Michael–Michael adduct 323 
 
General procedure A was followed with DKP 296 (22 mg, 0.075 mmol), 314 (approx. 50 mg used crude) 
and DBU (2 mg, 2 L, 0.015 mmol). Flash chromatography (30–50% EtOAc in hexane) gave adduct 323 
(25 mg, 0.044 mmol, 58%, 1.1:1 dr) as a colourless solid; m.p. 159 – 161 °C;  IR (thin film) νmax /cm-1: 
2955, 1739, 1682, 1526, 1444, 1371, 1320, 1265, 1222, 1148, 1130, 732, 699; major diastereoisomer - δ 
H (400 MHz, CDCl3) 7.97 (1 H, dd, J 8.4, 0.7, H-Ar), 7.63 (1 H, app. dt, J 7.9, 0.9, H-Ar), 7.46 (1 H, ddd, 
J 8.5, 7.2, 1.2, H-Ar), 7.38 – 7.26 (4 H, m, H-Ar), 7.19 – 7.13 (3 H, m, H-Ar), 5.34 (1 H, d, J 16.6, H-11a), 
4.68 (1 H, d, J 16.6, H-11b), 4.12 (1 H, dd, J 10.9, 5.6, H-19), 3.66 – 3.52 (2 H, m, H-10), 3.29 (1 H, d, J 
18.4, H-16a), 2.82 (1 H, d, J 18.4, H-16b), 2.64 – 2.53 (1 H, m, H-8a), 2.39 (1 H, dd, J 13.7, 5.6, H-18a), 
2.24 (1 H, dd, J 13.7, 10.9, H-18b), 1.88 – 1.64 (5 H, m, H-7, H-8b, H-9), 1.62 (9 H, s, H-31); δ C (101 
MHz, CDCl3) 189.7 (C-20), 171.8 (C-1), 167.8 (C-4), 149.5 (C-29), 139.0 (C-Ar), 137.1 (C-Ar), 137.0 
(C-12), 129.3 (C-Ar), 128.5 (C-Ar), 128.0 (C-Ar), 127.1 (C-Ar), 126.4 (C-Ar), 123.7 (C-Ar), 123.1 (C-
Ar), 117.7 (C-Ar), 116.8 (C-17), 114.9 (C-Ar), 85.5 (C-30), 63.1 (C-3), 59.0 (C-6), 50.9 (C-19), 44.7 (C-
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11), 40.4 (C-10), 36.4 (C-18), 27.8 (C-31), 27.1 (C-8), 21.8 (C-9), 18.8 (C-16), 18.0 (C-7); m/z 589.2 
([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C33H34N4O5Na: 589.2427, Found 589.2426. 
Indole adduct 326 
 
To a solution of TiCl4 (1.0 M, 120 l, 0.119 mmol) in CH2Cl2 (1.0 mL) cooled to –40 °C was added Me2Zn 
(1.2 M, 100 L, 119 mmol) and the mixture was stirred for 20 mins. To this solution was then added a 
solution of adduct 315 (22 mg, 0.040 mmol) in CH2Cl2 (0.5 mL) and the mixture was then allowed to 
warm to 5 °C over 1.5 hours. The reaction was quenched with water and extracted with EtOAc (3x10 mL) 
and then washed with brine, dried over MgSO4. The residue was then purified by flash chromatography 
(50–55% EtOAc in hexane) to give 326 (17 mg, 0.038 mmol, 94%) as a colourless solid; m.p. 130 – 133 
°C;  IR (thin film) νmax /cm-1: 3313 (br), 2941, 1687, 1649, 1619, 1519, 1497,  1387, 1245, 1141, 732, 699; 
δ H (400 MHz, CDCl3) 9.22 (1 H, s), 7.69 (1 H, d, J 8.2), 7.49 – 7.31 (5 H, m), 7.23 – 7.12 (3 H, m), 7.06 
(1 H, d, J 1.6), 5.26 (1 H, d, J 16.5), 4.83 (1 H, d, J 16.5), 4.21 (1 H, dd, J 10.9, 5.3), 3.73 – 3.59 (2 H, m), 
3.20 (1 H, d, J 18.3), 2.94 (1 H, app. dt, J 13.2, 6.7), 2.82 (1 H, d, J 18.3), 2.53 (1 H, dd, J 13.2, 10.8), 2.16 
– 2.03 (3 H, m), 1.97 – 1.85 (1 H, m); δ C (101 MHz, CDCl3) 189.4, 171.9, 164.4, 138.3, 137.1, 133.7, 
129.4, 128.2, 127.7, 127.3, 126.6, 123.5, 121.6, 116.8, 112.5, 111.9, 65.9, 64.6, 49.6, 44.9, 44.7, 35.9, 29.8, 
24.4, 18.7; m/z 475.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C27H24N4O3Na: 475.1746, Found 
475.1747. 
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Indole adduct 331 
 
LiI (550 mg) was added to a solution of 318 (40 mg, 0.068 mmol) in pyridine (1.0 mL) and the mixture 
was heated to reflux for 1 hour. To the cooled solution was added EtOAc (20 mL) and HCl (2M, 10 mL), 
and extracted with EtOAc (3 × 10 mL). The organic layers were combined, dried over MgSO4 and then 
purified by flash chromatography (60–100% EtOAc in hexane) in give adduct 331 (18 mg, 0.042 mmol, 
61%) as a colourless solid; m.p. 212 – 214 °C; IR (thin film) νmax /cm-1: 3298 (br), 2924, 1651, 1620, 1520, 
1432, 1342, 751, 564; δ H (400 MHz, DMSO) 11.94 (1 H, s, H-27), 8.66 (1 H, t, J 6.0, H-2), 7.61 – 7.58 
(1 H, m, H-Ar), 7.49 – 7.43 (1 H, m, H-Ar), 7.33 – 7.27 (3 H, m, H-Ar), 7.25 – 7.20 (3 H, m, H-Ar), 7.12 
– 7.06 (1 H, m, H-Ar), 7.00 – 6.96 (1 H, m, H-Ar), 4.52 (1 H, dd, J 15.2, 6.6, H-10a), 4.19 (1 H, dd, J 15.2, 
5.3, H-10b), 3.80 – 3.71 (1 H, m, H-9a), 3.62 – 3.51 (1 H, m, H-9b), 3.22 (1 H, d, J 16.6, H-16a), 2.91 (1 
H, dd, J 16.7, 2.8, H-16b), 2.29 (1 H, dd, J 11.7, 5.9, H-7a), 2.10 – 1.95 (2 H, m, H-7b, H-8a), 1.77 – 1.60 
(4 H, m, H-8b, H-15); δ C (101 MHz, DMSO) 188.3 (C-18), 173.0 (C-1), 163.8 (C-4), 140.2 (C-Ar), 140.0 
(C-3), 139.0 (C-Ar), 134.1 (C-Ar), 130.5 (C-17), 128.6 (C-Ar), 127.3 (C-Ar), 127.1 (C-Ar), 126.7 (C-Ar), 
123.5 (C-Ar), 121.0 (C-Ar), 113.3 (C-Ar), 112.3 (C-Ar), 68.0 (C-6), 45.8 (C-9), 43.1 (C-10), 38.9 (C-7), 
36.4 (C-16), 22.0 (C-8), 14.2 (C-15); m/z 450.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For 
C26H25N3O4Na: 450.1794, Found 450.1795. 
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Indole adduct 333 
 
A solution of indole adduct 318 (10 mg, 0.017 mmol) and LiI (60 mg, 0.45 mmol) in EtOAc (1.0 mL) 
was refluxed for 1 hour. Reaction mixture was diluted with EtOAc (10 mL) and then washed with 1M 
HCl (aq, 10 mL × 3), dried over MgSO4 and evaporated under reduced pressure. The residue was then 
purified by flash chromatography (80% EtOAc in hexane to EtOAc) to give indole adduct 333 as a 
colourless gum; IR (thin film) νmax /cm-1: 3316 (br), 2948, 1738, 1687, 1651, 1518, 1393, 1199, 1174, 
1142; δ H (400 MHz, CDCl3) 8.94 (1 H, s, H-29), 7.68 – 7.62 (1 H, m, H-27), 7.42 – 7.31 (5 H, m, H-13, 
H-14, H-24), 7.21 – 7.12 (3 H, m, H-12, H-25), 6.74 (1 H, d, J 1.8, H-22), 4.96 (1 H, d, J 16.3, H-10a), 
4.86 (1 H, d, J 16.3, H-10b), 4.36 (1 H, dd, J 10.6, 5.4, H-19), 3.74 – 3.59 (2 H, m, H-9), 3.53 (3 H, s, H-
17), 3.18 (1 H, d, J 18.3, H-15a), 2.93 (1 H, app. dt, J 13.5, 7.0, H-7a), 2.84 (1 H, d, J 18.3, H-15b), 2.39 
(1 H, dd, J 13.1, 10.7, H-18a), 2.13 – 2.04 (3 H, m, H-8, H-18b), 1.92 – 1.84 (1 H, m, H-7b); δ C (101 
MHz, CDCl3) 190.3 (C-20), 172.3 (C-1), 170.8 (C-16), 165.4 (C-4), 138.1 (C-11), 137.9 (C-23), 134.5 
(C-21), 129.1 (C-13), 127.7 (C-Ar), 127.4 (C-Ar), 127.3 (C-Ar), 127.0 (C-12), 123.3 (C-27), 121.4 (C-
Ar), 112.3 (C-22), 110.9 (C-24), 66.2 (C-3), 65.6 (C-6), 52.0 (C-17), 48.6 (C-19), 45.7 (C-10), 44.6 (C-9), 
35.7 (C-18), 33.0 (C-15), 29.8 (C-7), 24.2 (C-8); m/z 508.2 ([MNa]+, 100), 486.2 ([MH]+, 60); HRMS 
(ESI/[MNa]+) Calcd. For C28H28N3O5: 486.2029, Found 486.2032. 
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Indole acid 334 
 
A solution of indole adduct 318 (7 mg, 0.012 mmol) and LiI (60 mg, 0.45 mmol) in EtOAc (0.5 mL) was 
refluxed for 16 hours. Reaction mixture was diluted with EtOAc (10 mL) and then washed with 1M HCl 
(aq, 10 mL × 3), dried over MgSO4 and evaporated under reduced pressure. The residue was then purified 
by flash chromatography (80% EtOAc in hexane to 5% MeOH/0.05% HCOOH in EtOAc) to give indole 
acid 334 (3 mg, 6.4 mol, 53%) as a colourless gum; IR (thin film) νmax /cm-1: 3309 (br), 2925, 1730, 
1678, 1649, 1519, 1398, 1170, 1140, 733, 699; δ H (400 MHz, CDCl3) 9.14 (1 H, s), 7.61 – 7.57 (1 H, m), 
7.47 – 7.41 (4 H, m), 7.38 – 7.31 (2 H, m), 7.26 – 7.25 (1 H, m), 7.17 – 7.12 (1 H, m), 6.37 (1 H, d, J 1.8), 
5.31 (1 H, d, J 15.8), 4.56 (1 H, d, J 15.8), 3.80 (1 H, dd, J 10.3, 5.2), 3.74 – 3.66 (1 H, m), 3.65 – 3.58 (1 
H, m), 3.07 (1 H, d, J 16.5), 2.95 (1 H, dt, J 13.5, 6.9), 2.88 (1 H, d, J 16.5), 2.28 (1 H, dd, J 13.2, 10.4), 
2.15 – 2.03 (3 H, m), 2.02 – 1.92 (1 H, m); δ C (101 MHz, CDCl3) 189.6, 172.0, 170.5, 167.2, 138.3, 138.1, 
134.5, 129.2, 128.2, 128.1, 127.7, 127.2, 123.4, 121.5, 112.4, 111.7, 77.3, 77.0, 76.7, 67.2, 66.3, 50.3, 45.2, 
45.1, 36.0, 35.3, 29.6, 24.1; m/z (ESI-) 470.2 (M-H, 100); HRMS (ESI/[M-H]-) Calcd. For C27H24N3O5: 
470.1716 found 470.1708. 
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Indole Michael adduct 351 
 
General procedure A was followed with DKP 295 (49 mg, 0.16 mmol), 311 (75 mg, 0.44 mmol) and 
Qn:Qd (1:1, 15 mg, 0.031 mmol) as base. Flash chromatography (40–50% EtOAc in hexane) gave 
Michael adduct 351 (78 mg, 0.16 mmol, 99%) as a colourless solid; m.p. 160 – 162 °C; IR (thin film) νmax 
/ cm-1: 1701, 1664, 1606, 1512, 1440, 1364, 1247, 1176, 910, 728; δ H (400 MHz, CDCl3) 7.71 (1 H, d, J 
8.1, H-Ar), 7.46 – 7.34 (2 H, m, H-Ar), 7.25 – 7.20 (2 H, m, H-12), 7.20 – 7.14 (2 H, m, H-22, H-Ar), 6.87 
– 6.78 (2 H, m, H-13), 5.91 (1 H, s, H-16), 5.56 (1 H, d, J 15.7, H-10a), 5.20 (1 H, d, J 15.7, H-10b), 4.06 
(3 H, s, H-29), 3.88 – 3.75 (1 H, m, H-9a), 3.69 (4 H, s, H-15, H-9b), 3.02 – 2.83 (2 H, m, H-19), 2.35 – 
2.23 (3 H, m, H18a, H-7), 2.21 – 2.02 (3 H, m, H-8, H-18b); δ C (101 MHz, CDCl3) 190.8 (C-20), 168.8 
(C-1), 159.3 (C-14), 156.0 (C-4), 144.7 (C-3), 140.3 (C-28), 133.9 (C-21), 129.1 (C-12), 126.7 (C-11), 
126.3 (C-Ar), 125.7 (C-23), 123.1 (C-Ar), 121.0 (C-Ar), 115.9 (C-17), 114.3 (C-13), 111.7 (C-Ar), 110.4 
(C-Ar), 84.0 (C-16), 67.5 (C-6), 55.2 (C-15), 46.3 (C-10), 45.7 (C-9), 34.1 (C-19), 33.9 (C-7), 32.7 (C-
18), 32.2 (C-29), 20.2 (C-8); m/z (ESI) 497.22 (MH+, 100), 389.16 (25); HRMS (ESI/[MH]+) Calcd. For 
C29H29N4O4: 497.2189 found 497.2191. 
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Indole Michael adduct 353 
 
General procedure A was followed with DKP 295 (60 mg, 0.19 mmol), 314 (approx. 131 mg, 0.48 mmol) 
and Qn:Qd (1:1, 15 mg, 0.038 mmol) as base. Once the reaction was complete by TLC, TFA (0.2 mL) 
was added and the reaction mixture was stirred for 2 hours at room temperature. The solvent was then 
removed under reduced pressure. Flash chromatography (40–50% EtOAc in hexane) gave deprotected 
Michael adduct 353 (66 mg, 0.14 mmol, 72%.) as a colourless gum;  IR (thin film) νmax /cm-1: 3315 (br), 
2965, 2211, 1702, 1673, 1605, 1354, 1175, 735; δ H (400 MHz, CDCl3) 9.16 (1 H, s), 7.72 – 7.65 (1 H, 
m), 7.45 – 7.35 (2 H, m), 7.20 – 7.11 (3 H, m), 7.09 – 7.02 (1 H, m), 6.95 – 6.86 (2 H, m), 5.19 (1 H, d, J 
16.3), 4.78 (1 H, d, J 16.3), 4.18 (1 H, dd, J 10.8, 5.3), 3.82 (3 H, s), 3.66 (2 H, qt, J 7.6, 3.3), 3.18 (1 H, d, 
J 18.3), 2.94 (1 H, dt, J 13.3, 6.7), 2.86 (1 H, d, J 18.2), 2.50 (1 H, dd, J 13.2, 10.9), 2.14 – 2.03 (3 H, m), 
1.90 (1 H, dt, J 13.3, 7.4), 1.36 – 1.21 (1 H, m); δ C (101 MHz, CDCl3) 189.5, 172.0, 164.6, 159.6, 138.4, 
133.9, 129.1, 128.1, 127.8, 127.5, 123.6, 121.7, 117.0, 114.9, 112.6, 112.0, 66.1, 64.8, 55.5, 49.7, 44.8, 
44.6, 36.0, 29.9, 24.5, 18.8; m/z 505.2 ([MNa]+, 100); HRMS (ESI/[MNa]+) Calcd. For C28H26N4O4Na: 
505.1852, Found 505.1851.  
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Appendix 
Select NMR Spectra
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Select HPLC Traces 
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X-ray Data 
 
Identification code 151 
Empirical formula C23H22N2O4 
Formula weight 390.44 
Temperature/K N/A 
Crystal system orthorhombic 
Space group P212121 
a/Å 5.84241(14) 
b/Å 13.0771(2) 
c/Å 24.8049(5) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å3 1895.14(7) 
Z 4 
ρcalcg/cm3 1.3683 
μ/mm-1 0.769 
F(000) 826.7 
Crystal size/mm3 0.3385 × 0.0368 × 0.0229 
Radiation Cu Kα (λ = 1.54184) 
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2Θ range for data collection/° 7.12 to 140.06 
Index ranges -5 ≤ h ≤ 6, -16 ≤ k ≤ 16, -31 ≤ l ≤ 30 
Reflections collected 17969 
Independent reflections 3553 [Rint = 0.0489, Rsigma = 0.0348] 
Data/restraints/parameters 3553/0/261 
Goodness-of-fit on F2 1.114 
Final R indexes [I>=2σ (I)] R1 = 0.0403, wR2 = 0.1015 
Final R indexes [all data] R1 = 0.0470, wR2 = 0.1038 
Largest diff. peak/hole / e Å-3 0.34/-0.31 
Flack parameter 0.0(2) 
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Identification code 159 
Empirical formula C30.5H30N2O4.5 
Formula weight 496.56 
Temperature/K 100.00(10) 
Crystal system orthorhombic 
Space group P212121 
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a/Å 8.73850(10) 
b/Å 8.77985(12) 
c/Å 65.4284(6) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å3 5019.84(10) 
Z 8 
ρcalcg/cm3 1.314 
μ/mm-1 0.713 
F(000) 2104.0 
Crystal size/mm3 0.3083 × 0.2449 × 0.1824 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 12.946 to 140.118 
Index ranges -10 ≤ h ≤ 10, -10 ≤ k ≤ 10, -79 ≤ l ≤ 79 
Reflections collected 72415 
Independent reflections 9525 [Rint = 0.0465, Rsigma = 0.0234] 
Data/restraints/parameters 9525/13/715 
Goodness-of-fit on F2 1.123 
Final R indexes [I>=2σ (I)] R1 = 0.0490, wR2 = 0.1100 
Final R indexes [all data] R1 = 0.0496, wR2 = 0.1104 
Largest diff. peak/hole / e Å-3 0.24/-0.24 
Flack parameter 0.01(6) 
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Identification code 209 
Empirical formula C24H25N3O4 
Formula weight 419.47 
Temperature/K 100.01(10) 
Crystal system monoclinic 
Space group P21 
a/Å 10.50637(13) 
b/Å 9.14301(12) 
c/Å 11.61629(15) 
α/° 90 
β/° 110.5829(14) 
γ/° 90 
Volume/Å3 1044.63(3) 
Z 2 
ρcalcg/cm3 1.334 
μ/mm-1 0.748 
F(000) 444.0 
Crystal size/mm3 0.2137 × 0.1306 × 0.0679 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 12.648 to 144.19 
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Index ranges -12 ≤ h ≤ 12, -10 ≤ k ≤ 11, -14 ≤ l ≤ 14 
Reflections collected 36789 
Independent reflections 4014 [Rint = 0.0302, Rsigma = 0.0145] 
Data/restraints/parameters 4014/1/289 
Goodness-of-fit on F2 1.103 
Final R indexes [I>=2σ (I)] R1 = 0.0308, wR2 = 0.0818 
Final R indexes [all data] R1 = 0.0321, wR2 = 0.0829 
Largest diff. peak/hole / e Å-3 0.20/-0.16 
Flack parameter -0.01(5) 
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